activity_comment	activity_id	assay_chembl_id	assay_description	assay_type	canonical_smiles	data_validity_comment	molecule_chembl_id	relation	standard_type	standard_units	standard_value	target_chembl_id	target_organism	type	units	value
	1666801	CHEMBL864602	Binding affinity to Tec SH3 domain	B	c1c[nH]c(CNc2ccc3ccccc3n2)c1	Outside typical range	CHEMBL199638	=	Kd	nM	285000.0	CHEMBL4246	Homo sapiens	Kd	uM	285.0
	1666801	CHEMBL864602	Binding affinity to Tec SH3 domain	B	c1c[nH]c(CNc2ccc3ccccc3n2)c1	Outside typical range	CHEMBL199638	=	Kd	nM	285000.0	CHEMBL4246	Homo sapiens	Kd	uM	285.0
	1666802	CHEMBL864602	Binding affinity to Tec SH3 domain	B	Oc1ccc(CNc2ccc3ccccc3n2)cc1	Outside typical range	CHEMBL202984	=	Kd	nM	292000.0	CHEMBL4246	Homo sapiens	Kd	uM	292.0
	1666803	CHEMBL864602	Binding affinity to Tec SH3 domain	B	Oc1cccc(CNc2ccc3ccccc3n2)c1	Outside typical range	CHEMBL382999	=	Kd	nM	234000.0	CHEMBL4246	Homo sapiens	Kd	uM	234.0
	1666804	CHEMBL864602	Binding affinity to Tec SH3 domain	B	Fc1cccc(CNc2ccc3ccccc3n2)c1	Outside typical range	CHEMBL201328	=	Kd	nM	177000.0	CHEMBL4246	Homo sapiens	Kd	uM	177.0
	1666805	CHEMBL864602	Binding affinity to Tec SH3 domain	B	Fc1ccccc1CNc1ccc2ccccc2n1	Outside typical range	CHEMBL381361	=	Kd	nM	208000.0	CHEMBL4246	Homo sapiens	Kd	uM	208.0
	1666806	CHEMBL864602	Binding affinity to Tec SH3 domain	B	c1ccc(CNc2ccc3ccccc3n2)cc1	Outside typical range	CHEMBL201720	=	Kd	nM	193000.0	CHEMBL4246	Homo sapiens	Kd	uM	193.0
	1734753	CHEMBL865399	Inhibition of Tec	B	COc1cc(C)c(Sc2cnc(NC(=O)c3ccc(CNC(C)C(C)(C)C)cc3)s2)cc1C(=O)N1CCN(C(C)=O)CC1		CHEMBL209148	=	IC50	nM	17000.0	CHEMBL4246	Homo sapiens	IC50	uM	17.0
	1968061	CHEMBL896372	Inhibition of TEC	B	CN(C(=O)C1CCCCC1)c1ccc2c(c1)nc(NC(=O)c1cccs1)n2CCCN		CHEMBL233338	=	IC50	nM	22000.0	CHEMBL4246	Homo sapiens	IC50	uM	22.0
	2000782	CHEMBL901557	Inhibition of TEC at 10 nM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCF)CC2)n1		CHEMBL240158	=	Inhibition	%	98.1	CHEMBL4246	Homo sapiens	Inhibition	%	98.1
	2000803	CHEMBL901557	Inhibition of TEC at 10 nM	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Inhibition	%	92.5	CHEMBL4246	Homo sapiens	Inhibition	%	92.5
Active	2150085	CHEMBL923534	Binding affinity to Tec kinase from human K562 cells extract by LC-MSMS	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421		Activity			CHEMBL4246	Homo sapiens	Activity		
	2150089	CHEMBL924605	Inhibition of recombinant Tec kinase	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	IC50	nM	297.0	CHEMBL4246	Homo sapiens	IC50	nM	297.0
	2468094	CHEMBL992550	Inhibition of Tec kinase	B	CN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL460824	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	2468107	CHEMBL992550	Inhibition of Tec kinase	B	CCN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(C#N)cc1)n2CCC(N)=O		CHEMBL462301	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	2468108	CHEMBL992550	Inhibition of Tec kinase	B	CN(C(=O)c1ccccc1)c1ccc2c(c1)nc(NC(=O)c1ccc(Cl)cc1)n2CCC(N)=O		CHEMBL485203	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	2470375	CHEMBL981757	Inhibition of TEC at 3 uM	B	CN(C)CCOc1cc(-c2cn[nH]c2)ccc1NC(=O)C1COc2ccccc2O1		CHEMBL521179	<	Inhibition	%	10.0	CHEMBL4246	Homo sapiens	INH	%	10.0
	2904175	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904176	CHEMBL1061929	Binding constant for TEC kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904177	CHEMBL1061929	Binding constant for TEC kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904178	CHEMBL1061929	Binding constant for TEC kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904179	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904180	CHEMBL1061929	Binding constant for TEC kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904181	CHEMBL1061929	Binding constant for TEC kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904182	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904183	CHEMBL1061929	Binding constant for TEC kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1500.0	CHEMBL4246	Homo sapiens	Kd	nM	1500.0
	2904184	CHEMBL1061929	Binding constant for TEC kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904185	CHEMBL1061929	Binding constant for TEC kinase domain	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904186	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	13.0	CHEMBL4246	Homo sapiens	Kd	nM	13.0
	2904187	CHEMBL1061929	Binding constant for TEC kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904188	CHEMBL1061929	Binding constant for TEC kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904189	CHEMBL1061929	Binding constant for TEC kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904190	CHEMBL1061929	Binding constant for TEC kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904191	CHEMBL1061929	Binding constant for TEC kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904192	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904193	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904194	CHEMBL1061929	Binding constant for TEC kinase domain	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Kd	nM	1000.0	CHEMBL4246	Homo sapiens	Kd	nM	1000.0
	2904195	CHEMBL1061929	Binding constant for TEC kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904196	CHEMBL1061929	Binding constant for TEC kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904197	CHEMBL1061929	Binding constant for TEC kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904198	CHEMBL1061929	Binding constant for TEC kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	730.0	CHEMBL4246	Homo sapiens	Kd	nM	730.0
	2904199	CHEMBL1061929	Binding constant for TEC kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904200	CHEMBL1061929	Binding constant for TEC kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904201	CHEMBL1061929	Binding constant for TEC kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904202	CHEMBL1061929	Binding constant for TEC kinase domain	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904203	CHEMBL1061929	Binding constant for TEC kinase domain	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904204	CHEMBL1061929	Binding constant for TEC kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904205	CHEMBL1061929	Binding constant for TEC kinase domain	B	NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL440084	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904206	CHEMBL1061929	Binding constant for TEC kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904207	CHEMBL1061929	Binding constant for TEC kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1300.0	CHEMBL4246	Homo sapiens	Kd	nM	1300.0
	2904208	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904209	CHEMBL1061929	Binding constant for TEC kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904210	CHEMBL1061929	Binding constant for TEC kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904211	CHEMBL1061929	Binding constant for TEC kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2904212	CHEMBL1061929	Binding constant for TEC kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	2922014	CHEMBL1059373	Inhibition of TEC assessed as enzyme activity at 1 uM relative to untreated control	B	Cc1ccc2c(Nc3ccc(Cl)cc3)nccc2c1Nc1ncccc1-c1ncnc2[nH]cnc12.Cl.Cl.Cl		CHEMBL3215582	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	2928499	CHEMBL1045667	Binding affinity to TEC assessed as percentage of kinase remaining bound to the bead at 1 uM by T7 phage display based binding assay	B	COc1ccccc1-n1c(-c2cc(O)ccc2C)cn2c3c(=O)[nH]c(=O)n(C)c3nc12		CHEMBL566515	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	3052495	CHEMBL1072533	Residual activity of TEC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	96.0	CHEMBL4246	Homo sapiens	Residual activity	%	96.0
	3052747	CHEMBL1043826	Residual activity of TEC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	90.0	CHEMBL4246	Homo sapiens	Residual activity	%	90.0
	3054056	CHEMBL1071985	Residual activity of TEC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3F)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL604483	=	Residual activity	%	25.0	CHEMBL4246	Homo sapiens	Residual activity	%	25.0
	3055343	CHEMBL1072533	Residual activity of TEC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	105.0	CHEMBL4246	Homo sapiens	Residual activity	%	105.0
	3055595	CHEMBL1043826	Residual activity of TEC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	96.0	CHEMBL4246	Homo sapiens	Residual activity	%	96.0
	3056900	CHEMBL1071985	Residual activity of TEC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCN(C)CC1		CHEMBL595143	=	Residual activity	%	61.0	CHEMBL4246	Homo sapiens	Residual activity	%	61.0
	3057152	CHEMBL1072533	Residual activity of TEC at 0.1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	98.0	CHEMBL4246	Homo sapiens	Residual activity	%	98.0
	3058472	CHEMBL1043826	Residual activity of TEC at 1 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	93.0	CHEMBL4246	Homo sapiens	Residual activity	%	93.0
	3059756	CHEMBL1071985	Residual activity of TEC at 10 uM by microplate scintillation counting	B	COc1cc2c(Oc3ccc(-c4nc5ccccc5s4)cc3)ncnc2cc1OCCCN1CCCC1		CHEMBL595373	=	Residual activity	%	45.0	CHEMBL4246	Homo sapiens	Residual activity	%	45.0
	3213859	CHEMBL1111275	Inhibition of TEC at 5 uM	B	O=C(Nc1ccccc1Cl)c1cnc2ccc(C3CCNCC3)cn12.O=C(O)C(=O)O		CHEMBL1077739	=	Inhibition	%	101.0	CHEMBL4246	Homo sapiens	INH	%	101.0
	3316811	CHEMBL1120370	Inhibition of TEC at 1 uM	B	O=C(Nc1cccc(-n2ccc3c(NC(=O)c4ccccc4)nccc32)c1)c1ccc(N2CCOCC2)c(C(F)(F)F)c1		CHEMBL1084450	=	Inhibition	%	14.0	CHEMBL4246	Homo sapiens	INH	%	14.0
	3332172	CHEMBL1168124	Inhibition of TEC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(F)ccc3F)CCN4)cn2)CC1		CHEMBL1165499	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3333587	CHEMBL1168124	Inhibition of TEC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)cn2)CC1		CHEMBL1164180	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3334992	CHEMBL1168124	Inhibition of TEC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3Cl)CCN4)cn2)CC1		CHEMBL1164181	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3336412	CHEMBL1168124	Inhibition of TEC at 1 uM	B	CN1CCN(c2ccc(-c3cnc4c(c3)N(Cc3c(F)ccc(F)c3Cl)CCN4)cn2)CC1		CHEMBL1164265	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3341954	CHEMBL1168124	Inhibition of TEC at 1 uM	B	FC(F)(F)c1ccc(Cl)cc1CN1CCNc2ncc(-c3ccnc(N4CCNCC4)c3)cc21		CHEMBL1163566	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3343401	CHEMBL1168124	Inhibition of TEC at 1 uM	B	CC(=O)N1CCN(c2cc(-c3cnc4c(c3)N(Cc3cc(Cl)ccc3C(F)(F)F)CCN4)ccn2)CC1		CHEMBL1163565	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	3351778	CHEMBL1175092	Inhibition of TEC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cnc5[nH]ccc5c4)c3)cc2C(F)(F)F)CC1		CHEMBL1170139	=	Inhibition	%	0.1	CHEMBL4246	Homo sapiens	INH	%	0.1
	3358830	CHEMBL1175092	Inhibition of TEC at 10 uM	B	CCN1CCN(Cc2ccc(NC(=O)c3ccc(C)c(C#Cc4cccnc4)c3)cc2C(F)(F)F)CC1		CHEMBL1171523	=	Inhibition	%	3.7	CHEMBL4246	Homo sapiens	INH	%	3.7
	3446207	CHEMBL1244347	Inhibition of TEC	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	IC50	nM	282.0	CHEMBL4246	Homo sapiens	IC50	nM	282.0
	3448645	CHEMBL1244998	Binding affinity to TEC	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	3448802	CHEMBL1244998	Binding affinity to TEC	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1200.0	CHEMBL4246	Homo sapiens	Kd	nM	1200.0
	3449871	CHEMBL1244998	Binding affinity to TEC	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	3450256	CHEMBL1244998	Binding affinity to TEC	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	3450418	CHEMBL1244998	Binding affinity to TEC	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	3450875	CHEMBL1244998	Binding affinity to TEC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	3451163	CHEMBL1244998	Binding affinity to TEC	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL1240703	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	uM	10.0
	6341136	CHEMBL1826993	Activity of TEC kinase at 1 uM	B	CC(=O)Nc1cn2nc(-c3cnc(Cl)c(NS(=O)(=O)c4ccc(F)cc4)c3)ccc2n1		CHEMBL1822054	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	7567303	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7567762	CHEMBL1908605	Binding constant for TEC kinase domain	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7568233	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7568259	CHEMBL1908605	Binding constant for TEC kinase domain	B	CSc1cccc(Nc2ncc3cc(-c4c(Cl)cccc4Cl)c(=O)n(C)c3n2)c1		CHEMBL386051	=	Kd	nM	600.0	CHEMBL4246	Homo sapiens	Kd	nM	600.0
	7568691	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7569276	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7569736	CHEMBL1908605	Binding constant for TEC kinase domain	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7570229	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(S(=O)(=O)Cc4c(Cl)cccc4Cl)cc32)c(C)c1C(=O)N1CCC[C@@H]1CN1CCCC1		CHEMBL450786	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7570656	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7571252	CHEMBL1908605	Binding constant for TEC kinase domain	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7571743	CHEMBL1908605	Binding constant for TEC kinase domain	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7572206	CHEMBL1908605	Binding constant for TEC kinase domain	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7572622	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncc(Cl)c(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL509032	=	Kd	nM	180.0	CHEMBL4246	Homo sapiens	Kd	nM	180.0
	7573248	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	13.0	CHEMBL4246	Homo sapiens	Kd	nM	13.0
	7573724	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN(C)CC(=O)N1CCC(c2ccc(NC(=O)c3nc(C#N)c[nH]3)c(C3=CCCCC3)c2)CC1.Cl		CHEMBL1908395	=	Kd	nM	2000.0	CHEMBL4246	Homo sapiens	Kd	nM	2000.0
	7574193	CHEMBL1908605	Binding constant for TEC kinase domain	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7574601	CHEMBL1908605	Binding constant for TEC kinase domain	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7574769	CHEMBL1908605	Binding constant for TEC kinase domain	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7575230	CHEMBL1908605	Binding constant for TEC kinase domain	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7575701	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc(Oc2ccnc3cc(OC)c(OC)cc23)ccc1NC(=O)NC(C)c1nccs1		CHEMBL1908396	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7576166	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(Cl)cc23)c1F		CHEMBL1230020	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7576574	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7576743	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7577202	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	=	Kd	nM	310.0	CHEMBL4246	Homo sapiens	Kd	nM	310.0
	7577680	CHEMBL1908605	Binding constant for TEC kinase domain	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7578150	CHEMBL1908605	Binding constant for TEC kinase domain	B	CC(C)n1nc(-c2cc3cc(O)ccc3[nH]2)c2c(N)ncnc21		CHEMBL1241674	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7578555	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7578751	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1n[nH]c2ccc(-c3cncc(OC[C@@H](N)Cc4ccccc4)c3)cc12		CHEMBL379218	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7579125	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)Nc2ccc(OCCN3CCOCC3)c3ccccc23)cc1		CHEMBL103667	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7579575	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7580049	CHEMBL1908605	Binding constant for TEC kinase domain	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7580518	CHEMBL1908605	Binding constant for TEC kinase domain	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7581109	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7581494	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc2nc(NCCN)c3ncc(C)n3c2c1		CHEMBL249697	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7581939	CHEMBL1908605	Binding constant for TEC kinase domain	B	OCCn1cc(-c2ccc3c(c2)CC/C3=N\O)c(-c2ccncc2)n1		CHEMBL525191	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7582410	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7582832	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	=	Kd	nM	8700.0	CHEMBL4246	Homo sapiens	Kd	nM	8700.0
	7583455	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7583852	CHEMBL1908605	Binding constant for TEC kinase domain	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7584297	CHEMBL1908605	Binding constant for TEC kinase domain	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7584788	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	=	Kd	nM	1600.0	CHEMBL4246	Homo sapiens	Kd	nM	1600.0
	7585192	CHEMBL1908605	Binding constant for TEC kinase domain	B	O=c1ncn2nc(Sc3ccc(F)cc3F)ccc2c1-c1c(Cl)cccc1Cl		CHEMBL119385	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7585785	CHEMBL1908605	Binding constant for TEC kinase domain	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7586193	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7586639	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7586668	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7587122	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7587746	CHEMBL1908605	Binding constant for TEC kinase domain	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7588165	CHEMBL1908605	Binding constant for TEC kinase domain	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	=	Kd	nM	1200.0	CHEMBL4246	Homo sapiens	Kd	nM	1200.0
	7588647	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1c(Cl)cc2c([nH]c3cnccc32)c1NC(=O)c1cccnc1C		CHEMBL608154	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7589098	CHEMBL1908605	Binding constant for TEC kinase domain	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7590160	CHEMBL1908605	Binding constant for TEC kinase domain	B	CNC(=O)c1c(F)cccc1Nc1nc(Nc2cc3c(cc2OC)CCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL464552	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7590634	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7591085	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7591242	CHEMBL1908605	Binding constant for TEC kinase domain	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7591664	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7592136	CHEMBL1908605	Binding constant for TEC kinase domain	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7592609	CHEMBL1908605	Binding constant for TEC kinase domain	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	730.0	CHEMBL4246	Homo sapiens	Kd	nM	730.0
	7593062	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	=	Kd	nM	3200.0	CHEMBL4246	Homo sapiens	Kd	nM	3200.0
	7593209	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCN1CCN(Cc2ccc(NC(=O)Nc3ccc(Oc4cc(NC)ncn4)cc3)cc2C(F)(F)F)CC1		CHEMBL574738	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7593644	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7594116	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7594589	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7595041	CHEMBL1908605	Binding constant for TEC kinase domain	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7595177	CHEMBL1908605	Binding constant for TEC kinase domain	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7595621	CHEMBL1908605	Binding constant for TEC kinase domain	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	1500.0	CHEMBL4246	Homo sapiens	Kd	nM	1500.0
	7596095	CHEMBL1908605	Binding constant for TEC kinase domain	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7596566	CHEMBL1908605	Binding constant for TEC kinase domain	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7597149	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7597602	CHEMBL1908605	Binding constant for TEC kinase domain	B	O=C(NOCC1CC1)c1ccc(F)c(F)c1Nc1ccc(I)cc1Cl		CHEMBL105442	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7598075	CHEMBL1908605	Binding constant for TEC kinase domain	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	10000.0	CHEMBL4246	Homo sapiens	Kd	nM	10000.0
	7598545	CHEMBL1908605	Binding constant for TEC kinase domain	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Kd	nM	1300.0	CHEMBL4246	Homo sapiens	Kd	nM	1300.0
	7931137	CHEMBL1919474	Inhibition of TEC relative to control	B	Cc1ccccc1Nc1nc2cc(F)c(N(C)C(=O)/C=C/CN(C)C)cc2n2cncc12		CHEMBL1916891	=	Inhibition	%	42.0	CHEMBL4246	Homo sapiens	INH	%	42.0
	7982600	CHEMBL1936983	Inhibition of TEC at 10 uM after 1 hr by competitive binding assay	B	CNC(=O)NC[C@H]1O[C@@H](n2cnc3c(NC(=O)Nc4ccccc4)ncnc32)[C@H](O)[C@@H]1O		CHEMBL1079596	=	Inhibition	%	37.0	CHEMBL4246	Homo sapiens	INH	%	37.0
	7996729	CHEMBL1944381	Inhibition of TEC at 1 uM	B	CNC(=O)c1cccc(F)c1Nc1nc(Nc2ccc3c(c2)NC(=O)[C@H](NC(=O)N2CCCC2)CC3(C)C)ncc1Cl		CHEMBL1939491	=	Inhibition	%	98.0	CHEMBL4246	Homo sapiens	INH	%	98.0
	8061377	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	-0.99	CHEMBL4246	Homo sapiens	Inhibition	%	-0.99
	8061601	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3Cc2ccccc2)ccc1O		CHEMBL1789962	=	Inhibition	%	16.35	CHEMBL4246	Homo sapiens	Inhibition	%	16.35
	8061708	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.59	CHEMBL4246	Homo sapiens	Inhibition	%	3.59
	8062123	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	2.46	CHEMBL4246	Homo sapiens	Inhibition	%	2.46
	8062239	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	9.92	CHEMBL4246	Homo sapiens	Inhibition	%	9.92
	8062463	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	4.08	CHEMBL4246	Homo sapiens	Inhibition	%	4.08
	8062625	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	1.24	CHEMBL4246	Homo sapiens	Inhibition	%	1.24
	8062947	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	3.46	CHEMBL4246	Homo sapiens	Inhibition	%	3.46
	8063079	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	6.38	CHEMBL4246	Homo sapiens	Inhibition	%	6.38
	8063470	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.4	CHEMBL4246	Homo sapiens	Inhibition	%	1.4
	8063578	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(Nc3ccccc3)n2)CC1		CHEMBL318892	=	Inhibition	%	3.4	CHEMBL4246	Homo sapiens	Inhibition	%	3.4
	8063802	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	3.16	CHEMBL4246	Homo sapiens	Inhibition	%	3.16
	8063984	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cn1cc(C=C2C(=O)Nc3cccnc32)c2ccccc21		CHEMBL1516890	=	Inhibition	%	8.75	CHEMBL4246	Homo sapiens	Inhibition	%	8.75
	8064323	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cn1c(-c2nonc2N)nc2cnccc21		CHEMBL188048	=	Inhibition	%	3.99	CHEMBL4246	Homo sapiens	Inhibition	%	3.99
	8064533	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	2.88	CHEMBL4246	Homo sapiens	Inhibition	%	2.88
	8064671	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.NCc1ccc(-c2nc(-c3ccc(Cl)c(O)c3)c(-c3ccncc3)[nH]2)cc1		CHEMBL1909412	=	Inhibition	%	33.04	CHEMBL4246	Homo sapiens	Inhibition	%	33.04
	8064895	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	2.91	CHEMBL4246	Homo sapiens	Inhibition	%	2.91
	8065061	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(Cl)c(C(F)(F)F)c3)n2)cc1		CHEMBL188794	=	Inhibition	%	1.86	CHEMBL4246	Homo sapiens	Inhibition	%	1.86
	8065401	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL1909378	=	Inhibition	%	2.63	CHEMBL4246	Homo sapiens	Inhibition	%	2.63
	8065576	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	4.21	CHEMBL4246	Homo sapiens	Inhibition	%	4.21
	8065915	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	3.07	CHEMBL4246	Homo sapiens	Inhibition	%	3.07
	8066125	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@@H]1CN[C@@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL466412	=	Inhibition	%	6.39	CHEMBL4246	Homo sapiens	Inhibition	%	6.39
	8066485	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(Nc2ncc(-c3ccccc3)o2)cc1OC.Cl		CHEMBL1794060	=	Inhibition	%	9.41	CHEMBL4246	Homo sapiens	Inhibition	%	9.41
	8066651	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	0.87	CHEMBL4246	Homo sapiens	Inhibition	%	0.87
	8066999	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	4.37	CHEMBL4246	Homo sapiens	Inhibition	%	4.37
	8067174	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)c1		CHEMBL362155	=	Inhibition	%	15.53	CHEMBL4246	Homo sapiens	Inhibition	%	15.53
	8067398	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	3.65	CHEMBL4246	Homo sapiens	Inhibition	%	3.65
	8067519	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(N(C)C)cc4)c3)cc21		CHEMBL220465	=	Inhibition	%	2.35	CHEMBL4246	Homo sapiens	Inhibition	%	2.35
	8067729	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	1.47	CHEMBL4246	Homo sapiens	Inhibition	%	1.47
	8067953	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL365072	=	Inhibition	%	5.82	CHEMBL4246	Homo sapiens	Inhibition	%	5.82
	8068088	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	9.2	CHEMBL4246	Homo sapiens	Inhibition	%	9.2
	8068252	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3n2)cc1		CHEMBL408732	=	Inhibition	%	2.47	CHEMBL4246	Homo sapiens	Inhibition	%	2.47
	8068476	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	1.29	CHEMBL4246	Homo sapiens	Inhibition	%	1.29
	8068601	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(Br)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909370	=	Inhibition	%	3.43	CHEMBL4246	Homo sapiens	Inhibition	%	3.43
	8068999	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(S(=O)(=O)c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.Cl		CHEMBL1909367	=	Inhibition	%	2.49	CHEMBL4246	Homo sapiens	Inhibition	%	2.49
	8069124	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	1.22	CHEMBL4246	Homo sapiens	Inhibition	%	1.22
	8069419	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(-c3cnn4ncccc34)n2)cc(OC)c1		CHEMBL359999	=	Inhibition	%	42.86	CHEMBL4246	Homo sapiens	Inhibition	%	42.86
	8069804	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.N#Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL1794061	=	Inhibition	%	2.29	CHEMBL4246	Homo sapiens	Inhibition	%	2.29
	8069930	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.75	CHEMBL4246	Homo sapiens	Inhibition	%	1.75
	8070154	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)cc2)sc2c1CCCC2		CHEMBL397570	=	Inhibition	%	1.25	CHEMBL4246	Homo sapiens	Inhibition	%	1.25
	8070326	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	4.18	CHEMBL4246	Homo sapiens	Inhibition	%	4.18
	8070451	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ccccc3c2-c2ccncc2)cc1		CHEMBL485745	=	Inhibition	%	2.64	CHEMBL4246	Homo sapiens	Inhibition	%	2.64
	8070675	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.3	CHEMBL4246	Homo sapiens	Inhibition	%	2.3
	8070749	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	5.1	CHEMBL4246	Homo sapiens	Inhibition	%	5.1
	8070973	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(c2ccc(Nc3nccc(-c4cnn5ncccc45)n3)cc2C(F)(F)F)CC1		CHEMBL468963	=	Inhibition	%	22.94	CHEMBL4246	Homo sapiens	Inhibition	%	22.94
	8071130	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	2.23	CHEMBL4246	Homo sapiens	Inhibition	%	2.23
	8071480	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	0.76	CHEMBL4246	Homo sapiens	Inhibition	%	0.76
	8071653	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4)n3C)ccc2c1		CHEMBL399410	=	Inhibition	%	5.59	CHEMBL4246	Homo sapiens	Inhibition	%	5.59
	8072002	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL206544	=	Inhibition	%	2.11	CHEMBL4246	Homo sapiens	Inhibition	%	2.11
	8072316	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	1.48	CHEMBL4246	Homo sapiens	Inhibition	%	1.48
	8072473	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(Cl)cc2c1NC(=O)C2=NNc1ccc(S(N)(=O)=O)cc1		CHEMBL1909397	=	Inhibition	%	1.43	CHEMBL4246	Homo sapiens	Inhibition	%	1.43
	8072822	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(-c2n[nH]cc2-c2ccc3ncccc3n2)n1		CHEMBL185238	=	Inhibition	%	1.51	CHEMBL4246	Homo sapiens	Inhibition	%	1.51
	8072989	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	4.92	CHEMBL4246	Homo sapiens	Inhibition	%	4.92
	8073338	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	1.25	CHEMBL4246	Homo sapiens	Inhibition	%	1.25
	8073681	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	1.52	CHEMBL4246	Homo sapiens	Inhibition	%	1.52
	8073914	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3cccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)c3)ccc2[nH]1.Cl		CHEMBL1909366	=	Inhibition	%	2.64	CHEMBL4246	Homo sapiens	Inhibition	%	2.64
	8074066	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.83	CHEMBL4246	Homo sapiens	Inhibition	%	1.83
	8074290	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4ccccc4)cc3)ccc2[nH]1.Cl		CHEMBL1909371	=	Inhibition	%	1.84	CHEMBL4246	Homo sapiens	Inhibition	%	1.84
	8074420	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	0.84	CHEMBL4246	Homo sapiens	Inhibition	%	0.84
	8074577	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)c(Br)cc12)C1CC1		CHEMBL408564	=	Inhibition	%	9.1	CHEMBL4246	Homo sapiens	Inhibition	%	9.1
	8074801	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.14	CHEMBL4246	Homo sapiens	Inhibition	%	4.14
	8074928	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2s1.Cl		CHEMBL1909369	=	Inhibition	%	-0.83	CHEMBL4246	Homo sapiens	Inhibition	%	-0.83
	8075263	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL271843	=	Inhibition	%	4.33	CHEMBL4246	Homo sapiens	Inhibition	%	4.33
	8075500	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	-0.24	CHEMBL4246	Homo sapiens	Inhibition	%	-0.24
	8075865	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	3.38	CHEMBL4246	Homo sapiens	Inhibition	%	3.38
	8076007	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(=O)N(C)C)s3)c2cc1OC		CHEMBL482326	=	Inhibition	%	2.14	CHEMBL4246	Homo sapiens	Inhibition	%	2.14
	8076379	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)Cc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785002	=	Inhibition	%	4.45	CHEMBL4246	Homo sapiens	Inhibition	%	4.45
	8076513	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	0.93	CHEMBL4246	Homo sapiens	Inhibition	%	0.93
	8076737	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc3ncccc23)c2cc[nH]c2n1		CHEMBL458438	=	Inhibition	%	-0.14	CHEMBL4246	Homo sapiens	Inhibition	%	-0.14
	8076839	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	-0.04	CHEMBL4246	Homo sapiens	Inhibition	%	-0.04
	8077086	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(CN3CCCC3)cc21		CHEMBL1096290	=	Inhibition	%	1.81	CHEMBL4246	Homo sapiens	Inhibition	%	1.81
	8077438	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL156987	=	Inhibition	%	2.84	CHEMBL4246	Homo sapiens	Inhibition	%	2.84
	8077589	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	1.04	CHEMBL4246	Homo sapiens	Inhibition	%	1.04
	8077813	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4C(F)(F)F)c(C(N)=O)s3)c2c1		CHEMBL522709	=	Inhibition	%	-0.18	CHEMBL4246	Homo sapiens	Inhibition	%	-0.18
	8077956	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	2.52	CHEMBL4246	Homo sapiens	Inhibition	%	2.52
	8078319	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	-1.66	CHEMBL4246	Homo sapiens	Inhibition	%	-1.66
	8078421	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(CCCN3CCOCC3)c2-c2ccncc2)cc1		CHEMBL14112	=	Inhibition	%	2.36	CHEMBL4246	Homo sapiens	Inhibition	%	2.36
	8078645	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	1.46	CHEMBL4246	Homo sapiens	Inhibition	%	1.46
	8078671	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	0.79	CHEMBL4246	Homo sapiens	Inhibition	%	0.79
	8078895	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(O[C@@H](CN)c3ccccc3)cc21.O=C(O)C(F)(F)F		CHEMBL1909349	=	Inhibition	%	5.82	CHEMBL4246	Homo sapiens	Inhibition	%	5.82
	8079011	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	4.05	CHEMBL4246	Homo sapiens	Inhibition	%	4.05
	8079393	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.35	CHEMBL4246	Homo sapiens	Inhibition	%	-0.35
	8079535	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCCc4ccccc4)c(C(N)=O)s3)c2cc1OC		CHEMBL473629	=	Inhibition	%	4.4	CHEMBL4246	Homo sapiens	Inhibition	%	4.4
	8079898	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3ccc(O)c(F)c3)n[nH]2)cc1		CHEMBL103115	=	Inhibition	%	0.4	CHEMBL4246	Homo sapiens	Inhibition	%	0.4
	8080227	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.ON=C1CCc2cc(-c3nc(C4CCNCC4)[nH]c3-c3ccncc3)ccc21		CHEMBL1794071	=	Inhibition	%	2.88	CHEMBL4246	Homo sapiens	Inhibition	%	2.88
	8080479	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	0.3	CHEMBL4246	Homo sapiens	Inhibition	%	0.3
	8080594	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)Nc4cccc(C#N)c4)cc3)c2)o1		CHEMBL270164	=	Inhibition	%	3.86	CHEMBL4246	Homo sapiens	Inhibition	%	3.86
	8080818	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	2.8	CHEMBL4246	Homo sapiens	Inhibition	%	2.8
	8080982	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC[C@@H](O)CO)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794067	=	Inhibition	%	-0.09	CHEMBL4246	Homo sapiens	Inhibition	%	-0.09
	8081117	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	3.42	CHEMBL4246	Homo sapiens	Inhibition	%	3.42
	8081341	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(F)c5)c4c3)o2)CC1		CHEMBL1909391	=	Inhibition	%	4.7	CHEMBL4246	Homo sapiens	Inhibition	%	4.7
	8081485	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	2.15	CHEMBL4246	Homo sapiens	Inhibition	%	2.15
	8081812	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.84	CHEMBL4246	Homo sapiens	Inhibition	%	1.84
	8082064	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)COC(=O)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL269883	=	Inhibition	%	6.56	CHEMBL4246	Homo sapiens	Inhibition	%	6.56
	8082401	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909411	=	Inhibition	%	4.49	CHEMBL4246	Homo sapiens	Inhibition	%	4.49
	8082574	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.4	CHEMBL4246	Homo sapiens	Inhibition	%	-2.4
	8082921	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	3.37	CHEMBL4246	Homo sapiens	Inhibition	%	3.37
	8083077	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)CC1		CHEMBL476259	=	Inhibition	%	7.76	CHEMBL4246	Homo sapiens	Inhibition	%	7.76
	8083400	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc(Cl)c2)=C1Nc1ccc(O)c(Cl)c1		CHEMBL160333	=	Inhibition	%	1.44	CHEMBL4246	Homo sapiens	Inhibition	%	1.44
	8083654	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	-0.6	CHEMBL4246	Homo sapiens	Inhibition	%	-0.6
	8083988	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	3.52	CHEMBL4246	Homo sapiens	Inhibition	%	3.52
	8084173	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	-2.93	CHEMBL4246	Homo sapiens	Inhibition	%	-2.93
	8084515	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL517507	=	Inhibition	%	2.28	CHEMBL4246	Homo sapiens	Inhibition	%	2.28
	8084676	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	3.92	CHEMBL4246	Homo sapiens	Inhibition	%	3.92
	8084900	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCCn4ccnc4)cc32)cc1		CHEMBL272026	=	Inhibition	%	10.48	CHEMBL4246	Homo sapiens	Inhibition	%	10.48
	8084998	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	2.55	CHEMBL4246	Homo sapiens	Inhibition	%	2.55
	8085254	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CCCCC1		CHEMBL189231	=	Inhibition	%	1.22	CHEMBL4246	Homo sapiens	Inhibition	%	1.22
	8085586	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC1		CHEMBL95207	=	Inhibition	%	5.01	CHEMBL4246	Homo sapiens	Inhibition	%	5.01
	8085775	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	8.53	CHEMBL4246	Homo sapiens	Inhibition	%	8.53
	8085999	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc4ncccc4c32)cc1		CHEMBL409892	=	Inhibition	%	38.28	CHEMBL4246	Homo sapiens	Inhibition	%	38.28
	8086114	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4c(cnn4Cc4ccccc4)c3)ncnc2cn1		CHEMBL30432	=	Inhibition	%	3.97	CHEMBL4246	Homo sapiens	Inhibition	%	3.97
	8086500	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1		CHEMBL261129	=	Inhibition	%	-1.21	CHEMBL4246	Homo sapiens	Inhibition	%	-1.21
	8086599	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL103080	=	Inhibition	%	3.97	CHEMBL4246	Homo sapiens	Inhibition	%	3.97
	8086823	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccncc21		CHEMBL185710	=	Inhibition	%	2.56	CHEMBL4246	Homo sapiens	Inhibition	%	2.56
	8087034	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	5.68	CHEMBL4246	Homo sapiens	Inhibition	%	5.68
	8087192	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	8.61	CHEMBL4246	Homo sapiens	Inhibition	%	8.61
	8087530	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	26.96	CHEMBL4246	Homo sapiens	Inhibition	%	26.96
	8087892	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.67	CHEMBL4246	Homo sapiens	Inhibition	%	4.67
	8088034	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.87	CHEMBL4246	Homo sapiens	Inhibition	%	7.87
	8088406	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	0.8	CHEMBL4246	Homo sapiens	Inhibition	%	0.8
	8088534	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	4.27	CHEMBL4246	Homo sapiens	Inhibition	%	4.27
	8088758	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	1.7	CHEMBL4246	Homo sapiens	Inhibition	%	1.7
	8088851	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	3.65	CHEMBL4246	Homo sapiens	Inhibition	%	3.65
	8089203	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	1.0	CHEMBL4246	Homo sapiens	Inhibition	%	1.0
	8089351	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	2.99	CHEMBL4246	Homo sapiens	Inhibition	%	2.99
	8089575	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	2.44	CHEMBL4246	Homo sapiens	Inhibition	%	2.44
	8089695	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	3.6	CHEMBL4246	Homo sapiens	Inhibition	%	3.6
	8089875	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	0.64	CHEMBL4246	Homo sapiens	Inhibition	%	0.64
	8090099	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909402	=	Inhibition	%	4.1	CHEMBL4246	Homo sapiens	Inhibition	%	4.1
	8090264	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	5.26	CHEMBL4246	Homo sapiens	Inhibition	%	5.26
	8090431	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	4.89	CHEMBL4246	Homo sapiens	Inhibition	%	4.89
	8090655	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	2.69	CHEMBL4246	Homo sapiens	Inhibition	%	2.69
	8090794	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	4.44	CHEMBL4246	Homo sapiens	Inhibition	%	4.44
	8090999	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	4.73	CHEMBL4246	Homo sapiens	Inhibition	%	4.73
	8091223	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	1.49	CHEMBL4246	Homo sapiens	Inhibition	%	1.49
	8091360	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(Cl)cccc2Cl)c1		CHEMBL263796	=	Inhibition	%	23.41	CHEMBL4246	Homo sapiens	Inhibition	%	23.41
	8091515	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	3.13	CHEMBL4246	Homo sapiens	Inhibition	%	3.13
	8091739	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCC(=O)Nc1ccc(C)c(-c2ccc(C(=O)NCC3CC3)cc2)c1		CHEMBL517666	=	Inhibition	%	2.28	CHEMBL4246	Homo sapiens	Inhibition	%	2.28
	8091855	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	2.21	CHEMBL4246	Homo sapiens	Inhibition	%	2.21
	8092216	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-3.67	CHEMBL4246	Homo sapiens	Inhibition	%	-3.67
	8092367	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CCNCC3)c21.Cl		CHEMBL1909376	=	Inhibition	%	7.17	CHEMBL4246	Homo sapiens	Inhibition	%	7.17
	8092591	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.25	CHEMBL4246	Homo sapiens	Inhibition	%	7.25
	8092739	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2cc(-c3ccccc3)cc(C(N)=O)c2N)cc1		CHEMBL230597	=	Inhibition	%	1.3	CHEMBL4246	Homo sapiens	Inhibition	%	1.3
	8093092	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL521806	=	Inhibition	%	7.65	CHEMBL4246	Homo sapiens	Inhibition	%	7.65
	8093180	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccccc21		CHEMBL365286	=	Inhibition	%	7.35	CHEMBL4246	Homo sapiens	Inhibition	%	7.35
	8093404	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	3.37	CHEMBL4246	Homo sapiens	Inhibition	%	3.37
	8093544	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC(Oc2cc(Nc3nc(Nc4cccc(F)c4C(N)=O)c4cc[nH]c4n3)c(OC)cc2Cl)CC1		CHEMBL517171	=	Inhibition	%	3.16	CHEMBL4246	Homo sapiens	Inhibition	%	3.16
	8093907	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)=Cc1cccc2c1/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL270544	=	Inhibition	%	10.08	CHEMBL4246	Homo sapiens	Inhibition	%	10.08
	8094027	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	3.48	CHEMBL4246	Homo sapiens	Inhibition	%	3.48
	8094431	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	-0.18	CHEMBL4246	Homo sapiens	Inhibition	%	-0.18
	8094606	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3cccc(F)c3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN1CCN(C(C)C)CC1)CC2		CHEMBL505915	=	Inhibition	%	1.94	CHEMBL4246	Homo sapiens	Inhibition	%	1.94
	8094986	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1nc(-c2ccccc2)n2nc(NCCCN3CCOCC3)ncc12		CHEMBL486124	=	Inhibition	%	3.32	CHEMBL4246	Homo sapiens	Inhibition	%	3.32
	8095126	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	0.44	CHEMBL4246	Homo sapiens	Inhibition	%	0.44
	8095553	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)o1.Cl		CHEMBL1909385	=	Inhibition	%	7.43	CHEMBL4246	Homo sapiens	Inhibition	%	7.43
	8095694	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	6.08	CHEMBL4246	Homo sapiens	Inhibition	%	6.08
	8096066	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	3.95	CHEMBL4246	Homo sapiens	Inhibition	%	3.95
	8096183	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Nc1ncc(-c2ccccc2)o1.Cl		CHEMBL1794062	=	Inhibition	%	7.28	CHEMBL4246	Homo sapiens	Inhibition	%	7.28
	8096407	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	1.75	CHEMBL4246	Homo sapiens	Inhibition	%	1.75
	8096546	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccccc3)n2)cc1		CHEMBL275798	=	Inhibition	%	-1.69	CHEMBL4246	Homo sapiens	Inhibition	%	-1.69
	8096926	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1cc(-c2cc3c(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)ncnc3s2)cs1		CHEMBL475599	=	Inhibition	%	7.0	CHEMBL4246	Homo sapiens	Inhibition	%	7.0
	8097073	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	-0.73	CHEMBL4246	Homo sapiens	Inhibition	%	-0.73
	8097384	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	0.84	CHEMBL4246	Homo sapiens	Inhibition	%	0.84
	8097604	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)/C=C/C(=O)O.OCCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1		CHEMBL1909403	=	Inhibition	%	5.41	CHEMBL4246	Homo sapiens	Inhibition	%	5.41
	8097754	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	1.68	CHEMBL4246	Homo sapiens	Inhibition	%	1.68
	8098111	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	-2.22	CHEMBL4246	Homo sapiens	Inhibition	%	-2.22
	8098231	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3Cl)o2)c1		CHEMBL179453	=	Inhibition	%	5.03	CHEMBL4246	Homo sapiens	Inhibition	%	5.03
	8098455	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	-0.82	CHEMBL4246	Homo sapiens	Inhibition	%	-0.82
	8098635	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccco2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909353	=	Inhibition	%	4.27	CHEMBL4246	Homo sapiens	Inhibition	%	4.27
	8098820	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	6.32	CHEMBL4246	Homo sapiens	Inhibition	%	6.32
	8099188	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	4.07	CHEMBL4246	Homo sapiens	Inhibition	%	4.07
	8099330	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2ccc(OC(F)(F)F)cc2)cc1)c1ccnc(Nc2cccc(S(N)(=O)=O)c2)n1		CHEMBL188381	=	Inhibition	%	7.04	CHEMBL4246	Homo sapiens	Inhibition	%	7.04
	8099554	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	-0.08	CHEMBL4246	Homo sapiens	Inhibition	%	-0.08
	8099748	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	-0.44	CHEMBL4246	Homo sapiens	Inhibition	%	-0.44
	8099895	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCC=C(c2ccc(Nc3nc(Nc4ccccc4C(N)=O)c4cc[nH]c4n3)c(C)c2)C1		CHEMBL513897	=	Inhibition	%	8.24	CHEMBL4246	Homo sapiens	Inhibition	%	8.24
	8100119	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	6.46	CHEMBL4246	Homo sapiens	Inhibition	%	6.46
	8100265	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc4c(cnn4Cc4ccccc4)c3)c2cc1OC.Cl		CHEMBL1909380	=	Inhibition	%	17.73	CHEMBL4246	Homo sapiens	Inhibition	%	17.73
	8100605	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL275666	=	Inhibition	%	7.26	CHEMBL4246	Homo sapiens	Inhibition	%	7.26
	8100745	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	-0.94	CHEMBL4246	Homo sapiens	Inhibition	%	-0.94
	8101129	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	6.14	CHEMBL4246	Homo sapiens	Inhibition	%	6.14
	8101271	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5cccs5)cc34)cc2Cl)c1		CHEMBL506414	=	Inhibition	%	1.47	CHEMBL4246	Homo sapiens	Inhibition	%	1.47
	8101495	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	-2.02	CHEMBL4246	Homo sapiens	Inhibition	%	-2.02
	8101680	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2c1		CHEMBL493326	=	Inhibition	%	-2.01	CHEMBL4246	Homo sapiens	Inhibition	%	-2.01
	8101933	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	3.87	CHEMBL4246	Homo sapiens	Inhibition	%	3.87
	8102088	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@@H](N)c3ccccc3)cc21		CHEMBL1096626	=	Inhibition	%	6.92	CHEMBL4246	Homo sapiens	Inhibition	%	6.92
	8102312	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	17.39	CHEMBL4246	Homo sapiens	Inhibition	%	17.39
	8102443	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2cc(Oc3ccc(NC(=O)Nc4cccc(C(=O)O)c4)cc3)ccc2[nH]1.Cl		CHEMBL1909373	=	Inhibition	%	0.87	CHEMBL4246	Homo sapiens	Inhibition	%	0.87
	8102787	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(COc2cc(-n3cnc4ccccc43)sc2C(N)=O)c1		CHEMBL516248	=	Inhibition	%	0.59	CHEMBL4246	Homo sapiens	Inhibition	%	0.59
	8102965	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	1.31	CHEMBL4246	Homo sapiens	Inhibition	%	1.31
	8103161	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(N)=O)c2cc[nH]c2n1		CHEMBL458865	=	Inhibition	%	3.59	CHEMBL4246	Homo sapiens	Inhibition	%	3.59
	8103385	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	6.27	CHEMBL4246	Homo sapiens	Inhibition	%	6.27
	8103523	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1coc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)cc4)c3c2)c1.Cl		CHEMBL1909386	=	Inhibition	%	6.39	CHEMBL4246	Homo sapiens	Inhibition	%	6.39
	8103897	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(C)=O)s3)c2cc1OC		CHEMBL471789	=	Inhibition	%	5.16	CHEMBL4246	Homo sapiens	Inhibition	%	5.16
	8104082	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc2c(-c3ccnc(NC4CC4)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1885746	=	Inhibition	%	3.17	CHEMBL4246	Homo sapiens	Inhibition	%	3.17
	8104454	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C)cc4)ncnc32)c1		CHEMBL303687	=	Inhibition	%	5.78	CHEMBL4246	Homo sapiens	Inhibition	%	5.78
	8104600	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	-1.76	CHEMBL4246	Homo sapiens	Inhibition	%	-1.76
	8104938	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	2.34	CHEMBL4246	Homo sapiens	Inhibition	%	2.34
	8105078	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6ccccc6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909393	=	Inhibition	%	1.06	CHEMBL4246	Homo sapiens	Inhibition	%	1.06
	8105302	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	-1.47	CHEMBL4246	Homo sapiens	Inhibition	%	-1.47
	8105468	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2ccncc2)cc1C(N)=O		CHEMBL231013	=	Inhibition	%	5.31	CHEMBL4246	Homo sapiens	Inhibition	%	5.31
	8105830	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1OC		CHEMBL443563	=	Inhibition	%	4.55	CHEMBL4246	Homo sapiens	Inhibition	%	4.55
	8106110	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	5.52	CHEMBL4246	Homo sapiens	Inhibition	%	5.52
	8106275	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-c2c[nH]c3c(N/N=C/c4ccncc4)ncnc23)c1		CHEMBL206010	=	Inhibition	%	16.46	CHEMBL4246	Homo sapiens	Inhibition	%	16.46
	8106655	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cccc(Nc2nccc(Nc3cccc4[nH]ncc34)n2)c1		CHEMBL251549	=	Inhibition	%	62.55	CHEMBL4246	Homo sapiens	Inhibition	%	62.55
	8106784	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	2.99	CHEMBL4246	Homo sapiens	Inhibition	%	2.99
	8107129	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	-0.28	CHEMBL4246	Homo sapiens	Inhibition	%	-0.28
	8107301	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(COc2ccc(Nc3ncnc4ccc(-c5ccco5)cc34)cc2)cc1		CHEMBL215993	=	Inhibition	%	3.25	CHEMBL4246	Homo sapiens	Inhibition	%	3.25
	8107525	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	1.68	CHEMBL4246	Homo sapiens	Inhibition	%	1.68
	8107726	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OC[C@H](N)c3ccccc3)cc21		CHEMBL1096634	=	Inhibition	%	3.05	CHEMBL4246	Homo sapiens	Inhibition	%	3.05
	8107861	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	6.51	CHEMBL4246	Homo sapiens	Inhibition	%	6.51
	8108085	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.NC(=O)c1cccc(Nc2nccc(Nc3cccc(F)c3)n2)c1		CHEMBL1909382	=	Inhibition	%	34.29	CHEMBL4246	Homo sapiens	Inhibition	%	34.29
	8108243	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	1.74	CHEMBL4246	Homo sapiens	Inhibition	%	1.74
	8108418	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	-0.16	CHEMBL4246	Homo sapiens	Inhibition	%	-0.16
	8108789	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.45	CHEMBL4246	Homo sapiens	Inhibition	%	6.45
	8108931	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(-c4cnco4)cc32)cc1		CHEMBL269827	=	Inhibition	%	4.09	CHEMBL4246	Homo sapiens	Inhibition	%	4.09
	8109155	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.41	CHEMBL4246	Homo sapiens	Inhibition	%	0.41
	8109269	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL13972	=	Inhibition	%	5.61	CHEMBL4246	Homo sapiens	Inhibition	%	5.61
	8109623	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Cl)cc3)n2)cc1		CHEMBL275168	=	Inhibition	%	0.25	CHEMBL4246	Homo sapiens	Inhibition	%	0.25
	8109794	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	2.27	CHEMBL4246	Homo sapiens	Inhibition	%	2.27
	8110150	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	2.12	CHEMBL4246	Homo sapiens	Inhibition	%	2.12
	8110429	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL205798	=	Inhibition	%	8.88	CHEMBL4246	Homo sapiens	Inhibition	%	8.88
	8110595	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	-0.2	CHEMBL4246	Homo sapiens	Inhibition	%	-0.2
	8110819	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCNc1nccc(-c2c(-c3ccc(F)cc3)nn3cc(C(F)(F)F)ccc23)n1.CS(=O)(=O)O		CHEMBL1909405	=	Inhibition	%	1.41	CHEMBL4246	Homo sapiens	Inhibition	%	1.41
	8110977	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-2.6	CHEMBL4246	Homo sapiens	Inhibition	%	-2.6
	8111100	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)S(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL275473	=	Inhibition	%	11.9	CHEMBL4246	Homo sapiens	Inhibition	%	11.9
	8111324	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	2.07	CHEMBL4246	Homo sapiens	Inhibition	%	2.07
	8111451	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1cc(-c2ccnc3[nH]ccc23)c(-c2cccc(NC(=O)Nc3ccc(OCc4ccccc4)cc3)c2)n1		CHEMBL505187	=	Inhibition	%	0.98	CHEMBL4246	Homo sapiens	Inhibition	%	0.98
	8111841	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3cc(C(F)(F)F)ccc32)cc1OCc1ccccc1Br		CHEMBL480371	=	Inhibition	%	3.28	CHEMBL4246	Homo sapiens	Inhibition	%	3.28
	8112046	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	6.33	CHEMBL4246	Homo sapiens	Inhibition	%	6.33
	8112407	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	1.82	CHEMBL4246	Homo sapiens	Inhibition	%	1.82
	8112575	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL518968	=	Inhibition	%	9.64	CHEMBL4246	Homo sapiens	Inhibition	%	9.64
	8112747	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Oc3ccc(NC(=O)Nc4cccc(Cl)c4)cc3)cc2[nH]1.Cl		CHEMBL1909364	=	Inhibition	%	1.83	CHEMBL4246	Homo sapiens	Inhibition	%	1.83
	8112971	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	0.03	CHEMBL4246	Homo sapiens	Inhibition	%	0.03
	8113123	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794069	=	Inhibition	%	6.29	CHEMBL4246	Homo sapiens	Inhibition	%	6.29
	8113483	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=S(=O)(CCOCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL212250	=	Inhibition	%	0.9	CHEMBL4246	Homo sapiens	Inhibition	%	0.9
	8113607	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	0.84	CHEMBL4246	Homo sapiens	Inhibition	%	0.84
	8113947	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-4.39	CHEMBL4246	Homo sapiens	Inhibition	%	-4.39
	8114123	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1Cl		CHEMBL1794070	=	Inhibition	%	1.73	CHEMBL4246	Homo sapiens	Inhibition	%	1.73
	8114347	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	6.62	CHEMBL4246	Homo sapiens	Inhibition	%	6.62
	8114479	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc(-c3ccccc3)o2)cc(OC)c1		CHEMBL176553	=	Inhibition	%	7.94	CHEMBL4246	Homo sapiens	Inhibition	%	7.94
	8114755	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	4.18	CHEMBL4246	Homo sapiens	Inhibition	%	4.18
	8115145	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	3.07	CHEMBL4246	Homo sapiens	Inhibition	%	3.07
	8115310	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CCN)ncc(OCCCN)c21.O=C(O)C(F)(F)F		CHEMBL1794064	=	Inhibition	%	-1.5	CHEMBL4246	Homo sapiens	Inhibition	%	-1.5
	8115654	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(NC(=O)Nc2ccc(Oc3ccc4nc(NC(=O)OC)[nH]c4c3)cc2)c1		CHEMBL243907	=	Inhibition	%	3.91	CHEMBL4246	Homo sapiens	Inhibition	%	3.91
	8115787	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	0.03	CHEMBL4246	Homo sapiens	Inhibition	%	0.03
	8116011	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@@H]3CCCN3)c21.O=C(O)C(F)(F)F		CHEMBL1909375	=	Inhibition	%	1.67	CHEMBL4246	Homo sapiens	Inhibition	%	1.67
	8116170	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	0.59	CHEMBL4246	Homo sapiens	Inhibition	%	0.59
	8116373	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Nc2ncc(-c3ccccc3)o2)c1		CHEMBL192417	=	Inhibition	%	4.84	CHEMBL4246	Homo sapiens	Inhibition	%	4.84
	8116731	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2nc(C)c3c(N/N=C(\C)c4ccncc4)ncnc32)c1		CHEMBL442363	=	Inhibition	%	3.53	CHEMBL4246	Homo sapiens	Inhibition	%	3.53
	8116903	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	25.78	CHEMBL4246	Homo sapiens	Inhibition	%	25.78
	8117298	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccoc1-c1ccc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2c1.Cl		CHEMBL1909388	=	Inhibition	%	3.04	CHEMBL4246	Homo sapiens	Inhibition	%	3.04
	8117456	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	5.49	CHEMBL4246	Homo sapiens	Inhibition	%	5.49
	8117810	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	-0.91	CHEMBL4246	Homo sapiens	Inhibition	%	-0.91
	8117948	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)c1C.O=C(O)C(F)(F)F		CHEMBL1909400	=	Inhibition	%	3.75	CHEMBL4246	Homo sapiens	Inhibition	%	3.75
	8118172	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	-2.35	CHEMBL4246	Homo sapiens	Inhibition	%	-2.35
	8118288	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)CCc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1785003	=	Inhibition	%	-3.02	CHEMBL4246	Homo sapiens	Inhibition	%	-3.02
	8118684	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)o1.Cl		CHEMBL1909387	=	Inhibition	%	4.52	CHEMBL4246	Homo sapiens	Inhibition	%	4.52
	8118820	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	0.94	CHEMBL4246	Homo sapiens	Inhibition	%	0.94
	8119091	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CCCCC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477978	=	Inhibition	%	5.66	CHEMBL4246	Homo sapiens	Inhibition	%	5.66
	8119474	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL588025	=	Inhibition	%	5.25	CHEMBL4246	Homo sapiens	Inhibition	%	5.25
	8119641	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	-0.56	CHEMBL4246	Homo sapiens	Inhibition	%	-0.56
	8119984	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	3.79	CHEMBL4246	Homo sapiens	Inhibition	%	3.79
	8120347	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	-0.12	CHEMBL4246	Homo sapiens	Inhibition	%	-0.12
	8120507	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)(CO)CNC(=O)c1ccc2c(c1)/C(=N/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL410072	=	Inhibition	%	5.32	CHEMBL4246	Homo sapiens	Inhibition	%	5.32
	8120708	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	5.92	CHEMBL4246	Homo sapiens	Inhibition	%	5.92
	8120932	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794066	=	Inhibition	%	3.33	CHEMBL4246	Homo sapiens	Inhibition	%	3.33
	8121060	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	1.22	CHEMBL4246	Homo sapiens	Inhibition	%	1.22
	8121232	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncc(-c2cccc(S(N)(=O)=O)c2)c2scc(-c3ccc(F)c(Cl)c3)c12		CHEMBL241517	=	Inhibition	%	75.22	CHEMBL4246	Homo sapiens	Inhibition	%	75.22
	8121456	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	-0.07	CHEMBL4246	Homo sapiens	Inhibition	%	-0.07
	8121623	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	-0.23	CHEMBL4246	Homo sapiens	Inhibition	%	-0.23
	8121786	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)nc(OCCNC)cc21.Cl		CHEMBL1909350	=	Inhibition	%	3.22	CHEMBL4246	Homo sapiens	Inhibition	%	3.22
	8122010	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.6	CHEMBL4246	Homo sapiens	Inhibition	%	4.6
	8122131	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Cl)c4)c3c2)o1.Cl		CHEMBL529066	=	Inhibition	%	0.89	CHEMBL4246	Homo sapiens	Inhibition	%	0.89
	8122493	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(F)c(F)c3)n2)cc1		CHEMBL1785004	=	Inhibition	%	0.11	CHEMBL4246	Homo sapiens	Inhibition	%	0.11
	8122613	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	7.49	CHEMBL4246	Homo sapiens	Inhibition	%	7.49
	8122837	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1c(C(N)=O)cc(-c2ccc(Cl)cc2)cc1-c1ccc(S(N)(=O)=O)cc1		CHEMBL268885	=	Inhibition	%	3.79	CHEMBL4246	Homo sapiens	Inhibition	%	3.79
	8123004	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	6.97	CHEMBL4246	Homo sapiens	Inhibition	%	6.97
	8123146	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncnc4sc(-c5ccco5)cc34)cc2Cl)c1		CHEMBL514938	=	Inhibition	%	5.13	CHEMBL4246	Homo sapiens	Inhibition	%	5.13
	8123370	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	-1.86	CHEMBL4246	Homo sapiens	Inhibition	%	-1.86
	8123424	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	1.93	CHEMBL4246	Homo sapiens	Inhibition	%	1.93
	8123648	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(NC(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL511765	=	Inhibition	%	3.64	CHEMBL4246	Homo sapiens	Inhibition	%	3.64
	8123798	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	4.48	CHEMBL4246	Homo sapiens	Inhibition	%	4.48
	8123965	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)Nc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL205765	=	Inhibition	%	0.51	CHEMBL4246	Homo sapiens	Inhibition	%	0.51
	8124189	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	-2.49	CHEMBL4246	Homo sapiens	Inhibition	%	-2.49
	8124308	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(F)c(Cl)c4)c3c2)cs1.Cl		CHEMBL1909355	=	Inhibition	%	9.13	CHEMBL4246	Homo sapiens	Inhibition	%	9.13
	8124671	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c(-c3ccc(C(F)(F)F)cc3)nn2n1		CHEMBL188247	=	Inhibition	%	3.34	CHEMBL4246	Homo sapiens	Inhibition	%	3.34
	8124836	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.33	CHEMBL4246	Homo sapiens	Inhibition	%	2.33
	8125261	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	6.67	CHEMBL4246	Homo sapiens	Inhibition	%	6.67
	8125391	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc2c(c1)NC(=O)/C2=N/Nc1ccc(S(N)(=O)=O)cc1		CHEMBL271594	=	Inhibition	%	3.98	CHEMBL4246	Homo sapiens	Inhibition	%	3.98
	8125783	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(Cc5ccccc5)cc4)c3s2)C1)N1CCOCC1		CHEMBL1909409	=	Inhibition	%	4.05	CHEMBL4246	Homo sapiens	Inhibition	%	4.05
	8125947	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3cccc(CCc4ccncc4)c32)cc1		CHEMBL1909399	=	Inhibition	%	4.92	CHEMBL4246	Homo sapiens	Inhibition	%	4.92
	8126335	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccccc32)cc1OCc1ccccc1Br		CHEMBL518953	=	Inhibition	%	4.76	CHEMBL4246	Homo sapiens	Inhibition	%	4.76
	8126450	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-2.99	CHEMBL4246	Homo sapiens	Inhibition	%	-2.99
	8126674	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)c12		CHEMBL247228	=	Inhibition	%	-1.81	CHEMBL4246	Homo sapiens	Inhibition	%	-1.81
	8126810	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	1.96	CHEMBL4246	Homo sapiens	Inhibition	%	1.96
	8127156	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	7.61	CHEMBL4246	Homo sapiens	Inhibition	%	7.61
	8127323	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3cccc(F)c3)n2)cc1		CHEMBL14014	=	Inhibition	%	7.94	CHEMBL4246	Homo sapiens	Inhibition	%	7.94
	8127689	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4C(F)(F)F)c(C(N)=O)s3)c2cc1OC		CHEMBL514499	=	Inhibition	%	7.03	CHEMBL4246	Homo sapiens	Inhibition	%	7.03
	8127977	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	2.22	CHEMBL4246	Homo sapiens	Inhibition	%	2.22
	8128129	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C=NNc2ncnc3c2cnn3-c2ccccc2)ccc1O		CHEMBL1789961	=	Inhibition	%	12.87	CHEMBL4246	Homo sapiens	Inhibition	%	12.87
	8128520	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2cnc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL204934	=	Inhibition	%	5.03	CHEMBL4246	Homo sapiens	Inhibition	%	5.03
	8128639	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	4.27	CHEMBL4246	Homo sapiens	Inhibition	%	4.27
	8128863	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL187081	=	Inhibition	%	25.13	CHEMBL4246	Homo sapiens	Inhibition	%	25.13
	8129000	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	0.43	CHEMBL4246	Homo sapiens	Inhibition	%	0.43
	8129171	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(cnn5Cc5ccccc5)c4)c3s2)C1)N1CCOCC1		CHEMBL1909408	=	Inhibition	%	2.89	CHEMBL4246	Homo sapiens	Inhibition	%	2.89
	8129395	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	0.39	CHEMBL4246	Homo sapiens	Inhibition	%	0.39
	8129584	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL428877	=	Inhibition	%	4.84	CHEMBL4246	Homo sapiens	Inhibition	%	4.84
	8129723	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	0.17	CHEMBL4246	Homo sapiens	Inhibition	%	0.17
	8129947	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nnc(-c3cccnc3)cc12)C1CC1.O=C(O)C(F)(F)F		CHEMBL1909343	=	Inhibition	%	3.48	CHEMBL4246	Homo sapiens	Inhibition	%	3.48
	8130108	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	0.22	CHEMBL4246	Homo sapiens	Inhibition	%	0.22
	8130280	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	-1.63	CHEMBL4246	Homo sapiens	Inhibition	%	-1.63
	8130504	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(C(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.Cl		CHEMBL1909345	=	Inhibition	%	0.37	CHEMBL4246	Homo sapiens	Inhibition	%	0.37
	8130664	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	0.83	CHEMBL4246	Homo sapiens	Inhibition	%	0.83
	8131004	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	1.39	CHEMBL4246	Homo sapiens	Inhibition	%	1.39
	8131143	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/C=C2\C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL271595	=	Inhibition	%	10.64	CHEMBL4246	Homo sapiens	Inhibition	%	10.64
	8131487	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc(Oc4ccccc4)cc3)n2)cc1		CHEMBL13868	=	Inhibition	%	3.11	CHEMBL4246	Homo sapiens	Inhibition	%	3.11
	8131654	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	9.86	CHEMBL4246	Homo sapiens	Inhibition	%	9.86
	8131878	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(F)c3)o2)c1		CHEMBL179465	=	Inhibition	%	37.2	CHEMBL4246	Homo sapiens	Inhibition	%	37.2
	8132019	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	1.64	CHEMBL4246	Homo sapiens	Inhibition	%	1.64
	8132305	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(Oc5ccccc5)c4)n3n2)cc(OC)c1OC		CHEMBL519881	=	Inhibition	%	5.31	CHEMBL4246	Homo sapiens	Inhibition	%	5.31
	8132452	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	3.84	CHEMBL4246	Homo sapiens	Inhibition	%	3.84
	8132676	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)N(C)C)c1		CHEMBL220244	=	Inhibition	%	5.03	CHEMBL4246	Homo sapiens	Inhibition	%	5.03
	8132844	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	2.56	CHEMBL4246	Homo sapiens	Inhibition	%	2.56
	8133189	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	3.07	CHEMBL4246	Homo sapiens	Inhibition	%	3.07
	8133327	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2cccc([N+](=O)[O-])c2)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL352222	=	Inhibition	%	5.27	CHEMBL4246	Homo sapiens	Inhibition	%	5.27
	8133723	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2cc(-c3ccc4c(c3)CCC4=NO)c(-c3ccncc3)o2)cc1.Cl		CHEMBL1794072	=	Inhibition	%	1.01	CHEMBL4246	Homo sapiens	Inhibition	%	1.01
	8133903	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	10.14	CHEMBL4246	Homo sapiens	Inhibition	%	10.14
	8134275	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	-1.03	CHEMBL4246	Homo sapiens	Inhibition	%	-1.03
	8134435	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)CNc1nccc(-c2cnn3ncccc23)n1		CHEMBL446024	=	Inhibition	%	2.62	CHEMBL4246	Homo sapiens	Inhibition	%	2.62
	8134843	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	-2.97	CHEMBL4246	Homo sapiens	Inhibition	%	-2.97
	8135003	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCN(CC)Cc1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL1882194	=	Inhibition	%	3.21	CHEMBL4246	Homo sapiens	Inhibition	%	3.21
	8135342	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL418348	=	Inhibition	%	3.24	CHEMBL4246	Homo sapiens	Inhibition	%	3.24
	8135483	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	1.83	CHEMBL4246	Homo sapiens	Inhibition	%	1.83
	8135707	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1Oc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL417804	=	Inhibition	%	4.98	CHEMBL4246	Homo sapiens	Inhibition	%	4.98
	8135828	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	4.04	CHEMBL4246	Homo sapiens	Inhibition	%	4.04
	8136220	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.1	CHEMBL4246	Homo sapiens	Inhibition	%	4.1
	8136364	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cccc(C(F)(F)F)c4)cc3)c12		CHEMBL273564	=	Inhibition	%	5.89	CHEMBL4246	Homo sapiens	Inhibition	%	5.89
	8136654	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	-0.85	CHEMBL4246	Homo sapiens	Inhibition	%	-0.85
	8137013	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	2.26	CHEMBL4246	Homo sapiens	Inhibition	%	2.26
	8137176	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2Cl)c1		CHEMBL218970	=	Inhibition	%	10.2	CHEMBL4246	Homo sapiens	Inhibition	%	10.2
	8137520	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(CNc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL513330	=	Inhibition	%	7.34	CHEMBL4246	Homo sapiens	Inhibition	%	7.34
	8137668	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	0.83	CHEMBL4246	Homo sapiens	Inhibition	%	0.83
	8137892	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nnc(-c4cccc(F)c4F)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062289	=	Inhibition	%	2.99	CHEMBL4246	Homo sapiens	Inhibition	%	2.99
	8138058	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	-1.7	CHEMBL4246	Homo sapiens	Inhibition	%	-1.7
	8138237	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(N(C)c4ccnc(Nc5ccc(CS(C)(=O)=O)cc5)n4)cc3)cc2)CC1.Cl		CHEMBL1909360	=	Inhibition	%	37.09	CHEMBL4246	Homo sapiens	Inhibition	%	37.09
	8138461	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	4.74	CHEMBL4246	Homo sapiens	Inhibition	%	4.74
	8138609	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc3c(N)ncnc3o2)cc1		CHEMBL373073	=	Inhibition	%	3.07	CHEMBL4246	Homo sapiens	Inhibition	%	3.07
	8138767	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	0.28	CHEMBL4246	Homo sapiens	Inhibition	%	0.28
	8138991	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccoc2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477583	=	Inhibition	%	3.18	CHEMBL4246	Homo sapiens	Inhibition	%	3.18
	8139176	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(N/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL1794058	=	Inhibition	%	0.17	CHEMBL4246	Homo sapiens	Inhibition	%	0.17
	8139335	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	4.67	CHEMBL4246	Homo sapiens	Inhibition	%	4.67
	8139559	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(-c2ccccn2)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909354	=	Inhibition	%	12.45	CHEMBL4246	Homo sapiens	Inhibition	%	12.45
	8139673	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	0.36	CHEMBL4246	Homo sapiens	Inhibition	%	0.36
	8140038	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	2.12	CHEMBL4246	Homo sapiens	Inhibition	%	2.12
	8140161	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL269450	=	Inhibition	%	-0.84	CHEMBL4246	Homo sapiens	Inhibition	%	-0.84
	8140385	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	8.41	CHEMBL4246	Homo sapiens	Inhibition	%	8.41
	8140544	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(/C=N/Nc2ncnc3c2cnn3-c2cccc(OC)c2)c1		CHEMBL305477	=	Inhibition	%	4.79	CHEMBL4246	Homo sapiens	Inhibition	%	4.79
	8140687	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	2.04	CHEMBL4246	Homo sapiens	Inhibition	%	2.04
	8140911	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2ncn(C3CCNCC3)c2-c2ccnc(Oc3ccc4c(c3)OCO4)n2)cc1		CHEMBL273611	=	Inhibition	%	5.37	CHEMBL4246	Homo sapiens	Inhibition	%	5.37
	8140989	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(C)c(N(C)C(=O)CN(C)C)cc1Nc1nc(Nc2cccc(F)c2C(N)=O)c2cc[nH]c2n1		CHEMBL467581	=	Inhibition	%	1.07	CHEMBL4246	Homo sapiens	Inhibition	%	1.07
	8141343	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(Cl)c(Cl)c2)CC(=O)N1		CHEMBL374453	=	Inhibition	%	6.35	CHEMBL4246	Homo sapiens	Inhibition	%	6.35
	8141503	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	2.52	CHEMBL4246	Homo sapiens	Inhibition	%	2.52
	8141727	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCNc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL67241	=	Inhibition	%	7.76	CHEMBL4246	Homo sapiens	Inhibition	%	7.76
	8141846	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	5.68	CHEMBL4246	Homo sapiens	Inhibition	%	5.68
	8142231	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	1.33	CHEMBL4246	Homo sapiens	Inhibition	%	1.33
	8142399	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccccc2F)sc2c1CCCC2		CHEMBL234838	=	Inhibition	%	0.35	CHEMBL4246	Homo sapiens	Inhibition	%	0.35
	8142799	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1nc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(C(F)(F)F)c5)cc4)c3c2)cs1.Cl		CHEMBL1909356	=	Inhibition	%	5.07	CHEMBL4246	Homo sapiens	Inhibition	%	5.07
	8142948	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.75	CHEMBL4246	Homo sapiens	Inhibition	%	-2.75
	8143327	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	-0.48	CHEMBL4246	Homo sapiens	Inhibition	%	-0.48
	8143514	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	7.04	CHEMBL4246	Homo sapiens	Inhibition	%	7.04
	8143897	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	8.8	CHEMBL4246	Homo sapiens	Inhibition	%	8.8
	8144011	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(C(F)(F)F)c4)c3c2)o1.Cl		CHEMBL1909389	=	Inhibition	%	3.4	CHEMBL4246	Homo sapiens	Inhibition	%	3.4
	8144374	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.[O-][S+]1CCN(Cc2ccc(-c3ccc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4c3)o2)CC1		CHEMBL1909390	=	Inhibition	%	4.55	CHEMBL4246	Homo sapiens	Inhibition	%	4.55
	8144728	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C([O-])c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1.[Li+]		CHEMBL1909401	=	Inhibition	%	3.8	CHEMBL4246	Homo sapiens	Inhibition	%	3.8
	8144881	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	2.93	CHEMBL4246	Homo sapiens	Inhibition	%	2.93
	8145242	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	1.85	CHEMBL4246	Homo sapiens	Inhibition	%	1.85
	8145331	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	2.67	CHEMBL4246	Homo sapiens	Inhibition	%	2.67
	8145555	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(N3CCc4ccccc43)c3cc[nH]c3n1)N(C(=O)CN(C)C)CC2		CHEMBL458415	=	Inhibition	%	7.6	CHEMBL4246	Homo sapiens	Inhibition	%	7.6
	8145679	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	1.47	CHEMBL4246	Homo sapiens	Inhibition	%	1.47
	8146064	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	10.12	CHEMBL4246	Homo sapiens	Inhibition	%	10.12
	8146184	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2c(C)cccc2C)c1		CHEMBL218859	=	Inhibition	%	38.19	CHEMBL4246	Homo sapiens	Inhibition	%	38.19
	8146408	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	3.34	CHEMBL4246	Homo sapiens	Inhibition	%	3.34
	8146568	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL188257	=	Inhibition	%	11.93	CHEMBL4246	Homo sapiens	Inhibition	%	11.93
	8146735	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-1.52	CHEMBL4246	Homo sapiens	Inhibition	%	-1.52
	8147128	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.96	CHEMBL4246	Homo sapiens	Inhibition	%	2.96
	8147270	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC(C)C)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477979	=	Inhibition	%	-2.37	CHEMBL4246	Homo sapiens	Inhibition	%	-2.37
	8147494	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	-0.76	CHEMBL4246	Homo sapiens	Inhibition	%	-0.76
	8147647	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1ccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)cc1		CHEMBL205966	=	Inhibition	%	3.77	CHEMBL4246	Homo sapiens	Inhibition	%	3.77
	8147834	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(I)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1880739	=	Inhibition	%	3.72	CHEMBL4246	Homo sapiens	Inhibition	%	3.72
	8148216	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)c(-c3ccccc3)nn2n1		CHEMBL434729	=	Inhibition	%	38.26	CHEMBL4246	Homo sapiens	Inhibition	%	38.26
	8148330	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	-2.31	CHEMBL4246	Homo sapiens	Inhibition	%	-2.31
	8148554	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5ccccc5)c(Br)c4)c3c2)o1.Cl		CHEMBL1909392	=	Inhibition	%	1.49	CHEMBL4246	Homo sapiens	Inhibition	%	1.49
	8148693	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	1.98	CHEMBL4246	Homo sapiens	Inhibition	%	1.98
	8149055	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	8.39	CHEMBL4246	Homo sapiens	Inhibition	%	8.39
	8149214	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccc(S(=O)(=O)N3CCCC3)cc2)c1N		CHEMBL230592	=	Inhibition	%	3.29	CHEMBL4246	Homo sapiens	Inhibition	%	3.29
	8149572	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=S(=O)(CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1)c1ccccc1		CHEMBL1909395	=	Inhibition	%	5.02	CHEMBL4246	Homo sapiens	Inhibition	%	5.02
	8149894	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	8.66	CHEMBL4246	Homo sapiens	Inhibition	%	8.66
	8150019	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccco3)ccc12)C1CC1		CHEMBL101804	=	Inhibition	%	3.97	CHEMBL4246	Homo sapiens	Inhibition	%	3.97
	8150243	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	-1.71	CHEMBL4246	Homo sapiens	Inhibition	%	-1.71
	8150403	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)Nc2c(Cl)cccc2Cl)cc1)c1ccnc(Nc2cccc(CS(C)(=O)=O)c2)n1		CHEMBL189353	=	Inhibition	%	21.36	CHEMBL4246	Homo sapiens	Inhibition	%	21.36
	8150747	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)Nc1nc2ccc(Sc3ccc(NC(=O)Nc4cc(C(F)(F)F)ccc4F)cc3)cc2[nH]1.O=S(=O)(O)O		CHEMBL1909365	=	Inhibition	%	5.46	CHEMBL4246	Homo sapiens	Inhibition	%	5.46
	8150912	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	-0.19	CHEMBL4246	Homo sapiens	Inhibition	%	-0.19
	8151075	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C[C@@H](Oc1cc(-n2cnc3ccc(OCC4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1794068	=	Inhibition	%	-0.1	CHEMBL4246	Homo sapiens	Inhibition	%	-0.1
	8151299	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.67	CHEMBL4246	Homo sapiens	Inhibition	%	-3.67
	8151476	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nc(-c4ccc(O)cc4)c(Br)cc23)CC1.O=C(O)/C=C\C(=O)O		CHEMBL1909347	=	Inhibition	%	2.96	CHEMBL4246	Homo sapiens	Inhibition	%	2.96
	8151838	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1cccc(Nc2nccc(-c3cnn4nc(-c5ccccc5)ccc34)n2)c1		CHEMBL189415	=	Inhibition	%	4.7	CHEMBL4246	Homo sapiens	Inhibition	%	4.7
	8151992	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3cccc(C(F)(F)F)c3)n2)cc1		CHEMBL186213	=	Inhibition	%	1.14	CHEMBL4246	Homo sapiens	Inhibition	%	1.14
	8152180	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	9.11	CHEMBL4246	Homo sapiens	Inhibition	%	9.11
	8152404	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1ccc2c(c1)C(=Cc1cc(Br)c(O)c(Br)c1)C(=O)N2		CHEMBL1794052	=	Inhibition	%	7.75	CHEMBL4246	Homo sapiens	Inhibition	%	7.75
	8152562	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL318728	=	Inhibition	%	4.25	CHEMBL4246	Homo sapiens	Inhibition	%	4.25
	8152900	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2nccc(N(C)c3ccc4c(C)n[nH]c4c3)n2)c1.Cl		CHEMBL1909358	=	Inhibition	%	4.3	CHEMBL4246	Homo sapiens	Inhibition	%	4.3
	8153039	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)(C)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275200	=	Inhibition	%	3.44	CHEMBL4246	Homo sapiens	Inhibition	%	3.44
	8153263	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	0.53	CHEMBL4246	Homo sapiens	Inhibition	%	0.53
	8153400	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc(Oc2nccc(-c3c(-c4ccc(F)cc4)ncn3C3CCNCC3)n2)cc1		CHEMBL275724	=	Inhibition	%	6.14	CHEMBL4246	Homo sapiens	Inhibition	%	6.14
	8153557	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-2.12	CHEMBL4246	Homo sapiens	Inhibition	%	-2.12
	8153781	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCN(CC#N)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL384407	=	Inhibition	%	-1.96	CHEMBL4246	Homo sapiens	Inhibition	%	-1.96
	8153914	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)NCCNC)c21		CHEMBL506153	=	Inhibition	%	2.57	CHEMBL4246	Homo sapiens	Inhibition	%	2.57
	8154235	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)Oc1cc(C)c(/C=C/c2cncc(C(=O)NC)c2)c(C)c1		CHEMBL218932	=	Inhibition	%	39.1	CHEMBL4246	Homo sapiens	Inhibition	%	39.1
	8154585	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccco4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909368	=	Inhibition	%	0.35	CHEMBL4246	Homo sapiens	Inhibition	%	0.35
	8154744	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207410	=	Inhibition	%	0.86	CHEMBL4246	Homo sapiens	Inhibition	%	0.86
	8155088	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCOCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL476351	=	Inhibition	%	2.02	CHEMBL4246	Homo sapiens	Inhibition	%	2.02
	8155264	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2		CHEMBL456252	=	Inhibition	%	4.36	CHEMBL4246	Homo sapiens	Inhibition	%	4.36
	8155649	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(C(=O)NC2CC2)cc1-c1ccc2[nH]ncc2c1		CHEMBL495902	=	Inhibition	%	-3.15	CHEMBL4246	Homo sapiens	Inhibition	%	-3.15
	8155827	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1nn2ncccc2c1-c1ccnc(NC2CC2)n1		CHEMBL524057	=	Inhibition	%	3.41	CHEMBL4246	Homo sapiens	Inhibition	%	3.41
	8156189	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cccc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL183993	=	Inhibition	%	-0.08	CHEMBL4246	Homo sapiens	Inhibition	%	-0.08
	8156401	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	13.57	CHEMBL4246	Homo sapiens	Inhibition	%	13.57
	8156775	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	26.55	CHEMBL4246	Homo sapiens	Inhibition	%	26.55
	8156918	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	4.68	CHEMBL4246	Homo sapiens	Inhibition	%	4.68
	8157262	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	4.4	CHEMBL4246	Homo sapiens	Inhibition	%	4.4
	8157403	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	13.96	CHEMBL4246	Homo sapiens	Inhibition	%	13.96
	8157627	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	3.55	CHEMBL4246	Homo sapiens	Inhibition	%	3.55
	8157757	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	8.67	CHEMBL4246	Homo sapiens	Inhibition	%	8.67
	8158142	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	2.91	CHEMBL4246	Homo sapiens	Inhibition	%	2.91
	8158392	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	5.26	CHEMBL4246	Homo sapiens	Inhibition	%	5.26
	8158550	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	0.49	CHEMBL4246	Homo sapiens	Inhibition	%	0.49
	8158774	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)c2ccnc(N3CCCC3)c2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL477182	=	Inhibition	%	3.83	CHEMBL4246	Homo sapiens	Inhibition	%	3.83
	8158943	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	2.72	CHEMBL4246	Homo sapiens	Inhibition	%	2.72
	8159078	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	4.6	CHEMBL4246	Homo sapiens	Inhibition	%	4.6
	8159302	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	5.08	CHEMBL4246	Homo sapiens	Inhibition	%	5.08
	8159422	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	6.05	CHEMBL4246	Homo sapiens	Inhibition	%	6.05
	8159777	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.56	CHEMBL4246	Homo sapiens	Inhibition	%	5.56
	8159918	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	1.69	CHEMBL4246	Homo sapiens	Inhibition	%	1.69
	8160279	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	3.74	CHEMBL4246	Homo sapiens	Inhibition	%	3.74
	8160429	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	2.08	CHEMBL4246	Homo sapiens	Inhibition	%	2.08
	8160653	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	-0.76	CHEMBL4246	Homo sapiens	Inhibition	%	-0.76
	8160723	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	5.2	CHEMBL4246	Homo sapiens	Inhibition	%	5.2
	8160947	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(-c2cc3c(NC(=O)C4CC4)ncnc3o2)cc1		CHEMBL182283	=	Inhibition	%	13.13	CHEMBL4246	Homo sapiens	Inhibition	%	13.13
	8161097	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	5.49	CHEMBL4246	Homo sapiens	Inhibition	%	5.49
	8161240	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2ncc(-c3ccccc3)o2)cc1		CHEMBL194062	=	Inhibition	%	7.4	CHEMBL4246	Homo sapiens	Inhibition	%	7.4
	8161464	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	6.85	CHEMBL4246	Homo sapiens	Inhibition	%	6.85
	8161589	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]nc(C)c3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL218720	=	Inhibition	%	8.29	CHEMBL4246	Homo sapiens	Inhibition	%	8.29
	8161951	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2ncc3c(C)nc(-c4cccc(C(F)(F)F)c4)n3n2)cc(OC)c1OC		CHEMBL520037	=	Inhibition	%	16.9	CHEMBL4246	Homo sapiens	Inhibition	%	16.9
	8162081	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	3.74	CHEMBL4246	Homo sapiens	Inhibition	%	3.74
	8162305	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1C1=C(Nc2ccccc2)C(=O)NC1=O		CHEMBL156263	=	Inhibition	%	5.84	CHEMBL4246	Homo sapiens	Inhibition	%	5.84
	8162465	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	0.68	CHEMBL4246	Homo sapiens	Inhibition	%	0.68
	8162718	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	4.37	CHEMBL4246	Homo sapiens	Inhibition	%	4.37
	8163090	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	5.73	CHEMBL4246	Homo sapiens	Inhibition	%	5.73
	8163259	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3cc(F)ccc3F)ccc12)C1CC1		CHEMBL261440	=	Inhibition	%	4.04	CHEMBL4246	Homo sapiens	Inhibition	%	4.04
	8163617	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1)N1CCOCC1		CHEMBL507329	=	Inhibition	%	4.41	CHEMBL4246	Homo sapiens	Inhibition	%	4.41
	8163740	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-1.67	CHEMBL4246	Homo sapiens	Inhibition	%	-1.67
	8163964	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2c(-c3ccncc3)nc3n2CCS3)cc1		CHEMBL266707	=	Inhibition	%	-0.75	CHEMBL4246	Homo sapiens	Inhibition	%	-0.75
	8164098	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	4.67	CHEMBL4246	Homo sapiens	Inhibition	%	4.67
	8164238	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(-c2nc3n(c2-c2ccc4c(c2)OCO4)CCC3)nc1		CHEMBL1909377	=	Inhibition	%	0.69	CHEMBL4246	Homo sapiens	Inhibition	%	0.69
	8164462	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	1.41	CHEMBL4246	Homo sapiens	Inhibition	%	1.41
	8164617	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)CN2CCOCC2)sc2c1CCCC2.O=C(O)C(=O)O		CHEMBL1909342	=	Inhibition	%	7.22	CHEMBL4246	Homo sapiens	Inhibition	%	7.22
	8164985	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCC(O)CC2)n1		CHEMBL1888586	=	Inhibition	%	5.34	CHEMBL4246	Homo sapiens	Inhibition	%	5.34
	8165279	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	5.55	CHEMBL4246	Homo sapiens	Inhibition	%	5.55
	8165420	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(c1ccc(NC(=O)NCCN2CCOCC2)cc1)c1ccnc(Nc2ccc(CS(C)(=O)=O)cc2)n1.Cl		CHEMBL1909361	=	Inhibition	%	24.75	CHEMBL4246	Homo sapiens	Inhibition	%	24.75
	8165787	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(Nc4ccc5c(c4)OCCO5)n3)c2c1		CHEMBL361894	=	Inhibition	%	19.79	CHEMBL4246	Homo sapiens	Inhibition	%	19.79
	8165913	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	3.78	CHEMBL4246	Homo sapiens	Inhibition	%	3.78
	8166137	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cccc(O)c1		CHEMBL160937	=	Inhibition	%	4.55	CHEMBL4246	Homo sapiens	Inhibition	%	4.55
	8166275	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	3.27	CHEMBL4246	Homo sapiens	Inhibition	%	3.27
	8166629	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	5.02	CHEMBL4246	Homo sapiens	Inhibition	%	5.02
	8166730	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	23.65	CHEMBL4246	Homo sapiens	Inhibition	%	23.65
	8166954	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(Nc2nccc(Nc3ccc4c(C)n[nH]c4c3)n2)cc(OC)c1OC		CHEMBL479079	=	Inhibition	%	63.12	CHEMBL4246	Homo sapiens	Inhibition	%	63.12
	8167042	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cncc(C(=O)N3CC[C@H](N)C3)c21.Cl		CHEMBL1909384	=	Inhibition	%	3.68	CHEMBL4246	Homo sapiens	Inhibition	%	3.68
	8167407	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(NC=C2C(=O)Nc3ccc4ncsc4c32)cc1		CHEMBL1794055	=	Inhibition	%	22.42	CHEMBL4246	Homo sapiens	Inhibition	%	22.42
	8167571	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	2.31	CHEMBL4246	Homo sapiens	Inhibition	%	2.31
	8167928	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	6.29	CHEMBL4246	Homo sapiens	Inhibition	%	6.29
	8168276	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.11	CHEMBL4246	Homo sapiens	Inhibition	%	2.11
	8168417	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCN1CCCC(c2ccc(Nc3nc(Nc4cc(F)ccc4C(N)=O)c4cc[nH]c4n3)c(OC)c2)C1		CHEMBL477069	=	Inhibition	%	9.82	CHEMBL4246	Homo sapiens	Inhibition	%	9.82
	8168777	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1(C)CC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(N)n2)CC(C)(C)N1		CHEMBL95502	=	Inhibition	%	-0.41	CHEMBL4246	Homo sapiens	Inhibition	%	-0.41
	8168941	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	8.87	CHEMBL4246	Homo sapiens	Inhibition	%	8.87
	8169307	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	3.96	CHEMBL4246	Homo sapiens	Inhibition	%	3.96
	8169611	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1ncccc1Nc1nc(Nc2cc3c(cc2OC)CCCN3C(=O)CN(C)C)nc2[nH]ccc12		CHEMBL1895450	=	Inhibition	%	7.76	CHEMBL4246	Homo sapiens	Inhibition	%	7.76
	8169745	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	3.62	CHEMBL4246	Homo sapiens	Inhibition	%	3.62
	8169969	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2Cl)=C1Nc1cc(Cl)c(O)c(Cl)c1		CHEMBL157258	=	Inhibition	%	7.44	CHEMBL4246	Homo sapiens	Inhibition	%	7.44
	8170114	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	3.65	CHEMBL4246	Homo sapiens	Inhibition	%	3.65
	8170463	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	5.22	CHEMBL4246	Homo sapiens	Inhibition	%	5.22
	8170603	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.NS(=O)(=O)c1cccc(Nc2cc(-c3ccc(F)cc3)n[nH]2)c1		CHEMBL1909351	=	Inhibition	%	6.08	CHEMBL4246	Homo sapiens	Inhibition	%	6.08
	8170962	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Oc1cccc(-c2nc(-c3ccccc3)[nH]c2-c2ccncc2)c1		CHEMBL1909413	=	Inhibition	%	9.92	CHEMBL4246	Homo sapiens	Inhibition	%	9.92
	8171159	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(CCCNc2nc3ccc(Oc4ccc(NC(=O)Nc5cc(C(F)(F)F)ccc5F)cc4)cc3[nH]2)CC1.Cl		CHEMBL1909372	=	Inhibition	%	5.07	CHEMBL4246	Homo sapiens	Inhibition	%	5.07
	8171376	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	3.35	CHEMBL4246	Homo sapiens	Inhibition	%	3.35
	8171600	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2cnc(Oc3cccc(NC(=O)c4ccc(OCCN5CCOCC5)cc4)c3)cc21.Cl		CHEMBL1909363	=	Inhibition	%	5.81	CHEMBL4246	Homo sapiens	Inhibition	%	5.81
	8171741	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	5.38	CHEMBL4246	Homo sapiens	Inhibition	%	5.38
	8171894	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Inhibition	%	3.43	CHEMBL4246	Homo sapiens	Inhibition	%	3.43
	8172118	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	-1.33	CHEMBL4246	Homo sapiens	Inhibition	%	-1.33
	8172250	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2ccc(F)cc21		CHEMBL426800	=	Inhibition	%	3.97	CHEMBL4246	Homo sapiens	Inhibition	%	3.97
	8172602	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)NC(=O)N1		CHEMBL384073	=	Inhibition	%	2.37	CHEMBL4246	Homo sapiens	Inhibition	%	2.37
	8172744	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	5.81	CHEMBL4246	Homo sapiens	Inhibition	%	5.81
	8172968	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1ccc2c(-c3ccnc(NCCCO)n3)c(-c3ccc(F)cc3)nn2c1		CHEMBL1909404	=	Inhibition	%	16.13	CHEMBL4246	Homo sapiens	Inhibition	%	16.13
	8173104	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-1.67	CHEMBL4246	Homo sapiens	Inhibition	%	-1.67
	8173269	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1cccc(Nc2nccc(-c3cnn4ncccc34)n2)c1		CHEMBL495696	=	Inhibition	%	39.33	CHEMBL4246	Homo sapiens	Inhibition	%	39.33
	8173493	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	6.13	CHEMBL4246	Homo sapiens	Inhibition	%	6.13
	8173634	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)Nc1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL102936	=	Inhibition	%	7.11	CHEMBL4246	Homo sapiens	Inhibition	%	7.11
	8173945	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	5.46	CHEMBL4246	Homo sapiens	Inhibition	%	5.46
	8174301	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	6.12	CHEMBL4246	Homo sapiens	Inhibition	%	6.12
	8174449	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1ncnc2occ(-c3ccc(NC(=O)Nc4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc3)c12		CHEMBL396107	=	Inhibition	%	6.33	CHEMBL4246	Homo sapiens	Inhibition	%	6.33
	8174795	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cccc2c1NC(=O)/C2=N\Nc1ccc(S(N)(=O)=O)cc1		CHEMBL1909398	=	Inhibition	%	7.22	CHEMBL4246	Homo sapiens	Inhibition	%	7.22
	8174938	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	-0.71	CHEMBL4246	Homo sapiens	Inhibition	%	-0.71
	8175162	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OCC3CCNCC3)c21.O=C(O)C(F)(F)F		CHEMBL1794065	=	Inhibition	%	0.43	CHEMBL4246	Homo sapiens	Inhibition	%	0.43
	8175298	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	2.28	CHEMBL4246	Homo sapiens	Inhibition	%	2.28
	8175554	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	3.72	CHEMBL4246	Homo sapiens	Inhibition	%	3.72
	8175941	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	25.76	CHEMBL4246	Homo sapiens	Inhibition	%	25.76
	8176094	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2c(cc1Nc1nc(Nc3ccsc3C(N)=O)c3cc[nH]c3n1)N(C(=O)CN(C)C)CCC2(C)C		CHEMBL463931	=	Inhibition	%	8.93	CHEMBL4246	Homo sapiens	Inhibition	%	8.93
	8176467	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4cccc(F)c4)ncnc32)c1		CHEMBL69757	=	Inhibition	%	2.09	CHEMBL4246	Homo sapiens	Inhibition	%	2.09
	8176599	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	9.34	CHEMBL4246	Homo sapiens	Inhibition	%	9.34
	8176823	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc2[nH]c(=O)[nH]c2c1		CHEMBL1794057	=	Inhibition	%	13.83	CHEMBL4246	Homo sapiens	Inhibition	%	13.83
	8176953	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.42	CHEMBL4246	Homo sapiens	Inhibition	%	0.42
	8177319	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	15.11	CHEMBL4246	Homo sapiens	Inhibition	%	15.11
	8177457	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)c1		CHEMBL407113	=	Inhibition	%	-2.6	CHEMBL4246	Homo sapiens	Inhibition	%	-2.6
	8177845	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccncc4)ncnc32)c1		CHEMBL306865	=	Inhibition	%	17.23	CHEMBL4246	Homo sapiens	Inhibition	%	17.23
	8177985	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	3.68	CHEMBL4246	Homo sapiens	Inhibition	%	3.68
	8178209	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.O=C1Nc2ccc(-c3cccnc3)cc2C1=Cc1cc(Br)c(O)c(Br)c1		CHEMBL1794050	=	Inhibition	%	8.99	CHEMBL4246	Homo sapiens	Inhibition	%	8.99
	8178297	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCCc4c[nH]cn4)cc32)cc1		CHEMBL272028	=	Inhibition	%	12.07	CHEMBL4246	Homo sapiens	Inhibition	%	12.07
	8178648	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1cncc(/C=C/c2c(C)cc(O)cc2C)c1		CHEMBL220243	=	Inhibition	%	20.52	CHEMBL4246	Homo sapiens	Inhibition	%	20.52
	8178797	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	2.57	CHEMBL4246	Homo sapiens	Inhibition	%	2.57
	8179021	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(NCC1CC1)c1ccc(-c2cccc(C(=O)NC3CC3)c2)cc1		CHEMBL479038	=	Inhibition	%	6.01	CHEMBL4246	Homo sapiens	Inhibition	%	6.01
	8179144	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	4.9	CHEMBL4246	Homo sapiens	Inhibition	%	4.9
	8179512	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	3.82	CHEMBL4246	Homo sapiens	Inhibition	%	3.82
	8179649	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(C)c1ccc(Nc2nccc(-c3cnn4ncccc34)n2)cc1		CHEMBL359963	=	Inhibition	%	7.14	CHEMBL4246	Homo sapiens	Inhibition	%	7.14
	8179906	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C/Nc1ccc(-n2cncn2)cc1		CHEMBL1794056	=	Inhibition	%	5.42	CHEMBL4246	Homo sapiens	Inhibition	%	5.42
	8180130	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	3.47	CHEMBL4246	Homo sapiens	Inhibition	%	3.47
	8180284	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1nn(C)c2cc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)ccc12.Cl		CHEMBL1794073	=	Inhibition	%	67.92	CHEMBL4246	Homo sapiens	Inhibition	%	67.92
	8180440	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.69	CHEMBL4246	Homo sapiens	Inhibition	%	4.69
	8180664	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NCc1ccc(-n2c(-c3nonc3N)nc3cnccc32)cc1		CHEMBL188268	=	Inhibition	%	4.95	CHEMBL4246	Homo sapiens	Inhibition	%	4.95
	8180812	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	1.4	CHEMBL4246	Homo sapiens	Inhibition	%	1.4
	8181169	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	77.91	CHEMBL4246	Homo sapiens	Inhibition	%	77.91
	8181300	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCn4ccnc4)cc3)c2)nc1		CHEMBL208437	=	Inhibition	%	0.73	CHEMBL4246	Homo sapiens	Inhibition	%	0.73
	8181664	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(-c2nn[nH]n2)c1.Cl		CHEMBL1909352	=	Inhibition	%	64.98	CHEMBL4246	Homo sapiens	Inhibition	%	64.98
	8181803	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	6.89	CHEMBL4246	Homo sapiens	Inhibition	%	6.89
	8182027	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2[nH]c3c4[nH]c5ccc(OC)cc5c4c4c(c3c2c1)C(=O)NC4=O		CHEMBL1956068	=	Inhibition	%	31.01	CHEMBL4246	Homo sapiens	Inhibition	%	31.01
	8182190	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	4.57	CHEMBL4246	Homo sapiens	Inhibition	%	4.57
	8182554	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	4.32	CHEMBL4246	Homo sapiens	Inhibition	%	4.32
	8182646	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	3.98	CHEMBL4246	Homo sapiens	Inhibition	%	3.98
	8182870	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)C(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL517123	=	Inhibition	%	6.52	CHEMBL4246	Homo sapiens	Inhibition	%	6.52
	8182992	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	5.0	CHEMBL4246	Homo sapiens	Inhibition	%	5.0
	8183365	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	8.3	CHEMBL4246	Homo sapiens	Inhibition	%	8.3
	8183494	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCNC(=O)O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3s2)C1		CHEMBL512076	=	Inhibition	%	5.79	CHEMBL4246	Homo sapiens	Inhibition	%	5.79
	8183860	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(C(=O)NCc4ccncc4)cc32)cc1		CHEMBL272165	=	Inhibition	%	7.13	CHEMBL4246	Homo sapiens	Inhibition	%	7.13
	8183996	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	2.93	CHEMBL4246	Homo sapiens	Inhibition	%	2.93
	8184220	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCCN(CCS(C)(=O)=O)Cc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1.Cl		CHEMBL1909394	=	Inhibition	%	4.68	CHEMBL4246	Homo sapiens	Inhibition	%	4.68
	8184486	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(C(=O)Nc2n[nH]c3nnc(-c4ccccc4)cc23)CC1.Cl		CHEMBL1909344	=	Inhibition	%	4.52	CHEMBL4246	Homo sapiens	Inhibition	%	4.52
	8184633	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	-0.22	CHEMBL4246	Homo sapiens	Inhibition	%	-0.22
	8185014	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	11.3	CHEMBL4246	Homo sapiens	Inhibition	%	11.3
	8185163	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1ccc2c(c1)/C(=C/Nc1ccc(S(N)(=O)=O)cc1)C(=O)N2		CHEMBL272414	=	Inhibition	%	2.35	CHEMBL4246	Homo sapiens	Inhibition	%	2.35
	8185518	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2ccc(S(C)(=O)=O)cc12		CHEMBL237347	=	Inhibition	%	82.71	CHEMBL4246	Homo sapiens	Inhibition	%	82.71
	8185649	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-1.54	CHEMBL4246	Homo sapiens	Inhibition	%	-1.54
	8185873	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C/C(Nc1ccc(S(N)(=O)=O)cc1)=C1/C(=O)Nc2ccccc21		CHEMBL405042	=	Inhibition	%	-2.14	CHEMBL4246	Homo sapiens	Inhibition	%	-2.14
	8186012	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	7.27	CHEMBL4246	Homo sapiens	Inhibition	%	7.27
	8186377	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	6.05	CHEMBL4246	Homo sapiens	Inhibition	%	6.05
	8186541	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccc(F)cc2)c(-c2ccc3ncccc3n2)s1		CHEMBL361237	=	Inhibition	%	6.46	CHEMBL4246	Homo sapiens	Inhibition	%	6.46
	8186904	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(Nc2nccc(-c3c(-c4ccc(C(F)(F)F)cc4)nn4ncccc34)n2)cc1F		CHEMBL188784	=	Inhibition	%	6.72	CHEMBL4246	Homo sapiens	Inhibition	%	6.72
	8187226	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	5.81	CHEMBL4246	Homo sapiens	Inhibition	%	5.81
	8187350	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(F)cc4)ncnc32)c1		CHEMBL65884	=	Inhibition	%	9.02	CHEMBL4246	Homo sapiens	Inhibition	%	9.02
	8187722	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(OC)c3)o2)c1		CHEMBL179311	=	Inhibition	%	35.47	CHEMBL4246	Homo sapiens	Inhibition	%	35.47
	8187851	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	3.97	CHEMBL4246	Homo sapiens	Inhibition	%	3.97
	8188075	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	FC(F)(F)c1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL185939	=	Inhibition	%	5.21	CHEMBL4246	Homo sapiens	Inhibition	%	5.21
	8188218	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	4.2	CHEMBL4246	Homo sapiens	Inhibition	%	4.2
	8188577	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	-0.19	CHEMBL4246	Homo sapiens	Inhibition	%	-0.19
	8188851	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	4.75	CHEMBL4246	Homo sapiens	Inhibition	%	4.75
	8188999	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1cccc(COc2ccc(Nc3ncnc4cc(-c5ccc[nH]5)sc34)cc2Cl)c1		CHEMBL1909415	=	Inhibition	%	3.69	CHEMBL4246	Homo sapiens	Inhibition	%	3.69
	8189223	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	3.27	CHEMBL4246	Homo sapiens	Inhibition	%	3.27
	8189379	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc4c(c3)OCCO4)n2)cc1		CHEMBL365297	=	Inhibition	%	45.28	CHEMBL4246	Homo sapiens	Inhibition	%	45.28
	8189528	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.58	CHEMBL4246	Homo sapiens	Inhibition	%	0.58
	8189752	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC(=O)NCc1cccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)c1		CHEMBL207247	=	Inhibition	%	0.89	CHEMBL4246	Homo sapiens	Inhibition	%	0.89
	8189884	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	5.96	CHEMBL4246	Homo sapiens	Inhibition	%	5.96
	8190240	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	4.41	CHEMBL4246	Homo sapiens	Inhibition	%	4.41
	8190380	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccccc3)ccc12)C1CC1		CHEMBL405021	=	Inhibition	%	16.38	CHEMBL4246	Homo sapiens	Inhibition	%	16.38
	8190741	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccc(F)c(F)c3)n2)cc1		CHEMBL427159	=	Inhibition	%	7.67	CHEMBL4246	Homo sapiens	Inhibition	%	7.67
	8190905	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	5.51	CHEMBL4246	Homo sapiens	Inhibition	%	5.51
	8191129	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(C2=C(N3CCc4ccccc43)C(=O)NC2=O)cc1		CHEMBL347580	=	Inhibition	%	6.81	CHEMBL4246	Homo sapiens	Inhibition	%	6.81
	8191267	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	5.73	CHEMBL4246	Homo sapiens	Inhibition	%	5.73
	8191587	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(N)=O)c1		CHEMBL218088	=	Inhibition	%	32.24	CHEMBL4246	Homo sapiens	Inhibition	%	32.24
	8191709	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	6.32	CHEMBL4246	Homo sapiens	Inhibition	%	6.32
	8191933	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2c(-c3ccnc(Nc4cccc(OC(F)(F)F)c4)n3)cnn2n1		CHEMBL365248	=	Inhibition	%	11.92	CHEMBL4246	Homo sapiens	Inhibition	%	11.92
	8192082	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	4.18	CHEMBL4246	Homo sapiens	Inhibition	%	4.18
	8192435	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	2.72	CHEMBL4246	Homo sapiens	Inhibition	%	2.72
	8192579	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(N/N=C2\C(=O)Nc3ccc(Cl)cc32)cc1		CHEMBL270054	=	Inhibition	%	6.14	CHEMBL4246	Homo sapiens	Inhibition	%	6.14
	8192803	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	6.1	CHEMBL4246	Homo sapiens	Inhibition	%	6.1
	8192939	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(S(C)(=O)=O)cc4)ncnc32)c1		CHEMBL66292	=	Inhibition	%	10.42	CHEMBL4246	Homo sapiens	Inhibition	%	10.42
	8193211	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCN(Cc2ccc(-c3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4s3)o2)CC1		CHEMBL475761	=	Inhibition	%	6.65	CHEMBL4246	Homo sapiens	Inhibition	%	6.65
	8193580	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3c2cnn3C(C)C)ccc1O		CHEMBL63728	=	Inhibition	%	13.56	CHEMBL4246	Homo sapiens	Inhibition	%	13.56
	8193737	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	4.94	CHEMBL4246	Homo sapiens	Inhibition	%	4.94
	8194110	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-1.85	CHEMBL4246	Homo sapiens	Inhibition	%	-1.85
	8194241	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	C#Cc1cccc(Nc2ncnc3ccc(OCCCCNCCS(C)(=O)=O)cc23)c1		CHEMBL517907	=	Inhibition	%	9.84	CHEMBL4246	Homo sapiens	Inhibition	%	9.84
	8194596	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccccc1-c1cc(/C=C2\C(=O)Nc3ncc(Br)cc32)cc(Br)c1O		CHEMBL176857	=	Inhibition	%	10.27	CHEMBL4246	Homo sapiens	Inhibition	%	10.27
	8194739	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	18.53	CHEMBL4246	Homo sapiens	Inhibition	%	18.53
	8194963	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccncc2)cc(-c2ccccc2)c1N		CHEMBL230911	=	Inhibition	%	58.7	CHEMBL4246	Homo sapiens	Inhibition	%	58.7
	8195096	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	6.05	CHEMBL4246	Homo sapiens	Inhibition	%	6.05
	8195484	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	3.56	CHEMBL4246	Homo sapiens	Inhibition	%	3.56
	8195623	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCNC(=O)Nc1ccc(N(C)c2ccnc(Nc3ccc(CS(C)(=O)=O)cc3)n2)cc1.Cl		CHEMBL1909362	=	Inhibition	%	14.7	CHEMBL4246	Homo sapiens	Inhibition	%	14.7
	8195945	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	3.03	CHEMBL4246	Homo sapiens	Inhibition	%	3.03
	8196286	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	4.4	CHEMBL4246	Homo sapiens	Inhibition	%	4.4
	8196436	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCc1cccc(CC)c1/C=C/c1cncc(C(=O)NC)c1		CHEMBL385426	=	Inhibition	%	7.25	CHEMBL4246	Homo sapiens	Inhibition	%	7.25
	8196660	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	10.57	CHEMBL4246	Homo sapiens	Inhibition	%	10.57
	8196788	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(CNC(=O)c2ccc(-c3cc(-c4nnc(C)o4)ccc3C)cc2)cc1		CHEMBL269985	=	Inhibition	%	3.52	CHEMBL4246	Homo sapiens	Inhibition	%	3.52
	8197153	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CNC(=O)c1cncc(/C=C/c2ccccc2C)c1		CHEMBL218969	=	Inhibition	%	16.41	CHEMBL4246	Homo sapiens	Inhibition	%	16.41
	8197290	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	2.25	CHEMBL4246	Homo sapiens	Inhibition	%	2.25
	8197565	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	2.88	CHEMBL4246	Homo sapiens	Inhibition	%	2.88
	8197929	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	1.67	CHEMBL4246	Homo sapiens	Inhibition	%	1.67
	8198086	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(N/C=C2\C(=O)Nc3ccccc32)c1		CHEMBL1794059	=	Inhibition	%	7.41	CHEMBL4246	Homo sapiens	Inhibition	%	7.41
	8198448	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCn1c(-c2nonc2N)nc2c(N3CCCC3)nccc21		CHEMBL187985	=	Inhibition	%	-3.76	CHEMBL4246	Homo sapiens	Inhibition	%	-3.76
	8198578	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	11.11	CHEMBL4246	Homo sapiens	Inhibition	%	11.11
	8198802	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncnc(Nc3ccc(C)c(O)c3)c2cc1OC.Cl		CHEMBL1909357	=	Inhibition	%	36.6	CHEMBL4246	Homo sapiens	Inhibition	%	36.6
	8198933	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	6.1	CHEMBL4246	Homo sapiens	Inhibition	%	6.1
	8199305	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	5.94	CHEMBL4246	Homo sapiens	Inhibition	%	5.94
	8199439	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN1CCC(n2cnc(-c3ccc(F)cc3)c2-c2ccnc(NCCO)n2)CC1		CHEMBL330422	=	Inhibition	%	5.09	CHEMBL4246	Homo sapiens	Inhibition	%	5.09
	8199663	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.69	CHEMBL4246	Homo sapiens	Inhibition	%	4.69
	8199826	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccc(C(=O)c3ccco3)cc2C1=Cc1cc(Cl)c(O)c(Cl)c1		CHEMBL1789963	=	Inhibition	%	9.55	CHEMBL4246	Homo sapiens	Inhibition	%	9.55
	8199964	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	7.61	CHEMBL4246	Homo sapiens	Inhibition	%	7.61
	8200188	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	OCc1ccc(-c2nc(-c3ccccn3)c(-c3ccc4c(c3)OCO4)[nH]2)cc1		CHEMBL267228	=	Inhibition	%	11.1	CHEMBL4246	Homo sapiens	Inhibition	%	11.1
	8200292	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc(F)cc2)N=C(c2ccc(C(F)(F)F)nc2)N1		CHEMBL485598	=	Inhibition	%	7.4	CHEMBL4246	Homo sapiens	Inhibition	%	7.4
	8200631	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Cc2nc3ccc(Nc4ncnc5ccccc45)cc3[nH]2)cc1		CHEMBL1909379	=	Inhibition	%	8.08	CHEMBL4246	Homo sapiens	Inhibition	%	8.08
	8201005	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc2c(-c3ccnc(Nc4ccccc4)n3)c(-c3ccc(F)cc3)nn2n1		CHEMBL189459	=	Inhibition	%	38.08	CHEMBL4246	Homo sapiens	Inhibition	%	38.08
	8201135	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	-0.38	CHEMBL4246	Homo sapiens	Inhibition	%	-0.38
	8201494	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	2.94	CHEMBL4246	Homo sapiens	Inhibition	%	2.94
	8201627	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCOc1ccc2c(-c3ccnc(Nc4cc(OC)cc(C(F)(F)F)c4)n3)cnn2n1		CHEMBL188426	=	Inhibition	%	7.24	CHEMBL4246	Homo sapiens	Inhibition	%	7.24
	8201851	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.44	CHEMBL4246	Homo sapiens	Inhibition	%	0.44
	8201906	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1cc(-c2ccc(F)cc2)cc(-c2ccncc2)c1N		CHEMBL231623	=	Inhibition	%	5.71	CHEMBL4246	Homo sapiens	Inhibition	%	5.71
	8202130	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	3.58	CHEMBL4246	Homo sapiens	Inhibition	%	3.58
	8202270	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL514162	=	Inhibition	%	7.65	CHEMBL4246	Homo sapiens	Inhibition	%	7.65
	8202437	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	0.9	CHEMBL4246	Homo sapiens	Inhibition	%	0.9
	8202661	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL1909406	=	Inhibition	%	2.31	CHEMBL4246	Homo sapiens	Inhibition	%	2.31
	8202786	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.71	CHEMBL4246	Homo sapiens	Inhibition	%	3.71
	8203140	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	5.62	CHEMBL4246	Homo sapiens	Inhibition	%	5.62
	8203271	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(N2CCc3ccccc32)=C1c1ccc(Cl)cc1		CHEMBL156524	=	Inhibition	%	9.11	CHEMBL4246	Homo sapiens	Inhibition	%	9.11
	8203495	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	13.82	CHEMBL4246	Homo sapiens	Inhibition	%	13.82
	8203641	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)c1cc2c(Nc3ccc4nc(Cc5ccccc5)[nH]c4c3)ncnc2cn1		CHEMBL531804	=	Inhibition	%	11.87	CHEMBL4246	Homo sapiens	Inhibition	%	11.87
	8203999	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1cccc(COc2ccc(Nc3ncncc3C#Cc3ccccc3)cc2Cl)c1		CHEMBL379093	=	Inhibition	%	4.11	CHEMBL4246	Homo sapiens	Inhibition	%	4.11
	8204165	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	5.96	CHEMBL4246	Homo sapiens	Inhibition	%	5.96
	8204526	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	45.98	CHEMBL4246	Homo sapiens	Inhibition	%	45.98
	8204631	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	2.78	CHEMBL4246	Homo sapiens	Inhibition	%	2.78
	8204855	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Clc1ccc(-c2nn3ncccc3c2-c2ccnc(Nc3ccccc3)n2)cc1		CHEMBL189148	=	Inhibition	%	15.15	CHEMBL4246	Homo sapiens	Inhibition	%	15.15
	8204970	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	8.19	CHEMBL4246	Homo sapiens	Inhibition	%	8.19
	8205343	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	5.06	CHEMBL4246	Homo sapiens	Inhibition	%	5.06
	8205479	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4cccs4)c(C(N)=O)s3)c2cc1OC		CHEMBL480382	=	Inhibition	%	2.67	CHEMBL4246	Homo sapiens	Inhibition	%	2.67
	8205703	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	3.96	CHEMBL4246	Homo sapiens	Inhibition	%	3.96
	8205842	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2cc3ccncc3cc2OCc2ccccc2)cc1		CHEMBL483748	=	Inhibition	%	4.44	CHEMBL4246	Homo sapiens	Inhibition	%	4.44
	8206198	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc([S+](C)[O-])cc4C)n3C)ccc2c1		CHEMBL237570	=	Inhibition	%	0.84	CHEMBL4246	Homo sapiens	Inhibition	%	0.84
	8206474	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(C(F)(F)F)c4)c3c2)o1		CHEMBL215814	=	Inhibition	%	4.26	CHEMBL4246	Homo sapiens	Inhibition	%	4.26
	8206617	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.8	CHEMBL4246	Homo sapiens	Inhibition	%	-1.8
	8207021	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.0	CHEMBL4246	Homo sapiens	Inhibition	%	4.0
	8207147	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Fc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL381948	=	Inhibition	%	3.67	CHEMBL4246	Homo sapiens	Inhibition	%	3.67
	8207371	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.56	CHEMBL4246	Homo sapiens	Inhibition	%	5.56
	8207501	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccccc2)=C1Nc1ccccc1		CHEMBL346551	=	Inhibition	%	9.18	CHEMBL4246	Homo sapiens	Inhibition	%	9.18
	8207857	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1c2ccc(N(C)c3ccnc(Nc4cccc(S(N)(=O)=O)c4)n3)cc2nn1C.Cl		CHEMBL1909359	=	Inhibition	%	50.17	CHEMBL4246	Homo sapiens	Inhibition	%	50.17
	8208002	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	2.64	CHEMBL4246	Homo sapiens	Inhibition	%	2.64
	8208358	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	4.44	CHEMBL4246	Homo sapiens	Inhibition	%	4.44
	8208524	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1cc(O)cc(C)c1/C=C/c1cncc(C(=O)OC(C)(C)C)c1		CHEMBL374060	=	Inhibition	%	30.16	CHEMBL4246	Homo sapiens	Inhibition	%	30.16
	8208748	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	2.81	CHEMBL4246	Homo sapiens	Inhibition	%	2.81
	8208881	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(O)cc1Nc1ccnc2cc(-c3ccccn3)ccc12.Cl		CHEMBL581096	=	Inhibition	%	83.4	CHEMBL4246	Homo sapiens	Inhibition	%	83.4
	8209210	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	2.94	CHEMBL4246	Homo sapiens	Inhibition	%	2.94
	8209326	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(/C=N/Nc2ncnc3[nH]ncc23)ccc1O		CHEMBL66004	=	Inhibition	%	38.57	CHEMBL4246	Homo sapiens	Inhibition	%	38.57
	8209550	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	3.91	CHEMBL4246	Homo sapiens	Inhibition	%	3.91
	8209700	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1cc(-c2cnn3nc(N4CCOCC4)ccc23)nc(NC2CC2)n1		CHEMBL495771	=	Inhibition	%	8.36	CHEMBL4246	Homo sapiens	Inhibition	%	8.36
	8210060	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCOc1nccc2c1nc(-c1nonc1N)n2CC		CHEMBL188240	=	Inhibition	%	5.87	CHEMBL4246	Homo sapiens	Inhibition	%	5.87
	8210201	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	5.07	CHEMBL4246	Homo sapiens	Inhibition	%	5.07
	8210561	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.0	CHEMBL4246	Homo sapiens	Inhibition	%	-2.0
	8210820	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.01	CHEMBL4246	Homo sapiens	Inhibition	%	0.01
	8210964	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.Nc1nc(-c2ccc3c(c2)C(=Cc2cc(Br)c(O)c(Br)c2)C(=O)N3)cs1		CHEMBL1794053	=	Inhibition	%	-1.0	CHEMBL4246	Homo sapiens	Inhibition	%	-1.0
	8211188	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	3.18	CHEMBL4246	Homo sapiens	Inhibition	%	3.18
	8211358	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCCn1c(-c2nonc2N)nc2cnccc21		CHEMBL191105	=	Inhibition	%	4.06	CHEMBL4246	Homo sapiens	Inhibition	%	4.06
	8211705	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2cccc(Cl)c2)c(-c2ccc3ncccc3n2)s1		CHEMBL365663	=	Inhibition	%	5.26	CHEMBL4246	Homo sapiens	Inhibition	%	5.26
	8211834	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	6.51	CHEMBL4246	Homo sapiens	Inhibition	%	6.51
	8212190	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	5.34	CHEMBL4246	Homo sapiens	Inhibition	%	5.34
	8212331	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1cnn2ncc(-c3ccnc(NCCCN4CCOCC4)n3)c2c1		CHEMBL524901	=	Inhibition	%	3.12	CHEMBL4246	Homo sapiens	Inhibition	%	3.12
	8212555	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	3.06	CHEMBL4246	Homo sapiens	Inhibition	%	3.06
	8212688	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2cc(-c3c[nH]nc3-c3ccccn3)ccn2)cc1		CHEMBL202891	=	Inhibition	%	5.59	CHEMBL4246	Homo sapiens	Inhibition	%	5.59
	8213082	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2ccc3[nH]ncc3c2)C(c2ccc3ccccc3c2)CC(=O)N1		CHEMBL441702	=	Inhibition	%	9.73	CHEMBL4246	Homo sapiens	Inhibition	%	9.73
	8213211	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	4.66	CHEMBL4246	Homo sapiens	Inhibition	%	4.66
	8213539	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(-c4ccccc4F)c3)o2)c1		CHEMBL372474	=	Inhibition	%	12.71	CHEMBL4246	Homo sapiens	Inhibition	%	12.71
	8213876	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nc(-c2ccccn2)c(-c2ccc3ncccc3n2)s1		CHEMBL181361	=	Inhibition	%	7.33	CHEMBL4246	Homo sapiens	Inhibition	%	7.33
	8214023	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	4.93	CHEMBL4246	Homo sapiens	Inhibition	%	4.93
	8214384	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	5.59	CHEMBL4246	Homo sapiens	Inhibition	%	5.59
	8214518	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(NC(=O)CC2CC2)cc1-c1ccc(C(=O)NCC2CC2)cc1		CHEMBL516908	=	Inhibition	%	8.67	CHEMBL4246	Homo sapiens	Inhibition	%	8.67
	8214742	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	17.96	CHEMBL4246	Homo sapiens	Inhibition	%	17.96
	8214894	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CCN1CCC(CC(=O)Nc2n[nH]c3nc(-c4cccs4)c(Br)cc23)CC1.O=C(O)C(O)C(O)C(=O)O		CHEMBL2062290	=	Inhibition	%	-2.77	CHEMBL4246	Homo sapiens	Inhibition	%	-2.77
	8215145	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2ccc(C)c(-c3ccc(C(=O)NCc4ccc(Cl)cc4)cc3)c2)o1		CHEMBL402108	=	Inhibition	%	0.03	CHEMBL4246	Homo sapiens	Inhibition	%	0.03
	8215522	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COC(=O)c1sc(-n2cnc3cc(OC)c(OC)cc32)cc1OCc1ccccc1C(F)(F)F		CHEMBL473420	=	Inhibition	%	6.98	CHEMBL4246	Homo sapiens	Inhibition	%	6.98
	8215686	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	4.74	CHEMBL4246	Homo sapiens	Inhibition	%	4.74
	8216029	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.33	CHEMBL4246	Homo sapiens	Inhibition	%	1.33
	8216148	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2nc(-c3ccc(O)cc3)c(Br)cc12)C1CC1		CHEMBL260417	=	Inhibition	%	14.43	CHEMBL4246	Homo sapiens	Inhibition	%	14.43
	8216372	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.5	CHEMBL4246	Homo sapiens	Inhibition	%	2.5
	8216508	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1cccc(-c2cc3ccncc3cc2OCc2ccccc2)c1		CHEMBL483747	=	Inhibition	%	8.79	CHEMBL4246	Homo sapiens	Inhibition	%	8.79
	8216870	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(Nc1n[nH]c2cc(-c3ccc(F)cc3)ccc12)C1CC1		CHEMBL419903	=	Inhibition	%	4.11	CHEMBL4246	Homo sapiens	Inhibition	%	4.11
	8217004	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	5.71	CHEMBL4246	Homo sapiens	Inhibition	%	5.71
	8217228	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1nnc(-c2cccc(-c3ccc(C(=O)NCC4CC4)cc3)c2)o1		CHEMBL257113	=	Inhibition	%	6.71	CHEMBL4246	Homo sapiens	Inhibition	%	6.71
	8217402	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.6	CHEMBL4246	Homo sapiens	Inhibition	%	2.6
	8217533	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	7.39	CHEMBL4246	Homo sapiens	Inhibition	%	7.39
	8217757	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	7.94	CHEMBL4246	Homo sapiens	Inhibition	%	7.94
	8217858	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.66	CHEMBL4246	Homo sapiens	Inhibition	%	-1.66
	8218197	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	4.78	CHEMBL4246	Homo sapiens	Inhibition	%	4.78
	8218324	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(-c2ccc3c(NC(=O)C4CC4)n[nH]c3c2)cc1		CHEMBL103098	=	Inhibition	%	10.26	CHEMBL4246	Homo sapiens	Inhibition	%	10.26
	8218548	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	4.74	CHEMBL4246	Homo sapiens	Inhibition	%	4.74
	8218691	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(O[C@H](C)c4ccccc4Cl)c(C(N)=O)s3)c2cc1OC		CHEMBL222419	=	Inhibition	%	19.28	CHEMBL4246	Homo sapiens	Inhibition	%	19.28
	8219046	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cc1ccc(Nc2ccnc(Nc3cccc(C(N)=O)c3)n2)cc1O.Cl		CHEMBL1909381	=	Inhibition	%	57.07	CHEMBL4246	Homo sapiens	Inhibition	%	57.07
	8219206	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	3.84	CHEMBL4246	Homo sapiens	Inhibition	%	3.84
	8219456	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.86	CHEMBL4246	Homo sapiens	Inhibition	%	3.86
	8219680	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2CCCN2CCOCC2)n1		CHEMBL274863	=	Inhibition	%	3.98	CHEMBL4246	Homo sapiens	Inhibition	%	3.98
	8219841	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	3.6	CHEMBL4246	Homo sapiens	Inhibition	%	3.6
	8220010	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C(O)C(F)(F)F.O=C(O[C@H]1CN[C@H](C#Cc2cc3ncnc(Nc4ccc5c(ccn5Cc5cc(F)ccc5F)c4)c3s2)C1)N1CCOCC1		CHEMBL1909410	=	Inhibition	%	7.34	CHEMBL4246	Homo sapiens	Inhibition	%	7.34
	8220234	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.19	CHEMBL4246	Homo sapiens	Inhibition	%	4.19
	8220363	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2ccc(F)cc2C(=O)NC[C@@H](O)CO)c2cc[nH]c2n1		CHEMBL450071	=	Inhibition	%	1.93	CHEMBL4246	Homo sapiens	Inhibition	%	1.93
	8220701	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	NC(=O)c1sc(-n2cnc3ccc(C(F)(F)F)cc32)cc1OCc1ccccc1Br		CHEMBL481510	=	Inhibition	%	2.78	CHEMBL4246	Homo sapiens	Inhibition	%	2.78
	8220839	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	5.96	CHEMBL4246	Homo sapiens	Inhibition	%	5.96
	8221199	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.83	CHEMBL4246	Homo sapiens	Inhibition	%	-0.83
	8221556	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	4.02	CHEMBL4246	Homo sapiens	Inhibition	%	4.02
	8221721	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Cl.c1ccc(Oc2ccc(Nc3ncc(-c4ccccc4)o3)cc2)cc1		CHEMBL1909341	=	Inhibition	%	2.98	CHEMBL4246	Homo sapiens	Inhibition	%	2.98
	8222076	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc2ncn(-c3cc(OCc4ccccc4S(C)(=O)=O)c(C#N)s3)c2cc1OC		CHEMBL373751	=	Inhibition	%	35.47	CHEMBL4246	Homo sapiens	Inhibition	%	35.47
	8222174	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1NC(=O)C(c2ccc(Cl)cc2)=C1Nc1ccc(Cl)c(C(=O)O)c1		CHEMBL160876	=	Inhibition	%	-1.1	CHEMBL4246	Homo sapiens	Inhibition	%	-1.1
	8222398	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CCS(=O)(=O)c1ccc(OC)c(Nc2ncc(-c3cccc(C(C)=O)c3)o2)c1		CHEMBL191705	=	Inhibition	%	6.22	CHEMBL4246	Homo sapiens	Inhibition	%	6.22
	8222532	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	CN(C)CCOc1ccc(-c2nc(-c3ccncc3)c(-c3ccc4c(c3)CC/C4=N\O)[nH]2)cc1.Cl.O		CHEMBL1909414	=	Inhibition	%	5.79	CHEMBL4246	Homo sapiens	Inhibition	%	5.79
	8222874	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cccc(-n2ncc3c(N/N=C/c4ccc(C(=O)NCCN(C)C)cc4)ncnc32)c1.Cl		CHEMBL1909383	=	Inhibition	%	19.6	CHEMBL4246	Homo sapiens	Inhibition	%	19.6
	8223018	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(-c2oc3ncnc(N)c3c2-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)cc2)cc1.Cl		CHEMBL1909396	=	Inhibition	%	5.43	CHEMBL4246	Homo sapiens	Inhibition	%	5.43
	8223371	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.O=C(Nc1ccc(Oc2ccc3[nH]c(NC(=O)c4ccccc4)nc3c2)cc1)Nc1cc(C(F)(F)F)ccc1F		CHEMBL1909374	=	Inhibition	%	4.86	CHEMBL4246	Homo sapiens	Inhibition	%	4.86
	8223532	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	c1ccc(-c2n[nH]cc2-c2ccnc(-c3ccc(OCCN4CCOCC4)cc3)c2)nc1		CHEMBL205158	=	Inhibition	%	4.59	CHEMBL4246	Homo sapiens	Inhibition	%	4.59
	8223756	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Inhibition	%	1.62	CHEMBL4246	Homo sapiens	Inhibition	%	1.62
	8224006	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	COc1ccc2cc(-c3c(-c4ccncc4)nc(-c4ccc(S(C)(=O)=O)cc4C)n3C)ccc2c1		CHEMBL237571	=	Inhibition	%	4.38	CHEMBL4246	Homo sapiens	Inhibition	%	4.38
	8224168	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1ccc(-c2coc3ncnc(N)c23)cc1		CHEMBL196022	=	Inhibition	%	5.59	CHEMBL4246	Homo sapiens	Inhibition	%	5.59
	8224562	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2ccc(F)c3ccccc23)sc2c1CCCC2		CHEMBL233002	=	Inhibition	%	4.14	CHEMBL4246	Homo sapiens	Inhibition	%	4.14
	8224697	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCN2C(=O)C1CC1		CHEMBL232601	=	Inhibition	%	5.71	CHEMBL4246	Homo sapiens	Inhibition	%	5.71
	8225035	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	CC1=C(C(=O)Nc2cc(Cl)c3[nH]ncc3c2)C(c2ccc(C(F)(F)F)cc2)CC(=O)N1		CHEMBL427058	=	Inhibition	%	3.36	CHEMBL4246	Homo sapiens	Inhibition	%	3.36
	8225169	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	O=C1Nc2ccccc2/C1=C1\CCc2cc(O)ccc21		CHEMBL175321	=	Inhibition	%	10.2	CHEMBL4246	Homo sapiens	Inhibition	%	10.2
	8225393	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	NS(=O)(=O)c1ccc(Nc2cc(-c3cccc(O)c3)n[nH]2)cc1		CHEMBL103104	=	Inhibition	%	5.22	CHEMBL4246	Homo sapiens	Inhibition	%	5.22
	8225531	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	Nc1nonc1-c1nc2cnccc2n1C1CC1		CHEMBL185962	=	Inhibition	%	-0.23	CHEMBL4246	Homo sapiens	Inhibition	%	-0.23
	8225890	CHEMBL1962177	GSK_PKIS: TEC mean inhibition at 1 uM [Nanosyn]	B	COc1cc(N2CCN(C(C)C)CC2)ccc1Nc1nc(Nc2cccc(F)c2C(=O)O)c2cc[nH]c2n1		CHEMBL514261	=	Inhibition	%	5.87	CHEMBL4246	Homo sapiens	Inhibition	%	5.87
	8226048	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Cl.Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL1909407	=	Inhibition	%	0.94	CHEMBL4246	Homo sapiens	Inhibition	%	0.94
	8226397	CHEMBL1962176	GSK_PKIS: TEC mean inhibition at 0.1 uM [Nanosyn]	B	Nc1nccc(C#Cc2cncnc2Nc2ccc(OCc3cccc(F)c3)c(Cl)c2)n1		CHEMBL381604	=	Inhibition	%	5.34	CHEMBL4246	Homo sapiens	Inhibition	%	5.34
	10838632	CHEMBL2014510	Inhibition of TEC at 10 uM	B	COc1ccc2c3ccnc(C(F)(F)F)c3n(CCCCN)c2c1		CHEMBL2012574	=	Inhibition	%	2.0	CHEMBL4246	Homo sapiens	INH	%	2.0
Active	10884070	CHEMBL2033679	Binding affinity to TEC	B	C=CC(=O)Nc1cccc(N2C(=O)N(c3ccccc3)Cc3cnc(Nc4ccc(N5CCN(C)CC5)cc4OC)nc32)c1		CHEMBL2029436		Activity			CHEMBL4246	Homo sapiens	Activity		
	12081726	CHEMBL2166433	Inhibition of CSK assessed as residual enzyme activity at 10 uM by radiometric protein kinase assay	B	Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-]		CHEMBL2164692	=	Activity	%	10.0	CHEMBL4246	Homo sapiens	Activity	%	10.0
	12081727	CHEMBL2166434	Inhibition of TEC assessed as residual enzyme activity at 10 uM by radiometric protein kinase assay	B	Cc1c2c(cc[n+]1Cc1ccc(F)cc1)c1ccc(OCc3cccc(F)c3)cc1n2Cc1cccc(F)c1.[Br-]		CHEMBL2164692	=	Activity	%	8.0	CHEMBL4246	Homo sapiens	Activity	%	8.0
	12172185	CHEMBL2209263	Inhibition of TEC assessed as residual activity at 10 uM relative to control	B	O=C(Nc1cccnc1)c1cc(-c2ccnc(F)c2)ccc1OCc1ccccc1		CHEMBL2204495	=	Activity	%	53.0	CHEMBL4246	Homo sapiens	Activity	%	53.0
	12183803	CHEMBL2214458	Inhibition of TEC	B	CC(C)(C)NS(=O)(=O)c1cncc(-c2ccn3nc(N)nc3c2)c1		CHEMBL2205766	<	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	pIC50		5.0
	12258395	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12258396	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12258397	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12258398	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12258399	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12258400	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	99.0	CHEMBL4246	Homo sapiens	Residual Activity	%	99.0
	12258401	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	52.0	CHEMBL4246	Homo sapiens	Residual Activity	%	52.0
	12258402	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	95.0	CHEMBL4246	Homo sapiens	Residual Activity	%	95.0
	12258403	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12258404	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12258405	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	62.0	CHEMBL4246	Homo sapiens	Residual Activity	%	62.0
	12258406	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12258407	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12258408	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	53.0	CHEMBL4246	Homo sapiens	Residual Activity	%	53.0
	12258409	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12258410	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12258411	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12258412	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12258413	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12258414	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12258415	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12258416	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	87.0	CHEMBL4246	Homo sapiens	Residual Activity	%	87.0
	12258417	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12258418	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12258419	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12258420	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	74.0	CHEMBL4246	Homo sapiens	Residual Activity	%	74.0
	12258421	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	58.0	CHEMBL4246	Homo sapiens	Residual Activity	%	58.0
	12258422	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	76.0	CHEMBL4246	Homo sapiens	Residual Activity	%	76.0
	12258423	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12258424	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12258425	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12258426	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	84.0	CHEMBL4246	Homo sapiens	Residual Activity	%	84.0
	12258427	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	95.0	CHEMBL4246	Homo sapiens	Residual Activity	%	95.0
	12258428	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12258429	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	100.0	CHEMBL4246	Homo sapiens	Residual Activity	%	100.0
	12258430	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	97.0	CHEMBL4246	Homo sapiens	Residual Activity	%	97.0
	12258431	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12258432	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12258433	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	97.0	CHEMBL4246	Homo sapiens	Residual Activity	%	97.0
	12258434	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	105.0	CHEMBL4246	Homo sapiens	Residual Activity	%	105.0
	12259843	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12259844	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	104.0	CHEMBL4246	Homo sapiens	Residual Activity	%	104.0
	12259845	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	4.0	CHEMBL4246	Homo sapiens	Residual Activity	%	4.0
	12259846	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259847	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12259848	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259849	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259850	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	100.0	CHEMBL4246	Homo sapiens	Residual Activity	%	100.0
	12259851	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259852	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259853	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12259854	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	10.0	CHEMBL4246	Homo sapiens	Residual Activity	%	10.0
	12259855	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12259856	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	100.0	CHEMBL4246	Homo sapiens	Residual Activity	%	100.0
	12259857	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259858	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259859	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	97.0	CHEMBL4246	Homo sapiens	Residual Activity	%	97.0
	12259860	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259861	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259862	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12259863	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12259864	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12259865	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259866	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12259867	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	119.0	CHEMBL4246	Homo sapiens	Residual Activity	%	119.0
	12259868	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	87.0	CHEMBL4246	Homo sapiens	Residual Activity	%	87.0
	12259869	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12259870	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259871	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12259872	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	40.0	CHEMBL4246	Homo sapiens	Residual Activity	%	40.0
	12259873	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259874	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12259875	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	113.0	CHEMBL4246	Homo sapiens	Residual Activity	%	113.0
	12259876	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	107.0	CHEMBL4246	Homo sapiens	Residual Activity	%	107.0
	12259877	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259878	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	105.0	CHEMBL4246	Homo sapiens	Residual Activity	%	105.0
	12259879	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12259880	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12259881	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12259882	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	19.0	CHEMBL4246	Homo sapiens	Residual Activity	%	19.0
	12259883	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	97.0	CHEMBL4246	Homo sapiens	Residual Activity	%	97.0
	12259884	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12259885	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12259886	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12259887	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12259888	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12259889	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	104.0	CHEMBL4246	Homo sapiens	Residual Activity	%	104.0
	12259890	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259891	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259892	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	64.0	CHEMBL4246	Homo sapiens	Residual Activity	%	64.0
	12259893	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12259894	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12259895	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	38.0	CHEMBL4246	Homo sapiens	Residual Activity	%	38.0
	12259896	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259897	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12259898	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259899	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	102.0	CHEMBL4246	Homo sapiens	Residual Activity	%	102.0
	12259900	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	95.0	CHEMBL4246	Homo sapiens	Residual Activity	%	95.0
	12259901	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12259902	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12259903	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	70.0	CHEMBL4246	Homo sapiens	Residual Activity	%	70.0
	12259904	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	3.0	CHEMBL4246	Homo sapiens	Residual Activity	%	3.0
	12259905	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	87.0	CHEMBL4246	Homo sapiens	Residual Activity	%	87.0
	12259906	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	66.0	CHEMBL4246	Homo sapiens	Residual Activity	%	66.0
	12259907	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12259908	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259909	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12259910	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12259911	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12259912	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12259913	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12259914	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259915	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12259916	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	101.0	CHEMBL4246	Homo sapiens	Residual Activity	%	101.0
	12259917	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	106.0	CHEMBL4246	Homo sapiens	Residual Activity	%	106.0
	12259918	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	97.0	CHEMBL4246	Homo sapiens	Residual Activity	%	97.0
	12259919	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	49.0	CHEMBL4246	Homo sapiens	Residual Activity	%	49.0
	12259920	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	102.0	CHEMBL4246	Homo sapiens	Residual Activity	%	102.0
	12259921	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	101.0	CHEMBL4246	Homo sapiens	Residual Activity	%	101.0
	12259922	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	108.0	CHEMBL4246	Homo sapiens	Residual Activity	%	108.0
	12259923	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	38.0	CHEMBL4246	Homo sapiens	Residual Activity	%	38.0
	12259924	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	39.0	CHEMBL4246	Homo sapiens	Residual Activity	%	39.0
	12259925	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	71.0	CHEMBL4246	Homo sapiens	Residual Activity	%	71.0
	12259926	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259927	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	47.0	CHEMBL4246	Homo sapiens	Residual Activity	%	47.0
	12259928	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259929	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12259930	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	100.0	CHEMBL4246	Homo sapiens	Residual Activity	%	100.0
	12259931	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	51.0	CHEMBL4246	Homo sapiens	Residual Activity	%	51.0
	12259932	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12259933	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259934	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	102.0	CHEMBL4246	Homo sapiens	Residual Activity	%	102.0
	12259935	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12259936	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259937	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	17.0	CHEMBL4246	Homo sapiens	Residual Activity	%	17.0
	12259938	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	61.0	CHEMBL4246	Homo sapiens	Residual Activity	%	61.0
	12259939	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	81.0	CHEMBL4246	Homo sapiens	Residual Activity	%	81.0
	12259940	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	24.0	CHEMBL4246	Homo sapiens	Residual Activity	%	24.0
	12259941	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	15.0	CHEMBL4246	Homo sapiens	Residual Activity	%	15.0
	12259942	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259943	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12259944	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259945	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	99.0	CHEMBL4246	Homo sapiens	Residual Activity	%	99.0
	12259946	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12259947	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12259948	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259949	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	59.0	CHEMBL4246	Homo sapiens	Residual Activity	%	59.0
	12259950	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12259951	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12259952	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	102.0	CHEMBL4246	Homo sapiens	Residual Activity	%	102.0
	12259953	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	101.0	CHEMBL4246	Homo sapiens	Residual Activity	%	101.0
	12259954	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259955	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259956	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12259957	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259958	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	84.0	CHEMBL4246	Homo sapiens	Residual Activity	%	84.0
	12259959	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	87.0	CHEMBL4246	Homo sapiens	Residual Activity	%	87.0
	12259960	CHEMBL2219311	Millipore: Percentage of residual kinase activity of TEC at 1uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259961	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)c1cc(C=C(C#N)C#N)cc(Br)c1O		CHEMBL2218926	=	Residual Activity	%	103.0	CHEMBL4246	Homo sapiens	Residual Activity	%	103.0
	12259962	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2c[nH]c3ccccc23)=C1c1c[nH]c2ccccc12		CHEMBL266487	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12259963	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1cccc(Nc2cc(Nc3cccc(C(F)(F)F)c3)ncn2)c1)C1CC1		CHEMBL387187	=	Residual Activity	%	27.0	CHEMBL4246	Homo sapiens	Residual Activity	%	27.0
	12259964	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(Cl)cc1NC(=O)Nc1cc(C)nc2ccccc12		CHEMBL439259	=	Residual Activity	%	55.0	CHEMBL4246	Homo sapiens	Residual Activity	%	55.0
	12259965	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CNc1cc2c(Nc3cccc(Br)c3)ncnc2cn1		CHEMBL53753	=	Residual Activity	%	52.0	CHEMBL4246	Homo sapiens	Residual Activity	%	52.0
	12259966	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2c1cnn2-c1ccccc1		CHEMBL65063	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259967	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1cc(/C=C2\C(=O)Nc3ccc(S(N)(=O)=O)cc32)c2ccccc21		CHEMBL104279	=	Residual Activity	%	6.0	CHEMBL4246	Homo sapiens	Residual Activity	%	6.0
	12259968	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3cccc(Cl)c3)c2cc1OC		CHEMBL7917	=	Residual Activity	%	43.0	CHEMBL4246	Homo sapiens	Residual Activity	%	43.0
	12259969	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1nc2cc3nc(-c4cccs4)cnc3cc2n1C		CHEMBL2218927	=	Residual Activity	%	101.0	CHEMBL4246	Homo sapiens	Residual Activity	%	101.0
	12259970	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1cnc2cc3c(Nc4cccc(Br)c4)ncnc3cc21		CHEMBL174426	=	Residual Activity	%	73.0	CHEMBL4246	Homo sapiens	Residual Activity	%	73.0
	12259971	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC#CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cn1		CHEMBL203644	=	Residual Activity	%	70.0	CHEMBL4246	Homo sapiens	Residual Activity	%	70.0
	12259972	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1nc2ccccc2n1CCN1CCOCC1)c1cccc([N+](=O)[O-])c1		CHEMBL379787	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12259973	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCC(=O)Nc1ccc2ncnc(Nc3cccc(Br)c3)c2c1		CHEMBL188762	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259974	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)n1nc(Cc2cccc3ccccc23)c2c(N)ncnc21		CHEMBL573578	=	Residual Activity	%	10.0	CHEMBL4246	Homo sapiens	Residual Activity	%	10.0
	12259975	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NCCNc1ncc(C(N)=O)c(Nc2cccc(C(F)(F)F)c2)n1		CHEMBL471901	=	Residual Activity	%	37.0	CHEMBL4246	Homo sapiens	Residual Activity	%	37.0
	12259976	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccccc32)c1C		CHEMBL86943	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12259977	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC[n+]1c(/C=C/N(C)c2ccccc2)n(-c2ccccc2)c2ccc(-c3nc4ccccc4s3)cc21		CHEMBL1186409	=	Residual Activity	%	27.0	CHEMBL4246	Homo sapiens	Residual Activity	%	27.0
	12259978	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c[n+](C)c3c4cc5c(cc4ccc23)OCO5)c1OC		CHEMBL13045	=	Residual Activity	%	66.0	CHEMBL4246	Homo sapiens	Residual Activity	%	66.0
	12259979	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(C(=O)Nc2sc3c(c2C(N)=O)CCCC3)cc1OC		CHEMBL210833	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12259980	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)(C)c1nc2c3ccc(F)cc3c3c(=O)[nH]ccc3c2[nH]1		CHEMBL21156	=	Residual Activity	%	50.0	CHEMBL4246	Homo sapiens	Residual Activity	%	50.0
	12259981	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCC(=O)Oc1ccc2[nH]c(C(=O)c3cc4ccccc4[nH]3)cc2c1		CHEMBL266325	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12259982	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2cc(Nc3ccc(F)cc3)c(Nc3ccc(F)cc3)cc21		CHEMBL7939	=	Residual Activity	%	60.0	CHEMBL4246	Homo sapiens	Residual Activity	%	60.0
	12259983	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=[N+]([O-])/C=C/c1ccc2c(c1)OCO2		CHEMBL596380	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259984	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1ccc(Cl)cc1)c1ccccc1NCc1ccncc1		CHEMBL101683	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12259985	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN1N=C(N)c2cn([C@@H]3O[C@H](CO)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL331237	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12259986	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOc1cc2ncnc(Nc3cccc(Br)c3)c2cc1OCC		CHEMBL35820	=	Residual Activity	%	38.0	CHEMBL4246	Homo sapiens	Residual Activity	%	38.0
	12259987	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(c1cc2cc(O)ccc2[nH]1)c1cc2cc(O)ccc2[nH]1		CHEMBL377193	=	Residual Activity	%	21.0	CHEMBL4246	Homo sapiens	Residual Activity	%	21.0
	12259988	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(O)c(Br)c3)c2cc1OC		CHEMBL473773	=	Residual Activity	%	34.0	CHEMBL4246	Homo sapiens	Residual Activity	%	34.0
	12259989	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(N3CCN(C(=O)Nc4ccc(Oc5ccccc5)cc4)CC3)c2cc1OC		CHEMBL102346	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12259990	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2cn(CCCn3ccnc3)c3ccccc23)=C1Nc1ccccc1		CHEMBL366266	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12259991	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2n[nH]cc2-c2ccnc3ccccc23)nc1		CHEMBL261454	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12259992	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	=	Residual Activity	%	65.0	CHEMBL4246	Homo sapiens	Residual Activity	%	65.0
	12259993	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1[nH]c2ccccc2n1C1CCN(Cc2ccc(-c3nc4cc5[nH]cnc5cc4nc3-c3ccccc3)cc2)CC1		CHEMBL258844	=	Residual Activity	%	38.0	CHEMBL4246	Homo sapiens	Residual Activity	%	38.0
	12259994	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCOCC2)oc2c1ccc1ccccc12		CHEMBL104468	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12259995	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(COc2ccc(Cc3cnc(N)nc3N)cc2OC)cc1		CHEMBL261849	=	Residual Activity	%	81.0	CHEMBL4246	Homo sapiens	Residual Activity	%	81.0
	12259996	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)N(CCC(=O)c1ccc2ccccc2c1)Cc1ccccc1		CHEMBL596674	=	Residual Activity	%	73.0	CHEMBL4246	Homo sapiens	Residual Activity	%	73.0
	12259997	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2c(cc1OC)-c1n[nH]c(Nc3cccc(F)c3)c1C2		CHEMBL120077	=	Residual Activity	%	18.0	CHEMBL4246	Homo sapiens	Residual Activity	%	18.0
	12259998	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12259999	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cccc(-c2[nH]c(C(C)(C)C)nc2-c2ccc3c(c2)OCO3)n1		CHEMBL226838	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12260000	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(Br)cc2/C1=C\c1cc2c([nH]1)CCCC2		CHEMBL2218925	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12260001	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)CCCCN1c2ccccc2Oc2ccc(Cl)cc21		CHEMBL1398474	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12260002	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(=O)c1ccc(N2CCOCC2)cc1O		CHEMBL1317546	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12260003	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1c2ccccc2c2c3c(c4c5ccccc5n(CCC#N)c4c21)CNC3=O		CHEMBL302449	=	Residual Activity	%	9.0	CHEMBL4246	Homo sapiens	Residual Activity	%	9.0
	12260004	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(-c3cccnc3)cc2/C1=C\c1ccc[nH]1		CHEMBL2218929	=	Residual Activity	%	32.0	CHEMBL4246	Homo sapiens	Residual Activity	%	32.0
	12260005	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2nccc(Oc3ccc(NC(=S)NC(=O)c4ccccc4C)cc3)c2cc1OC		CHEMBL2218930	=	Residual Activity	%	36.0	CHEMBL4246	Homo sapiens	Residual Activity	%	36.0
	12260006	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc2c(-c3ccncc3)c[nH]c2c1		CHEMBL380071	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12260007	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(C=C(C#N)C#N)cc1		CHEMBL77456	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12260008	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc(C)c(/C=C2\C(=O)Nc3ccccc32)[nH]1		CHEMBL276711	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12260009	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1c2ccccc2-c2nc3nnnn3nc21		CHEMBL599894	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12260010	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1cccc(-c2nc(N3CCOCC3)c3oc4ncccc4c3n2)c1		CHEMBL573339	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12260011	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c1)c(C1=C(c3c[nH]c4ccccc34)C(=O)NC1=O)cn2CCCN(C)C		CHEMBL261491	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12260012	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C1CCCC1		CHEMBL47940	=	Residual Activity	%	0.0	CHEMBL4246	Homo sapiens	Residual Activity	%	0.0
	12260013	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc3ncsc3c2/C1=C/c1c[nH]cn1		CHEMBL235641	=	Residual Activity	%	42.0	CHEMBL4246	Homo sapiens	Residual Activity	%	42.0
	12260014	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cncc2cccc(S(=O)(=O)N3CCCN(C(=O)CN)C[C@H]3C)c12		CHEMBL2218931	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12260015	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C\c1ccc(O)c(O)c1)C(=O)NCc1ccccc1		CHEMBL56543	=	Residual Activity	%	87.0	CHEMBL4246	Homo sapiens	Residual Activity	%	87.0
	12260016	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(-c2cnc3c(-c4ccsc4)cnn3c2)cc1		CHEMBL92461	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12260017	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(NC(=O)c4ccccc4)cc3)c2cc1OC		CHEMBL382590	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12260018	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1c2ccccc2[nH]c(=S)n1CCN1CCC(=C(c2ccc(F)cc2)c2ccc(F)cc2)CC1		CHEMBL261131	=	Residual Activity	%	44.0	CHEMBL4246	Homo sapiens	Residual Activity	%	44.0
	12260019	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2n[nH]c3c2oc2ccccc23)cc1		CHEMBL406375	=	Residual Activity	%	76.0	CHEMBL4246	Homo sapiens	Residual Activity	%	76.0
	12260020	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCOCC2)oc2c(-c3ccccc3)cccc12		CHEMBL98350	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12260021	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccc(Cl)cc2/C1=C/c1cc(Cl)c(O)c(Cl)c1		CHEMBL2218932	=	Residual Activity	%	70.0	CHEMBL4246	Homo sapiens	Residual Activity	%	70.0
	12260022	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	=	Residual Activity	%	40.0	CHEMBL4246	Homo sapiens	Residual Activity	%	40.0
	12260023	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#CC(C#N)=C(N)/C(C#N)=C/c1ccc(O)cc1		CHEMBL76589	=	Residual Activity	%	88.0	CHEMBL4246	Homo sapiens	Residual Activity	%	88.0
	12260024	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(c1ccccc1)c1ccc(N2CCOCC2)cc1O		CHEMBL478980	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12260025	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1cccc(-c2cc(Nc3ccc(OC(F)(F)F)cc3)ncn2)c1		CHEMBL483847	=	Residual Activity	%	108.0	CHEMBL4246	Homo sapiens	Residual Activity	%	108.0
	12260026	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)c1ccc(/C=C2\C(=O)Nc3ccccc32)cc1		CHEMBL328710	=	Residual Activity	%	68.0	CHEMBL4246	Homo sapiens	Residual Activity	%	68.0
	12260027	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CO[C@H]1/C=C/C=C(\C)C(=O)NC2=CC(=O)C=C(C2=O)[C@H](OC)[C@@H](C)C[C@H](OC)[C@H](OC)[C@@H](C)/C=C(\C)[C@@H]1OC(N)=O		CHEMBL479533	=	Residual Activity	%	84.0	CHEMBL4246	Homo sapiens	Residual Activity	%	84.0
	12260028	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(N2CCNCC2)oc2c(-c3ccccc3)cccc12		CHEMBL1363184	=	Residual Activity	%	80.0	CHEMBL4246	Homo sapiens	Residual Activity	%	80.0
	12260029	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)/C(=C\c2ccc3nccnc3c2)S1		CHEMBL2218934	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12260030	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(Oc4ccccc4)cc3)c2cc1OC		CHEMBL97771	=	Residual Activity	%	10.0	CHEMBL4246	Homo sapiens	Residual Activity	%	10.0
	12260031	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc2ncc(-c3ccccc3)nc2cc1C		CHEMBL7724	=	Residual Activity	%	71.0	CHEMBL4246	Homo sapiens	Residual Activity	%	71.0
	12260032	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(Nc1cccc(Nc2nccc(Nc3cccc(C(F)(F)F)c3)n2)c1)C1CC1		CHEMBL383899	=	Residual Activity	%	9.0	CHEMBL4246	Homo sapiens	Residual Activity	%	9.0
	12260033	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)CCCn1cc(C2=C(c3c[nH]c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL7463	=	Residual Activity	%	65.0	CHEMBL4246	Homo sapiens	Residual Activity	%	65.0
	12260034	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncnc(Nc3ccc(OCc4ccccc4)cc3)c2cc1OC		CHEMBL563845	=	Residual Activity	%	67.0	CHEMBL4246	Homo sapiens	Residual Activity	%	67.0
	12260035	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1ccc(-c2cnc(Nc3ccc(OCCN4CCCC4)cc3)s2)cc1		CHEMBL2218935	=	Residual Activity	%	54.0	CHEMBL4246	Homo sapiens	Residual Activity	%	54.0
	12260036	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC1=C(C(=O)N2CCN(C)CC2)C(C)=C(/C=C2\C(=O)Nc3ccc(S(=O)(=O)N(C)c4cccc(Cl)c4)cc32)C1		CHEMBL2218936	=	Residual Activity	%	114.0	CHEMBL4246	Homo sapiens	Residual Activity	%	114.0
	12260037	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)/C(=C/c2ccc3c(c2)OC(F)(F)O3)S1		CHEMBL1231533	=	Residual Activity	%	80.0	CHEMBL4246	Homo sapiens	Residual Activity	%	80.0
	12260038	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(Cl)cc32)c1C		CHEMBL13485	=	Residual Activity	%	29.0	CHEMBL4246	Homo sapiens	Residual Activity	%	29.0
	12260039	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc2ncc(-c3ccccc3)nc2cc1OC		CHEMBL71191	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12260040	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	Residual Activity	%	2.0	CHEMBL4246	Homo sapiens	Residual Activity	%	2.0
	12260041	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN([C@@H](Cc1ccc(OS(=O)(=O)c2cccc3cnccc23)cc1)C(=O)N1CCN(c2ccccc2)CC1)S(=O)(=O)c1cccc2cnccc12		CHEMBL28324	=	Residual Activity	%	69.0	CHEMBL4246	Homo sapiens	Residual Activity	%	69.0
	12260042	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=O)c1c(F)cccc1F		CHEMBL191003	=	Residual Activity	%	34.0	CHEMBL4246	Homo sapiens	Residual Activity	%	34.0
	12260043	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1c1[nH]c3cc(Br)ccc3c21		CHEMBL64758	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12260044	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	C[C@@H](N)[C@H]1CC[C@H](C(=O)Nc2ccncc2)CC1		CHEMBL559147	=	Residual Activity	%	98.0	CHEMBL4246	Homo sapiens	Residual Activity	%	98.0
	12260045	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CN(C)S(=O)(=O)c1ccc2c(c1)/C(=C/c1cc3c([nH]1)CCCC3)C(=O)N2		CHEMBL605003	=	Residual Activity	%	80.0	CHEMBL4246	Homo sapiens	Residual Activity	%	80.0
	12260046	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(CCCc1ccc(-c2ccccc2F)cc1)Nc1ccc(O)cc1		CHEMBL235658	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12260047	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CSc1nc(-c2ccc(F)cc2)c(-c2ccnc(NC(C)c3ccccc3)c2)[nH]1		CHEMBL111364	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12260048	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	C[S+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL10	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12260049	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=c1cc(-c2cccc3c2Sc2ccccc2S3)oc(N2CCOCC2)c1		CHEMBL222102	=	Residual Activity	%	75.0	CHEMBL4246	Homo sapiens	Residual Activity	%	75.0
	12260050	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=Nc1c(-c2c(O)[nH]c3ccccc23)[nH]c2ccccc12		CHEMBL126077	=	Residual Activity	%	22.0	CHEMBL4246	Homo sapiens	Residual Activity	%	22.0
	12260051	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(OC)c2c(=S)c3ccccc3[nH]c12		CHEMBL1331734	=	Residual Activity	%	84.0	CHEMBL4246	Homo sapiens	Residual Activity	%	84.0
	12260052	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL259551	=	Residual Activity	%	50.0	CHEMBL4246	Homo sapiens	Residual Activity	%	50.0
	12260053	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1cc(Nc2nc(-c3ccccc3)nc3ccccc23)n[nH]1		CHEMBL359482	=	Residual Activity	%	4.0	CHEMBL4246	Homo sapiens	Residual Activity	%	4.0
	12260054	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCOc1nc(NC(=O)Cc2cc(OC)ccc2OC)cc(N)c1C#N		CHEMBL210618	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12260055	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1c(-c2ccc(F)cc2)c(-c2ccncc2)nn1-c1ccc(Cl)cc1		CHEMBL91730	=	Residual Activity	%	83.0	CHEMBL4246	Homo sapiens	Residual Activity	%	83.0
	12260056	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	=	Residual Activity	%	94.0	CHEMBL4246	Homo sapiens	Residual Activity	%	94.0
	12260057	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(NC(NC(=S)Nc1ccc(F)c([N+](=O)[O-])c1)C(Cl)(Cl)Cl)C(c1ccccc1)c1ccccc1		CHEMBL1221601	=	Residual Activity	%	62.0	CHEMBL4246	Homo sapiens	Residual Activity	%	62.0
	12260058	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1ccc(S(=O)(=O)/C=C/C#N)cc1		CHEMBL403183	=	Residual Activity	%	90.0	CHEMBL4246	Homo sapiens	Residual Activity	%	90.0
	12260059	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1ccc(NC2=CC(=O)c3sc(C)nc3C2=O)cc1		CHEMBL290904	=	Residual Activity	%	93.0	CHEMBL4246	Homo sapiens	Residual Activity	%	93.0
	12260060	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1n[nH]c2nnc(-c3c(-c4ccccc4)nn4ccccc34)cc12		CHEMBL2218938	=	Residual Activity	%	66.0	CHEMBL4246	Homo sapiens	Residual Activity	%	66.0
	12260061	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3[nH]c1n1cncc21		CHEMBL413188	=	Residual Activity	%	65.0	CHEMBL4246	Homo sapiens	Residual Activity	%	65.0
	12260062	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	=	Residual Activity	%	2.0	CHEMBL4246	Homo sapiens	Residual Activity	%	2.0
	12260063	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cccc(-c2cc(=O)c3ccccc3o2)c1N		CHEMBL35482	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12260064	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)c2c1c1c3ccccc3n3c1c1c2c2ccccc2n1C1CCC3O1		CHEMBL304428	=	Residual Activity	%	76.0	CHEMBL4246	Homo sapiens	Residual Activity	%	76.0
	12260065	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Cc2c([nH]c3ccc([N+](=O)[O-])cc23)-c2ccccc2N1		CHEMBL50894	=	Residual Activity	%	72.0	CHEMBL4246	Homo sapiens	Residual Activity	%	72.0
	12260066	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)n1cnc2c(NCc3ccccc3)nc(NCCCO)nc21		CHEMBL83980	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12260067	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN1/C(=C/C(C)=O)Sc2ccc(OC)cc21		CHEMBL408982	=	Residual Activity	%	89.0	CHEMBL4246	Homo sapiens	Residual Activity	%	89.0
	12260068	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1c2ccccc2-[n+]2ccc3c([nH]c4ccccc43)c21		CHEMBL602937	=	Residual Activity	%	74.0	CHEMBL4246	Homo sapiens	Residual Activity	%	74.0
	12260069	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1cc(OC)c(/C=C2\C(=O)Nc3ccccc32)c(OC)c1		CHEMBL404941	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12260070	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Cc2c([nH]c3ccc(Br)cc23)-c2ccccc2N1		CHEMBL296586	=	Residual Activity	%	55.0	CHEMBL4246	Homo sapiens	Residual Activity	%	55.0
	12260071	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=[N+]([O-])c1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL17331	=	Residual Activity	%	70.0	CHEMBL4246	Homo sapiens	Residual Activity	%	70.0
	12260072	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cc1nc(-c2ccccc2)c(-c2ccncc2)o1		CHEMBL36450	=	Residual Activity	%	42.0	CHEMBL4246	Homo sapiens	Residual Activity	%	42.0
	12260073	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#CCCc1ccc2c(c1)-c1[nH]c3ccc([N+](=O)[O-])cc3c1CC(=O)N2		CHEMBL260138	=	Residual Activity	%	29.0	CHEMBL4246	Homo sapiens	Residual Activity	%	29.0
	12260074	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccccc2/C1=C\c1c(Cl)[nH]c2ccccc12		CHEMBL261425	=	Residual Activity	%	76.0	CHEMBL4246	Homo sapiens	Residual Activity	%	76.0
	12260075	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1ccc2[nH]c(-c3ccc(Oc4ccc(Cl)cc4)cc3)nc2c1		CHEMBL179583	=	Residual Activity	%	92.0	CHEMBL4246	Homo sapiens	Residual Activity	%	92.0
	12260076	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1sc(=O)n(Cc2ccccc2)c1=O		CHEMBL284861	=	Residual Activity	%	75.0	CHEMBL4246	Homo sapiens	Residual Activity	%	75.0
	12260077	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)Nc1sc(-c2ccc(F)cc2)cc1C(N)=O		CHEMBL257167	=	Residual Activity	%	8.0	CHEMBL4246	Homo sapiens	Residual Activity	%	8.0
	12260078	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(S(=O)(=O)N(CCO)c2ccccc2CN(C)C/C=C/c2ccc(Cl)cc2)cc1		CHEMBL155333	=	Residual Activity	%	36.0	CHEMBL4246	Homo sapiens	Residual Activity	%	36.0
	12261718	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nccc(-c2c(-c3ccc(F)cc3)ncn2C2CCNCC2)n1		CHEMBL274064	=	Residual Activity	%	77.0	CHEMBL4246	Homo sapiens	Residual Activity	%	77.0
	12261719	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Fc1ccc(-c2nc3n(c2-c2ccncc2)CCS3)cc1		CHEMBL313417	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12261720	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCCc1c(-c2ccc(O)cc2)[nH]c2nccnc12		CHEMBL75680	=	Residual Activity	%	9.0	CHEMBL4246	Homo sapiens	Residual Activity	%	9.0
	12261721	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCn1cnc2c(Nc3cccc(Cl)c3)nc(N[C@@H]3CCCC[C@@H]3N)nc21		CHEMBL367625	=	Residual Activity	%	7.0	CHEMBL4246	Homo sapiens	Residual Activity	%	7.0
	12261722	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)n1cnc2/c(=N/c3cccc(Cl)c3)nc(NCCO)[nH]c21		CHEMBL311228	=	Residual Activity	%	31.0	CHEMBL4246	Homo sapiens	Residual Activity	%	31.0
	12261723	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Ic1cccc(CSc2nnc(-c3ccncc3)o2)c1		CHEMBL288064	=	Residual Activity	%	64.0	CHEMBL4246	Homo sapiens	Residual Activity	%	64.0
	12261724	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2ccccc2/C1=C1/Nc2ccccc2/C1=N\OCCC(O)CO		CHEMBL1802727	=	Residual Activity	%	8.0	CHEMBL4246	Homo sapiens	Residual Activity	%	8.0
	12261725	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C(/N)SC1C=CC=CC1)c1cccc(C(O)c2ccncc2)c1		CHEMBL2218939	=	Residual Activity	%	61.0	CHEMBL4246	Homo sapiens	Residual Activity	%	61.0
	12261726	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)[C@H](CO)Nc1nc(Nc2cccc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL23327	=	Residual Activity	%	8.0	CHEMBL4246	Homo sapiens	Residual Activity	%	8.0
	12261727	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1ccc(Nc2nc(-c3ccc(Cl)cc3)cs2)cc1		CHEMBL1076555	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12261728	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCCCc1c(-c2ccc(OC)cc2)[nH]c2nccnc12		CHEMBL306498	=	Residual Activity	%	11.0	CHEMBL4246	Homo sapiens	Residual Activity	%	11.0
	12261729	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1nc(Nc2ccc(S(N)(=O)=O)cc2)nn1C(=S)Nc1c(F)cccc1F		CHEMBL261720	=	Residual Activity	%	23.0	CHEMBL4246	Homo sapiens	Residual Activity	%	23.0
	12261730	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(CNc2nc(N(CCO)CCO)nc3c2ncn3C(C)C)cc1		CHEMBL80713	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12261731	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc(CNC(=O)Nc2ncc([N+](=O)[O-])s2)cc1		CHEMBL259850	=	Residual Activity	%	107.0	CHEMBL4246	Homo sapiens	Residual Activity	%	107.0
	12261732	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1c2ccccc2c2c3c(cccc13)N=N2		CHEMBL1725279	=	Residual Activity	%	57.0	CHEMBL4246	Homo sapiens	Residual Activity	%	57.0
	12261733	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1C(Cl)=C(N2C(=O)CCC2=O)C(=O)c2ccccc21		CHEMBL404939	=	Residual Activity	%	79.0	CHEMBL4246	Homo sapiens	Residual Activity	%	79.0
	12261734	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1cccc(-c2cc3c(Oc4cccc(O)c4)ncnc3[nH]2)c1		CHEMBL405759	=	Residual Activity	%	0.0	CHEMBL4246	Homo sapiens	Residual Activity	%	0.0
	12261735	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)[C@H](CO)Nc1nc(Nc2cc(N)cc(Cl)c2)c2ncn(C(C)C)c2n1		CHEMBL286721	=	Residual Activity	%	13.0	CHEMBL4246	Homo sapiens	Residual Activity	%	13.0
	12261736	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1n[nH]c2nc3ccccc3nc12		CHEMBL259389	=	Residual Activity	%	86.0	CHEMBL4246	Homo sapiens	Residual Activity	%	86.0
	12261737	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCN(CC)C(=O)c1ccc(Nc2nc(OCC3CCCCC3)c3nc[nH]c3n2)cc1		CHEMBL1802728	=	Residual Activity	%	2.0	CHEMBL4246	Homo sapiens	Residual Activity	%	2.0
	12261738	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1Nc2cc(Br)ccc2/C1=C1/Nc2ccccc2/C1=N\O		CHEMBL409450	=	Residual Activity	%	13.0	CHEMBL4246	Homo sapiens	Residual Activity	%	13.0
	12261739	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Cn1nc2c3c(cccc31)C(=O)c1ccccc1-2		CHEMBL1802485	=	Residual Activity	%	69.0	CHEMBL4246	Homo sapiens	Residual Activity	%	69.0
	12261740	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C(\N)Sc1ccc(N)cc1)c1ccccc1C(F)(F)F		CHEMBL2218940	=	Residual Activity	%	63.0	CHEMBL4246	Homo sapiens	Residual Activity	%	63.0
	12261741	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=S(=O)(NCCNC/C=C/c1ccc(Br)cc1)c1cccc2cnccc12		CHEMBL104264	=	Residual Activity	%	72.0	CHEMBL4246	Homo sapiens	Residual Activity	%	72.0
	12261742	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(O)c1ccc2c3c1cccc3c(=O)n1c3ccccc3nc21		CHEMBL1182777	=	Residual Activity	%	82.0	CHEMBL4246	Homo sapiens	Residual Activity	%	82.0
	12261743	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	c1cc(-c2cnn3cc(-c4ccc(OCCN5CCCCC5)cc4)cnc23)ccn1		CHEMBL478629	=	Residual Activity	%	75.0	CHEMBL4246	Homo sapiens	Residual Activity	%	75.0
	12261744	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	NC(=O)c1ccc(-c2nc(-c3ccc4c(c3)OCCO4)c(-c3ccccn3)[nH]2)cc1		CHEMBL410456	=	Residual Activity	%	91.0	CHEMBL4246	Homo sapiens	Residual Activity	%	91.0
	12261745	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(C)c1nn(-c2c(Cl)cccc2Cl)c2nc(Cc3ccc(OCCO)cc3)[nH]c(=O)c12		CHEMBL258721	=	Residual Activity	%	85.0	CHEMBL4246	Homo sapiens	Residual Activity	%	85.0
	12261746	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CC(=O)O/N=C1C(=C2\C(=O)Nc3cc(Br)ccc32)\Nc2ccccc2\1		CHEMBL2218941	=	Residual Activity	%	21.0	CHEMBL4246	Homo sapiens	Residual Activity	%	21.0
	12261747	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#C/C(=C1/Nc2ccccc2S1)c1ccnc(NCCc2cccnc2)n1		CHEMBL191384	=	Residual Activity	%	17.0	CHEMBL4246	Homo sapiens	Residual Activity	%	17.0
	12261748	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ncnc2[nH]nc(Nc3ccc(F)cc3)c12		CHEMBL1240885	=	Residual Activity	%	21.0	CHEMBL4246	Homo sapiens	Residual Activity	%	21.0
	12261749	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	CCc1nc(-c2ccc(OC)cc2)[nH]c1-c1ccncc1		CHEMBL278724	=	Residual Activity	%	75.0	CHEMBL4246	Homo sapiens	Residual Activity	%	75.0
	12261750	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	COc1ccc2c(c1)/C(=C/c1cnc[nH]1)C(=O)N2		CHEMBL258805	=	Residual Activity	%	70.0	CHEMBL4246	Homo sapiens	Residual Activity	%	70.0
	12261751	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C(O)/C=C/c1cc(Br)c(Br)c(Br)c1Br		CHEMBL270724	=	Residual Activity	%	96.0	CHEMBL4246	Homo sapiens	Residual Activity	%	96.0
	12261752	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N/C(=N\[N+](=O)[O-])N/N=C\c1ccc(-c2cccc([N+](=O)[O-])c2)o1		CHEMBL221271	=	Residual Activity	%	78.0	CHEMBL4246	Homo sapiens	Residual Activity	%	78.0
	12261753	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	O=C1NC(=O)C(c2cn(CCCO)c3ncccc23)=C1c1cnccn1		CHEMBL272629	=	Residual Activity	%	73.0	CHEMBL4246	Homo sapiens	Residual Activity	%	73.0
	12261754	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#Cc1c(NC(=O)c2cccc3ccccc23)sc2c1CCCC2		CHEMBL233001	=	Residual Activity	%	69.0	CHEMBL4246	Homo sapiens	Residual Activity	%	69.0
	12261755	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Nc1ccc2ncnc(NCCc3ccc(Oc4ccccc4)cc3)c2c1		CHEMBL522502	=	Residual Activity	%	30.0	CHEMBL4246	Homo sapiens	Residual Activity	%	30.0
	12261756	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	Oc1ccc(-c2nc(-c3ccc(F)cc3)c(-c3ccncc3)[nH]2)cc1		CHEMBL278041	=	Residual Activity	%	55.0	CHEMBL4246	Homo sapiens	Residual Activity	%	55.0
	12261757	CHEMBL2219312	Millipore: Percentage of residual kinase activity of TEC at 10uM relative to control. Control inhibitor: Staurosporine at 100.0uM. Buffer: 8 mM MOPS pH 7.0, 0.2 mM EDTA, 1 mM Na3VO4, 5 mM Na-?-glycerophosphate	B	N#Cc1cnc2cnc(NCc3cccnc3)cc2c1Nc1ccc(F)c(Cl)c1		CHEMBL200381	=	Residual Activity	%	65.0	CHEMBL4246	Homo sapiens	Residual Activity	%	65.0
	12660154	CHEMBL2329207	Inhibition of TEC (unknown origin) at 1 uM	B	COc1cc(Oc2ccccc2)ccc1-c1nc([C@H]2C[C@@](C)(O)C2)n2ccnc(N)c12		CHEMBL2325940	>	Inhibition	%	80.0	CHEMBL4246	Homo sapiens	INH	%	80.0
	12729812	CHEMBL2352144	Inhibition of TEC (unknown origin) using [gamma-33P]ATP assessed as residual activity at 3 uM	B	CCc1ccc(-c2ccc3c(c2)-c2[nH]ncc2S(=O)(=O)N3C)cc1		CHEMBL2333445	=	Activity	%	102.0	CHEMBL4246	Homo sapiens	Activity	%	102.0
	13374324	CHEMBL2405490	Inhibition of TEC (unknown origin) at 10 uM relative to control	B	CC[C@@H]1C(=O)N(C)c2cnc(-n3ccnc3-c3ccc(F)cc3)nc2N1c1ccn(C)n1		CHEMBL2402081	=	Inhibition	%	2.0	CHEMBL4246	Homo sapiens	INH	%	2.0
	13439744	CHEMBL2428985	Competitive binding affinity to TEC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ccc4ccccc43)n2)CC1		CHEMBL2425646	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	13445577	CHEMBL2428985	Competitive binding affinity to TEC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3ncc4ccccc43)n2)CC1		CHEMBL2425645	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	13451564	CHEMBL2428985	Competitive binding affinity to TEC (unknown origin) at 10 uM in presence of ATP relative to control	B	O[C@H]1CC[C@H](Nc2nccc(-n3nnc4ccccc43)n2)CC1		CHEMBL2425654	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	13490914	CHEMBL2446678	Inhibition of Tec (unknown origin)	B	CCc1ccc2nc(Nc3cc(Cc4ccccc4)nc(N[C@H]4CC[C@H](O)CC4)n3)sc2c1		CHEMBL2441273	=	IC50	nM	251.19	CHEMBL4246	Homo sapiens	pIC50		6.6
	13906483	CHEMBL3117482	Inhibition of TEC (unknown origin) at 10 uM after 30 mins relative to control	B	COc1ccc(S(=O)(=O)Nc2cc(Sc3ncnc4nc[nH]c34)c(O)c3ccccc23)cc1OC		CHEMBL3113284	=	Inhibition	%	26.6	CHEMBL4246	Homo sapiens	INH	%	26.6
	14585342	CHEMBL3240759	Inhibition of human activated TEC assessed as enzyme activity at 1 uM relative to control	B	CCCS(=O)(=O)Nc1cccc(Nc2ccc3ncn(C)c(=O)c3c2)c1C#N		CHEMBL3236464	=	Activity	%	102.0	CHEMBL4246	Homo sapiens	Activity	%	102.0
	14645921	CHEMBL3270601	Inhibition of TEC (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	14.0	CHEMBL4246	Homo sapiens	IC50	uM	0.014
	14730380	CHEMBL3292444	Inhibition of Tec (unknown origin) after 1 hr by HTRF assay	B	C=CC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290142	=	IC50	nM	8.2	CHEMBL4246	Homo sapiens	IC50	nM	8.2
	14730381	CHEMBL3292444	Inhibition of Tec (unknown origin) after 1 hr by HTRF assay	B	C=CC(=O)NCC(=O)Nc1cccc(Nc2ncc(NC(=O)c3cc(NC(=O)c4cccc(C(F)(F)F)c4)ccc3C)cn2)c1		CHEMBL3290148	=	IC50	nM	6.3	CHEMBL4246	Homo sapiens	IC50	nM	6.3
	15622550	CHEMBL3588279	Inhibition of human recombinant Tec	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	IC50	nM	57.0	CHEMBL4246	Homo sapiens	IC50	nM	57.0
	15622563	CHEMBL3588266	Inhibition of human recombinant Tec at 1 uM	B	Cc1cc2cn[nH]c2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL3586447	=	Inhibition	%	92.0	CHEMBL4246	Homo sapiens	INH	%	92.0
	15649094	CHEMBL3594874	Inhibition of TEC (unknown origin)	B	N#Cc1ccc(N2CC[C@@H](Nc3c(C(N)=O)cnc4[nH]ccc34)[C@@H](F)C2)nc1		CHEMBL3593777	>	IC50	nM	1000.0	CHEMBL4246	Homo sapiens	IC50	nM	1000.0
	15730399	CHEMBL3627426	Inhibition of TEC (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4ccccc4F)c23)CC1		CHEMBL3621496	=	IC50	nM	116.0	CHEMBL4246	Homo sapiens	IC50	nM	116.0
	15730400	CHEMBL3627426	Inhibition of TEC (unknown origin)	B	CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4cc(C(=O)N5CCN(C)CC5)ccc4c23)c1C		CHEMBL3621515	=	IC50	nM	162.0	CHEMBL4246	Homo sapiens	IC50	nM	162.0
	15730401	CHEMBL3627426	Inhibition of TEC (unknown origin)	B	CN1CCN(C(=O)c2ccc3c(c2)[nH]c2c(C(N)=O)ccc(-c4cccc(NC(=O)c5ccc(N(C)C)cc5)c4F)c23)CC1		CHEMBL3622193	=	IC50	nM	41.0	CHEMBL4246	Homo sapiens	IC50	nM	41.0
	15756792	CHEMBL3631494	Inhibition of TEC (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(Oc3ccncc3)cc2)no1		CHEMBL166031	=	Inhibition	%	3.88	CHEMBL4246	Homo sapiens	INH	%	3.88
	15757931	CHEMBL3631494	Inhibition of TEC (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	CS(=O)(=O)c1cccc(Nc2nccc(-c3sc(N4CCOCC4)nc3-c3cccc(NS(=O)(=O)c4c(F)cccc4F)c3)n2)c1		CHEMBL3628627	=	Inhibition	%	89.15	CHEMBL4246	Homo sapiens	INH	%	89.15
	15758910	CHEMBL3631494	Inhibition of TEC (unknown origin) at 10 uM after 120 mins P33 radiolabeled kinase activity assay	B	COCCNC(=O)c1ccc2c(c1)nc(-c1cnc(-c3ccc(Cl)cc3)[nH]1)n2CCOC		CHEMBL3628628	=	Inhibition	%	5.53	CHEMBL4246	Homo sapiens	INH	%	5.53
	16369026	CHEMBL3734117	Inhibition of TEC (unknown origin)	B	O=C(c1c(F)ccc(NS(=O)(=O)c2ccc(C(F)(F)F)cc2)c1F)c1c[nH]c2ncncc12		CHEMBL3728149	<=	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	16369027	CHEMBL3734117	Inhibition of TEC (unknown origin)	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncncc23)c1F		CHEMBL3732311	<=	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	16425433	CHEMBL3749826	Inhibition of TEC (unknown origin) at 1 uM	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	Inhibition	%	87.9	CHEMBL4246	Homo sapiens	INH	%	87.9
	16426146	CHEMBL3750473	Inhibition of TEC (unknown origin)	B	Cc1c(-c2cc(Nc3cc4n(n3)CCN(C)C4)c(=O)[nH]n2)ccc(F)c1NC(=O)c1cc2ccccc2s1		CHEMBL3746293	=	IC50	nM	230.0	CHEMBL4246	Homo sapiens	IC50	nM	230.0
	16432026	CHEMBL3750180	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate	B	Cn1c(=O)c(S(=O)(=O)c2ccc(F)cc2F)cc2cnc(Nc3ccc4[nH]ccc4c3)nc21		CHEMBL3745885	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	16451626	CHEMBL3761207	Inhibition of TEC (unknown origin) at 100 nM	B	CC1(C)OCc2c(Nc3n[nH]c4ccccc34)nc(-c3cn[nH]c3)nc21		CHEMBL3758502	=	Inhibition	%	0.1	CHEMBL4246	Homo sapiens	INH	%	0.1
	16495241	CHEMBL3778884	Inhibition of N-terminal His6-tagged recombinant human activated TEC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CC[C@@H](O)C5)cc34)cc2)cn1		CHEMBL3775317	=	Activity	%	19.0	CHEMBL4246	Homo sapiens	Activity	%	19.0
	16496160	CHEMBL3778884	Inhibition of N-terminal His6-tagged recombinant human activated TEC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	Cn1cc(-c2ccc(Cc3n[nH]c4ccc(C(=O)N5CCOCC5)cc34)cc2)cn1		CHEMBL3774885	=	Activity	%	-6.0	CHEMBL4246	Homo sapiens	Activity	%	-6.0
	16508950	CHEMBL3778884	Inhibition of N-terminal His6-tagged recombinant human activated TEC expressed in baculovirus infected insect Sf9 cells assessed as remaining activity at 1 uM relative to control	B	CNC(=O)c1ccc2[nH]nc(Cc3ccc4c(cnn4C)c3)c2c1		CHEMBL3775576	=	Activity	%	8.0	CHEMBL4246	Homo sapiens	Activity	%	8.0
	16593527	CHEMBL3811534	Inhibition of His-tagged full length human recombinant TEC expressed in baculovirus using Fluorescein-Poly GT as substrate at 100 nM	B	COC(=O)c1cc2cc(NCc3cc(NC(=O)c4cc(-n5cnc(C)c5)cc(C(F)(F)F)c4)ccc3C)cnc2[nH]1		CHEMBL3808884	<	Inhibition	%	40.0	CHEMBL4246	Homo sapiens	INH	%	40.0
	16614646	CHEMBL3816862	Inhibition of human TEC at 1 uM using poly[Glu:Tyr] (4:1) as substrate	B	CNS(=O)(=O)c1ccc(N(C)C)c(Nc2ncnc3cc(OC)c(OC)cc23)c1		CHEMBL3815093	=	Inhibition	%	22.0	CHEMBL4246	Homo sapiens	INH	%	22.0
	16746291	CHEMBL3858959	Inhibition of TEC (unknown origin)	B	Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O		CHEMBL3900554	=	IC50	nM	10.0	CHEMBL4246	Homo sapiens	IC50	nM	10.0
342604	17719995	CHEMBL3887532	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	77.8	CHEMBL4246	Homo sapiens	IC50	nM	77.8
342625	17720016	CHEMBL3887532	HotSpot kinase assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 M ATP.). For enzyme inhibition assays, compounds were tested in range of ten concentrations from 10 uM to 0.0005 uM using purified enzymes and the Hotspot kinase assay. Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	108.0	CHEMBL4246	Homo sapiens	IC50	nM	108.0
384996	17758418	CHEMBL3888239	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	77.8	CHEMBL4246	Homo sapiens	IC50	nM	77.8
385017	17758439	CHEMBL3888239	In Vitro HotSpot Kinase Assay: IC50s were determined using the in vitro HotSpot kinase assay (purified enzymes, 33P-ATP, an appropriate substrate and 1 uM ATP.). Reaction conditions were 1 uM ATP, one hour incubation with inhibitor, and kinase activity detected using 33-ATP phosphorylation of an appropriately selected peptide substrate.	B	C=CC(=O)N[C@H]1CC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)CC1		CHEMBL3647967	=	IC50	nM	108.0	CHEMBL4246	Homo sapiens	IC50	nM	108.0
Inactive	17943949	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]ccc2cc(OC3CCNCC3)ccc12		CHEMBL1667969	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943950	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CC[C@H](N(C)C)C3)c(C(F)(F)F)c2)cc1Nc1nccc(-c2cncnc2)n1		CHEMBL206834	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943951	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)c(F)c2)ccn1		CHEMBL1946170	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943952	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OC)c(OCCCCCCC(=O)NO)cc23)c1		CHEMBL598797	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943953	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1nc(N)c2nc(-c3cccc(O)c3)c(-c3cccc(O)c3)nc2n1		CHEMBL230011	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943954	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(/C=C/c2nc(COc3ccc(CCCCn4ccnn4)cc3)co2)cc1		CHEMBL1614707	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943955	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(CNc2ccc3ncc(-c4cccc(OC(F)(F)F)c4)n3n2)CC1		CHEMBL1952329	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17943956	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCNC(=O)C#Cc1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(CN(C)C)cc1)c1ccccc1		CHEMBL3699142	=	Kd	nM	885.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	885.0
Inactive	17943957	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)NC4CCN(C)CC4)cc3OC)nc2N1C1CCCC1		CHEMBL513909	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943958	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC[C@H](O)CO)c1ccncc1Nc1ccc(I)cc1F		CHEMBL2107832	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943959	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cc2c(cc1N1CCC(N3CCOCC3)CC1)C(C)(C)c1[nH]c3cc(C#N)ccc3c1C2=O		CHEMBL1738797	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943960	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(CN3CCN(C)CC3)c(C(F)(F)F)c2)cc1C#Cc1cnc2cccnn12		CHEMBL1171837	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943961	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ncc(-c2ccc3nccc(-c4ccnnc4)c3c2)cc1NS(=O)(=O)c1ccc(F)cc1F		CHEMBL1236962	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943962	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(C2CCN(C(=O)Nc3cc(Oc4ccc(NC(=O)C5(C(=O)Nc6ccc(F)cc6)CC5)c(F)c4)ccn3)CC2)CC1		CHEMBL3039525	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943963	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3Cl)c(C(=O)NOCCO)cc21		CHEMBL1614701	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943964	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Br)cc3F)ncnc2cc1OCC1CCN(C)CC1		CHEMBL24828	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943965	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-n2cnc3ccc(CN4CCN(C)CC4)cc32)sc1C(N)=O)c1ccccc1C(F)(F)F		CHEMBL1908394	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943966	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1COC(Nc2ccc3ncnc(Nc4ccc(OCc5nccs5)c(Cl)c4)c3c2)=N1		CHEMBL2103842	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943967	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)Nc1cccc(-n2c(=O)n(C3CC3)c(=O)c3c(Nc4ccc(I)cc4F)n(C)c(=O)c(C)c32)c1		CHEMBL2103875	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943968	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1csc(-c2nnc(Nc3ccc(Oc4ncccc4-c4ccnc(N)n4)cc3)c3ccccc23)c1		CHEMBL2140408	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943969	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(F)c(F)c1Nc1ccc(I)cc1F)N1CC(O)([C@@H]2CCCCN2)C1		CHEMBL2146883	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943970	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(-c2nonc2N)nc2c(C#CC(C)(C)O)ncc(OC[C@H]3CCCNC3)c21		CHEMBL494089	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17943971	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn(C)c4ccccc34)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL3353410	=	Kd	nM	321.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	321.0
Inactive	17943972	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1)C1CCCN1		CHEMBL3545328	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943973	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Nc3ccc(Cl)c(Cl)c3F)ncnc2cc1OC[C@@H]1C[C@@H]2CN(C)C[C@@H]2C1		CHEMBL3544983	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943974	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)Nc4cc(C)on4)c(Cl)c3)c2cc1OC		CHEMBL1289494	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943975	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)CC(=O)Nc1n[nH]c2c1CN(C(=O)C1CCN(C)CC1)C2(C)C		CHEMBL1230607	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943976	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cc(C(F)(F)F)cc(C(F)(F)F)c1)c1cc(Cl)ccc1O		CHEMBL536151	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17943977	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1		CHEMBL31965	=	Kd	nM	2132.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	2132.0
Inactive	17943978	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1nc(C(N)=O)c(Nc2ccc(N3CCC(N4CCN(C)CC4)CC3)c(OC)c2)nc1NC1CCOCC1		CHEMBL3301622	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943979	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C[C@@H]1CCn2cc(c3ccccc32)C2=C(C(=O)NC2=O)c2cn(c3ccccc23)CCO1		CHEMBL91829	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943980	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc([C@@H]2c3cc4c(cc3[C@H](O)[C@H]3COC(=O)[C@@H]23)OCO4)cc(OC)c1OC		CHEMBL283120	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943981	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1ccc(N(C(N)=O)c2c(F)cccc2F)nc1-c1ccc(F)cc1F		CHEMBL1090090	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943982	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)c1c(OCc2c(F)cc(Br)cc2F)nsc1NC(=O)NCCCCN1CCCC1		CHEMBL253969	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943983	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCO)CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1		CHEMBL215152	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943984	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N[C@@H]1CCCN(c2c(/C=C3\SC(=O)NC3=O)cccc2-c2ccccc2)C1		CHEMBL2048872	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943985	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](CO)Nc1nc(NCc2ccccc2)c2ncn(C(C)C)c2n1		CHEMBL14762	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943986	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c(C)c1C(=O)NC[C@H](O)CN1CCOCC1		CHEMBL1721885	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943987	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cc(NC(=O)Nc2ccc(-c3cn4c(n3)sc3cc(OCCN5CCOCC5)ccc34)cc2)no1		CHEMBL576982	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943988	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4ccccn4)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL180022	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943989	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3cc(C(C)(C)C)nn3-c3ccc4ncccc4c3)c(F)c2)ccn1		CHEMBL1738757	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943990	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cccc(-c2nn3c(c2-c2ccnc4ccc(C(N)=O)cc24)CCC3)n1		CHEMBL2364611	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943991	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CC)CCNC(=O)c1c(C)[nH]c(/C=C2\C(=O)Nc3ccc(F)cc32)c1C		CHEMBL535	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943992	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)[C@@H](c2cn3c4c(cccc24)CCC3)[C@@H]1c1c[nH]c2ccccc12		CHEMBL2103882	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943993	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2cnccc12)N1CCCNCC1		CHEMBL38380	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943994	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1cccc(Cl)c1)Nc1ncc(CCN=c2[nH]cnc3ccsc23)s1		CHEMBL482767	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17943995	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H](C(=O)N1Cc2n[nH]c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)c2C1)c1ccccc1		CHEMBL402548	=	Kd	nM	1145.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	1145.0
Inactive	17943996	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CCN(c2ccc(Nc3ncc(C(N)=O)c(NC4CC4)n3)cc2)CC1.Cl		CHEMBL3991929	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943997	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(C)CNc2cc(NC(=O)c3cccnc3NCc3ccncc3)ccc21		CHEMBL572881	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943998	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN1CCCCC1		CHEMBL2110732	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17943999	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3ncc4c(c3c2)n(-c2ccc(N3CCNCC3)c(C(F)(F)F)c2)c(=O)n4C)cn1		CHEMBL3218578	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944000	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(Nc2ccc(OCCN3CCCC3)cc2)nc1Nc1cccc(S(=O)(=O)NC(C)(C)C)c1		CHEMBL1287853	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944001	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(F)c(Cl)c3)c2cc1OCCCN1CCOCC1		CHEMBL939	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944002	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC(C)C)cc1C1CCNCC1		CHEMBL2403108	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944003	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc2c(OCc3nnc4ccc(-c5ccccc5)nn34)ccnc2c1		CHEMBL496102	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944004	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc(C(=O)Nc3n[nH]c4ccc(Cc5cc(F)cc(F)c5)cc34)c(NC3CCOCC3)c2)CC1		CHEMBL1983268	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944005	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=S(=O)(c1cccc2c(O)nccc12)N1CCCNCC1		CHEMBL1233300	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944006	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)c1		CHEMBL2336325	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944007	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(F)c(F)c1C(=O)c1cnc(NC2CCN(S(C)(=O)=O)CC2)nc1N		CHEMBL384304	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944008	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(Nc2nccc(N(C)c3ccc4c(C)n(C)nc4c3)n2)cc1S(N)(=O)=O		CHEMBL477772	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944009	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCc1cnn2c(NCc3ccc[n+]([O-])c3)cc(N3CCCC[C@H]3CCO)nc12		CHEMBL2103840	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944010	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(N2CCC(N3CCN(C)CC3)CC2)ccc1Nc1ncnc(Nc2ccccc2S(=O)(=O)C(C)C)n1		CHEMBL3545360	=	Kd	nM	1024.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	1024.0
Inactive	17944011	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc(Nc2ncnn3ccc(CN4CC[C@@H](N)[C@H](O)C4)c23)c1		CHEMBL3545396	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944012	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc(F)c(C(F)(F)F)c2)nc1C1CCN(c2ncnc3[nH]ncc23)CC1		CHEMBL3545076	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944013	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNS(=O)(=O)Nc1nccc(Cc2c(C)c3ccc(Oc4ncccn4)cc3oc2=O)c1F		CHEMBL3264002	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944014	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2[nH]nc3c2CN(C(=O)N[C@H](CN(C)C)c2ccccc2)C3(C)C)c2sccc2n1		CHEMBL3128043	=	Kd	nM	1229.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	1229.0
Inactive	17944015	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cn(-c2cc(NC(=O)c3ccc(C)c(Nc4nccc(-c5cccnc5)n4)c3)cc(C(F)(F)F)c2)cn1		CHEMBL255863	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944016	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)N(COP(=O)(O)O)C(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL2103830	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944017	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc4c(cc23)OCCOCCOCCO4)c1		CHEMBL2087361	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944018	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(F)cc(C(=O)NC2CC2)cc1-c1ccc(C(=O)NCC(C)(C)C)cn1		CHEMBL1088752	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944019	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(CCOc2cc(OC3CCOCC3)c3c(Nc4c(Cl)ccc5c4OCO5)ncnc3c2)CC1		CHEMBL217092	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944020	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cnc(NC(=O)Nc2cc(Br)c(C)cc2OC[C@@H]2CNCCO2)cn1		CHEMBL3039517	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944021	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C(=O)c1cc2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n1C1CCCC1		CHEMBL3545110	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944022	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1c(C)c2cnc(Nc3ccc(N4CCNCC4)cn3)nc2n(C2CCCC2)c1=O		CHEMBL189963	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944023	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NC1CCNCC1)c1n[nH]cc1NC(=O)c1c(Cl)cccc1Cl		CHEMBL445813	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944024	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ncc(-c2ccnc(Nc3ccc(S(C)(=O)=O)cc3)n2)n1C(C)C		CHEMBL488436	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944025	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(Sc4ccc5ncccc5c4)n3n2)cn1		CHEMBL1236107	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944026	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@H]1C(=O)N(C)c2cnc(Nc3ccc(C(=O)N[C@H]4CC[C@H](N5CCN(CC6CC6)CC5)CC4)cc3OC)nc2N1C(C)C		CHEMBL1233528	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944027	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=Nc3cc(NC(=O)C(N)C4CCCCC4)cc4c3C2=CNNC4=O)cn1		CHEMBL3545137	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944028	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OP(C)(C)=O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL2103839	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944029	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(C(=O)N[C@@H](CCO)c2ccc(Cl)cc2)CCN(c2ncnc3[nH]ccc23)CC1		CHEMBL2325741	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944030	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2ncnc3ccc(NC4=NC(C)(C)CO4)cc23)ccc1Oc1ccn2ncnc2c1		CHEMBL3989868	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944031	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(-c3cc4c(N[C@H](C)c5ccccc5)ncnc4[nH]3)cc2)CC1		CHEMBL587723	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944032	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1c[nH]nc1-c1nc2ccc(CN3CCOCC3)cc2[nH]1)NC1CC1		CHEMBL495727	=	Kd	nM	135.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	135.0
Inactive	17944033	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1nn(C)c2c1C(C)(C)Cc1cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc1-2		CHEMBL564829	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944034	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2ccc(F)c(F)c2)oc1Cl		CHEMBL3137336	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944035	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)c(F)c(Nc2ccc(I)cc2F)c2c(=O)n(C[C@@H](O)CO)cnc21		CHEMBL1615025	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944036	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(-n2nc(C(C)(C)C)cc2NC(=O)NCc2cc(F)ccc2Oc2ccc3c(cnn3CCO)c2)cc1		CHEMBL3991932	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944037	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2c(C#N)cnc3cc(OCCCN4CCN(C)CC4)c(OC)cc23)c(Cl)cc1Cl		CHEMBL288441	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944038	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC(Oc2cc3c(Nc4ccc(Cl)c(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL3545154	=	Kd	nM	69.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	69.0
Inactive	17944039	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)NOCCO)c(Nc2ccc(I)cc2F)n(C)c1=O		CHEMBL3182621	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944040	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(F)c(NC(=O)Nc2ccc(-c3cccc4[nH]nc(N)c34)cc2)c1		CHEMBL223360	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944041	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2nc(C3=C(c4c[nH]c5ccccc45)C(=O)NC3=O)c3ccccc3n2)CC1		CHEMBL565612	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944042	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1[nH]c(C2CCCN2)nc2c1oc1ccc(Cl)cc12		CHEMBL3544944	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944043	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2cc3c(C)nc(N)nc3n([C@H]3CC[C@H](OCCO)CC3)c2=O)cn1		CHEMBL1234354	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944044	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCN(c2ccc3nc(-c4c(N)c5c(F)cccc5[nH]c4=O)[nH]c3c2)CC1		CHEMBL522892	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944045	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(N3CCN(C(=O)Nc4ccc(OC(C)C)cc4)CC3)ncnc2cc1OCCCN1CCCCC1		CHEMBL124660	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944046	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc3c2cc1OCCCCCN(C)Cc1ccc(Br)cc1N3		CHEMBL3109738	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944047	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)NC4CC4)c(Cl)c3)c2cc1C(N)=O		CHEMBL1289601	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944048	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1[nH]c(/C=C2\C(=O)Nc3ccccc32)c(C)c1CCC(=O)O		CHEMBL274654	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944049	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1ncc(Cl)c1-c1cc(C(=O)N[C@H](CN)Cc2cccc(F)c2)sc1Cl		CHEMBL2219422	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944050	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(=O)n(-c2ccc(C(C)(C)C#N)cc2)c2c3cc(-c4cnc5ccccc5c4)ccc3ncc21		CHEMBL1879463	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944051	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2ccc(-n3ncc(C(=O)c4cc5ccccc5[nH]4)c3N)cc2[nH]1		CHEMBL3907479	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944052	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc(-c2cc3nccc(Oc4ccc(NC(=S)NC(=O)Cc5ccccc5)cc4F)c3s2)c1		CHEMBL254760	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944053	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCc1c(-c2ccc(NC(=O)Nc3cc(C(F)(F)F)ccc3F)c(F)c2)c2c(N)ncnn2c1CN1CCOCC1		CHEMBL3991934	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944054	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)c1cnc2ccc(-c3cc(Cl)c(O)c(Cl)c3)nc2c1N[C@H]1CC[C@H](CN(C)C)CC1		CHEMBL3688339	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944055	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(C(=O)Nc2ccc(C(=O)N3CCN(C)CC3)cc2)nnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL2376648	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944056	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944057	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnc3ccc4ccc(CS(=O)(=O)NCc5ccccn5)cc4c(=O)c3c2)cn1		CHEMBL2323775	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944058	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(N2CCN(C)CC2)cc1Nc1ncc2c(n1)-c1c(c(C(N)=O)nn1C)CC2		CHEMBL1094408	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944059	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Nc1cc(F)cc(F)c1)c1cc(C(=O)N(C)C)cc2c(=O)cc(N3CCOCC3)oc12		CHEMBL3408248	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944060	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@@H]1CO.Cl		CHEMBL3991935	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944061	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CC[C@H](c2c(O)cc(O)c3c(=O)cc(-c4ccccc4Cl)oc23)[C@H](O)C1		CHEMBL428690	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944062	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B			CHEMBL4084193	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944063	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(C(=O)Nc2cc(Oc3ccc4nc(NC(=O)C5CC5)cn4n3)ccc2C)n(C)n1		CHEMBL2180604	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944064	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(OC)c(/C=C/S(=O)(=O)Cc2ccc(OC)c(NCC(=O)O)c2)c(OC)c1		CHEMBL1241855	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944065	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](N)c1ccc(C(=O)Nc2ccnc3[nH]ccc23)cc1		CHEMBL571948	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944066	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc([C@@H](C)Nc2ccccc2C(=O)O)c2nc(N3CCOCC3)cc(=O)n2c1		CHEMBL2165191	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944067	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOCCO)c1cc(CN2OCCCC2=O)c(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL1614766	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944068	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC[C@@](O)(c1ccc(Cl)cc1)c1ccc(-c2cn[nH]c2)cc1		CHEMBL3544960	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944069	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc(F)c(Nc3ccc4c(n3)NC(=O)C(C)(C)O4)n2)cc(OC)c1OC		CHEMBL475251	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944070	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	25.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	25.0
Inactive	17944071	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)OC(=O)[C@H](C)N)c(C)c34)ccc2[nH]1		CHEMBL270995	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944072	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)c1cc(CNc2nc(Nc3cc(C4CC4)[nH]n3)cc(N3CCN(C)CC3)n2)on1		CHEMBL3545085	=	Kd	nM	45.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	45.0
Inactive	17944073	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C1=C/COCc2cc(ccc2OCCN2CCCC2)Nc2nccc(n2)-c2cccc(c2)COC/1		CHEMBL2035187	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944074	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)C1(Cc2cccc(Nc3nccs3)n2)CCC(Oc2cccc(Cl)c2F)CC1		CHEMBL3182444	=	Kd	nM	707.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	707.0
Inactive	17944075	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@@H]1[C@H](N(C)C(=O)c2ccccc2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL608533	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944076	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C#Cc1cccc(Nc2ncnc3cc(OCCOC)c(OCCOC)cc23)c1		CHEMBL553	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944077	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(F)c(F)c(Nc2ccc(I)cc2F)c1NS(=O)(=O)C1(C[C@H](O)CO)CC1		CHEMBL1236682	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944078	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1nc(-c2cccc(NS(=O)(=O)c3c(F)cccc3F)c2F)c(-c2ccnc(N)n2)s1		CHEMBL2028663	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944079	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC1(c2ccc(-c3nc4ccn5c(=O)[nH]nc5c4cc3-c3ccccc3)cc2)CCC1		CHEMBL1079175	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944080	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(C(=O)Nc2ccc(Oc3cc4cnn(C)c4cc3-c3cn[nH]c3)c(F)c2)c(=O)n1-c1ccc(F)cc1		CHEMBL3545307	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944081	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=c1sn(-c2cccc3ccccc23)c(=O)n1Cc1ccccc1		CHEMBL3545157	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944082	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Oc3cccc(NC(=O)Nc4cc(C(C)(C)C(F)(F)F)on4)c3)c2cc1OC		CHEMBL2029988	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944083	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2nc(N[C@@H](C)c3ncc(F)cn3)ncc2Cl)[nH]n1		CHEMBL1231124	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944084	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)[C@@]1(O)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL281948	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944085	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944086	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1201182	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944087	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(CCc2cc(NC(=O)c3ccc(N4CC(C)NC(C)C4)cc3)n[nH]2)cc(OC)c1		CHEMBL3184679	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944088	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)c1cccc(-c2cc(C(=O)NC3CCN(C)CC3)c(C)c3[nH]c4ncc(C)cc4c23)c1		CHEMBL3544932	=	Kd	nM	282.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	282.0
Inactive	17944089	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(Sc3ccc(NC(=O)C4CC4)cc3)n2)n[nH]1		CHEMBL572878	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944090	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccccc1Sc1ccc2c(/C=C/c3ccccn3)n[nH]c2c1		CHEMBL1289926	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944091	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@]1(C(=O)Nc2ccc(F)nc2)CCCN1c1nc(Nc2cc(C3CC3)n[nH]2)c2cccn2n1		CHEMBL575448	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944092	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(S(=O)(=O)Nc2nc3ccccc3nc2Nc2ccc3nsnc3c2)cc1		CHEMBL3218575	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944093	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	NC(=O)Nc1cc(-c2cccc(F)c2)sc1C(=O)N[C@H]1CCCNC1		CHEMBL2041933	=	Kd	nM	2609.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	2609.0
Inactive	17944094	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCS(=O)(=O)N1CC(CC#N)(n2cc(-c3ncnc4[nH]ccc34)cn2)C1		CHEMBL2105759	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944095	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCn1c(=O)c2cnc(Nc3ccc(N4CCN(C)CC4)cc3)nc2n1-c1cccc(C(C)(C)O)n1		CHEMBL1976040	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944096	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1CCC(COc2cnc(-c3cccc(Cn4nc(-c5cccc(C#N)c5)ccc4=O)c3)nc2)CC1		CHEMBL3402762	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944097	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)CN1CCC(Oc2cc3c(Nc4cccc(Cl)c4F)ncnc3cc2OC)CC1		CHEMBL2408045	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944098	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Cc1ccc(-c2ccc(OCCN3CCOCC3)cc2)cn1)NCc1ccccc1		CHEMBL571546	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944099	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]12O[C@H](C[C@]1(O)CO)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)CNC4=O		CHEMBL603469	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944100	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(Cn2c(C)nc3c(C(=O)O)cc(N4CCOCC4)cc32)cccc1C(F)(F)F		CHEMBL3188551	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944101	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2ccc3nnc(C(F)(F)c4ccc5ncccc5c4)n3n2)cn1		CHEMBL2133806	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944102	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(CN2CCN(C(=O)[C@H](C)O)CC2)sc2c(N3CCOCC3)nc(-c3cnc(N)nc3)nc12		CHEMBL1922094	=	Kd	nM	570.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	570.0
Inactive	17944103	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(OC(=O)c3ccccc3)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL403989	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944104	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nc(-c2cccnc2)cs1		CHEMBL1908391	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944105	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCS(=O)(=O)Nc1ccc(F)c(C(=O)c2c[nH]c3ncc(-c4ccc(Cl)cc4)cc23)c1F		CHEMBL1229517	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Uncertain	17944106	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)N1CCC[C@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3991931	=	Kd	nM	6.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	6.0
Inactive	17944107	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1ncnc2c1c(-c1cccc(OCc3ccccc3)c1)cn2[C@H]1C[C@H](N2CCC2)C1		CHEMBL551064	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944108	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1c(OCCCN2CCOCC2)ccc2c1N=C(NC(=O)c1cnc(N)nc1)N1CCN=C21		CHEMBL3218576	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944109	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(NC(=O)N2CCC[C@H]2C(N)=O)sc1-c1ccnc(C(C)(C)C(F)(F)F)c1		CHEMBL2396661	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944110	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCCN1CCN(Cc2ccc(-c3n[nH]c4c3C(=O)c3c(NC(=O)NN5CCOCC5)cccc3-4)cc2)CC1		CHEMBL3545083	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944111	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](c1ccc2nccn2c1)n1nnc2ncc(-c3cnn(C)c3)nc21		CHEMBL3334567	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944112	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCCCCCCCCCCCCCCCCCOP(=O)([O-])OC1CC[N+](C)(C)CC1		CHEMBL372764	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944113	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(C(=O)N(C2CC2)C2CC2)cc2c3c(ncn3C)c(Nc3cc(C)n(C)n3)nc21		CHEMBL3545215	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944114	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1cc2ncc(C#N)c(Nc3ccc(F)c(Cl)c3)c2cc1NC(=O)/C=C/CN(C)C		CHEMBL607707	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944115	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@@](C)(Nc1ccnc(-c2c[nH]c3ncccc23)n1)C(=O)NCC(F)(F)F		CHEMBL3039513	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944116	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)N[C@@H](C)CNc1nccc(-c2cn(C(C)C)nc2-c2cc(Cl)cc(NS(C)(=O)=O)c2F)n1		CHEMBL3301612	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944117	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(c1ncccc1CNc1nc(Nc2ccc3c(c2)CC(=O)N3)ncc1C(F)(F)F)S(C)(=O)=O		CHEMBL1084546	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944118	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cccc2cc(Oc3ccnc4cc(OCC5(N)CC5)c(OC)cc34)ccc12		CHEMBL2220486	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944119	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC1(c2ccc(NC(=O)c3cccnc3NCc3ccncc3)cc2)CCCC1		CHEMBL3186534	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944120	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](O)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL413	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944121	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc4[nH]c(C)cc4c3F)ncnc2cc1OCCCN1CCCC1		CHEMBL491473	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944122	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2c(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3F)ccnc2cc1OCCCN1CCOCC1		CHEMBL1230609	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944123	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	=	Kd	nM	43.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	43.0
Inactive	17944124	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1N=C(N)c2cn([C@@H]3O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]3O)c3ncnc1c23		CHEMBL462018	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944125	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC1(COc2ccc3c(c2)ncn3-c2ccc3cccc(N4CCC(N)CC4)c3n2)COC1		CHEMBL2105728	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944126	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc2c(F)c(Oc3ncnn4cc(OC[C@@H](C)O)c(C)c34)ccc2[nH]1		CHEMBL377300	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944127	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2nccc(Oc3ccc(NC(=O)C4(C(=O)Nc5ccc(F)cc5)CC4)cc3)c2cc1OC		CHEMBL2105717	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944128	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C/C=C/C(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1O[C@H]1CCOC1		CHEMBL1173655	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944129	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H]1CCN(C(=O)CC#N)C[C@@H]1N(C)c1ncnc2[nH]ccc12		CHEMBL221959	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944130	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	c1cc(OCCN2CCCCC2)cc(-c2n[nH]c3ccc(-c4nnc[nH]4)cc23)c1		CHEMBL1614713	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944131	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CCN(/C=C1/C(=O)O[C@H](COC)[C@@]2(C)C1=C(O)C(=O)C1=C2[C@H](OC(C)=O)C[C@]2(C)C(=O)CC[C@@H]12)CC=C		CHEMBL411907	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944132	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C)C1CCN(C(=O)c2ccc(NC(=O)Nc3ccc(-c4nc(N5CCOCC5)nc(N5CCOCC5)n4)cc3)cc2)CC1		CHEMBL592445	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944133	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COC(=O)c1ccc2c(c1)NC(=O)/C2=C(\Nc1ccc(N(C)C(=O)CN2CCN(C)CC2)cc1)c1ccccc1		CHEMBL502835	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944134	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc2c(c1)nc(Nc1cccc(Cl)c1)c1ccncc12		CHEMBL1230165	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944135	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1c(NC(=O)OC[C@@H]2COCCN2)cn2ncnc(Nc3ccc4c(cnn4Cc4cccc(F)c4)c3)c12		CHEMBL1645462	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944136	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(S(=O)(=O)N(C(C)=O)c2ccccc2/C=C/c2cc[n+]([O-])cc2)cc1		CHEMBL3991927	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944137	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CCNC(=O)c1ccc(-c2ccnc(Nc3ccc(N4CCOCC4)cc3)n2)cc1		CHEMBL1078178	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944138	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1ccc(NC(=O)c2ccc(CN3CCN(C)CC3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL941	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944139	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)Nc1cc(-c2c[nH]c(C(=O)N[C@H](CO)c3cccc(Cl)c3)c2)c(Cl)cn1		CHEMBL3590106	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944140	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Nc1cc(C(F)(F)F)c(-c2cc(N3CCOCC3)nc(N3CCOCC3)n2)cn1		CHEMBL2017974	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944141	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](Oc1cc(-c2cnn(C3CCNCC3)c2)cnc1N)c1c(Cl)ccc(F)c1Cl		CHEMBL601719	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944142	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cnc2c(F)c(Nc3ccc(Br)cc3F)c(C(=O)NOCCO)cc21		CHEMBL3187723	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944143	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(O)CC(=O)NCCn1ccc2ncnc(Nc3ccc(Oc4cccc(C(F)(F)F)c4)c(Cl)c3)c21		CHEMBL1614725	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944144	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)CCNCc1ccc(-c2ccc3ncnc(Nc4ccc(OCc5cccc(F)c5)c(Cl)c4)c3c2)o1		CHEMBL554	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944145	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1cc(-c2ccnc3[nH]c(-c4cccc(CN(C)C)c4)cc23)c(-c2ccc(NC(=O)N(C)C)cc2)n1		CHEMBL1090479	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944146	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cccc2cc(-c3nc([C@H]4CC[C@H](C(=O)O)CC4)n4ncnc(N)c34)[nH]c12		CHEMBL3120215	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944147	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	OCCn1cc(-c2cnc3nnn(Cc4ccc5ncccc5c4)c3n2)cn1		CHEMBL2001019	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944148	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc2cc(-c3nn(C(C)C)c4ncnc(N)c34)ccc2o1		CHEMBL3991933	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944149	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(C)c(-n2c(C)cc(OCc3ccc(F)cc3F)c(Br)c2=O)c1		CHEMBL1088751	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944150	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1nc2cccc(-c3ccc(CN4CCS(=O)(=O)CC4)cc3)n2n1)C1CC1		CHEMBL3301607	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944151	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(C)(C)c1cnc(CSc2cnc(NC(=O)C3CCNCC3)s2)o1		CHEMBL296468	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944152	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(O)c1ccc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2F)=NC3)cc1		CHEMBL259084	=	Kd	nM	1252.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	1252.0
Inactive	17944153	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(Nc1ccc(OC(F)(F)F)cc1)c1sccc1NCc1ccnc2ccccc12		CHEMBL1614710	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944154	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@]1(O)C[C@@H](c2nc(-c3ccc4ccc(-c5ccccc5)nc4c3)c3c(N)nccn32)C1		CHEMBL1091644	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944155	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1ccc(-c2ccc3c(N4CCOC[C@@H]4C)nc(N4CCOC[C@@H]4C)nc3n2)cc1CO		CHEMBL1801204	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944156	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1ccc(-c2cnc3ncc(Cc4ccc5ncccc5c4)n3n2)cc1F		CHEMBL3188267	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944157	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)N[C@H]4O		CHEMBL574737	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944158	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN1C/C=C/CCOc2cccc(c2)-c2ccnc(n2)Nc2cccc(c2)C1		CHEMBL1944698	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944159	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COCC(=O)NC/C=C/c1ccc2ncnc(Nc3ccc(Oc4ccc(C)nc4)c(C)c3)c2c1		CHEMBL483321	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944160	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(Nc2cc(N3CCN(C)CC3)nc(/C=C/c3ccccc3)n2)n[nH]1		CHEMBL482968	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944161	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(-c2cnn3c(N)c(Br)c([C@@H]4CCCNC4)nc23)cn1		CHEMBL2386889	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Active	17944162	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(N4CCN(C(C)=O)CC4)cc3OC)ncc2C(F)(F)F)c1		CHEMBL3545308	=	Kd	nM	288.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	288.0
Active	17944163	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC(=O)NCC(=O)N1C2CCC1c1cc(Nc3ncc(C(F)(F)F)c(NC4CCC4)n3)ccc12		CHEMBL1983111	=	Kd	nM	2319.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	2319.0
Active	17944164	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C=CC(=O)Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1C#CC(C)(C)N1CCN(C)CC1		CHEMBL2138625	=	Kd	nM	422.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	422.0
Inactive	17944165	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1cc(C2=C(c3cn(C4CCN(Cc5ccccn5)CC4)c4ccccc34)C(=O)NC2=O)c2ccccc21		CHEMBL300138	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944166	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCOc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc(N)c2Cl)c(F)c1		CHEMBL460702	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944167	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CS(=O)(=O)N1CCN(Cc2cc3nc(-c4cccc5[nH]ncc45)nc(N4CCOCC4)c3s2)CC1		CHEMBL521851	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944168	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1nccc1Nc1nccc(-c2ccn([C@H](CO)c3ccc(Cl)c(F)c3)c(=O)c2)n1		CHEMBL3544964	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944169	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	N#CC[C@H](C1CCCC1)n1cc(-c2ncnc3[nH]ccc23)cn1		CHEMBL1789941	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944170	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cn1c(Nc2ccc(C(F)(F)F)cc2)nc2cc(Oc3ccnc(-c4ncc(C(F)(F)F)[nH]4)c3)ccc21		CHEMBL558752	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944171	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CNCCCN1S(=O)(=O)c1cccc2cncc(F)c12		CHEMBL3426621	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944172	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	S=C(NCc1ccc2c(c1)OCO2)N1CCN(c2ncnc3c2oc2ccccc23)CC1		CHEMBL2103851	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944173	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CO[C@H]1C[C@@H]2CC[C@@H](C)[C@@](O)(O2)C(=O)C(=O)N2CCCC[C@H]2C(=O)O[C@H]([C@H](C)C[C@@H]2CC[C@@H](OCCO)[C@H](OC)C2)CC(=O)[C@H](C)/C=C(\C)[C@@H](O)[C@@H](OC)C(=O)[C@H](C)C[C@H](C)/C=C/C=C/C=C/1C		CHEMBL1908360	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944174	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(Oc2ccc(NC(=O)Nc3ccc(Cl)c(C(F)(F)F)c3)cc2)ccn1		CHEMBL1336	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944175	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc2ncnc(Nc3ccc(O)cc3)c2cc1OC		CHEMBL405130	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944176	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CNC(=O)c1cc(COc2nnc(Nc3ccc(Cl)cc3)c3ccoc23)ccn1		CHEMBL2079588	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944177	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	COc1cc(Nc2ncc3c(n2)-c2ccc(Cl)cc2C(c2c(F)cccc2OC)=NC3)ccc1C(=O)O		CHEMBL483158	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944178	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(c1ccc(/C=C/c2n[nH]c3ccccc23)cc1)N1CCNCC1		CHEMBL1908397	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944179	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCN(CCCOc1ccc2c(Nc3cc(CC(=O)Nc4cccc(F)c4)[nH]n3)ncnc2c1)CCOP(=O)(O)O		CHEMBL415049	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944180	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1cc(-c2cc(O)ccc2Cl)cc2nnc(Nc3ccc(OCCN4CCCC4)cc3)nc12		CHEMBL400402	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944181	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	FC(F)(F)c1ccc(CNc2ccc(Cc3c[nH]c4ncc(Cl)cc34)cn2)cn1		CHEMBL3813873	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944182	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Cc1nc(N)sc1-c1ccnc(Nc2ccc(N3CCOCC3)cc2)n1		CHEMBL482967	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944183	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CCn1c(=O)c(-c2cc[nH]n2)cc2c(C)nc(N)nc21		CHEMBL3545366	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944184	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CN(C[C@@H]1COCCO1)S(=O)(=O)Nc1ccc2ccc3ncc(-c4cnn(C)c4)cc3c(=O)c2c1		CHEMBL1822792	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944185	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@H]1CN(C(=O)c2cc3c(C(=O)C(=O)N(C)C)cn(C)c3cc2Cl)[C@H](C)CN1Cc1ccc(F)cc1		CHEMBL514201	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944186	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	C[C@@H](NC(=O)c1ncnc(N)c1Cl)c1ncc(C(=O)Nc2cc(C(F)(F)F)c(Cl)cn2)s1		CHEMBL3348923	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944187	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C(NOC[C@H](O)CO)c1ccc(F)c(F)c1Nc1ccc(I)cc1F		CHEMBL507361	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944188	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O[C@H]1CC[C@H](Nc2ncc3nc(Nc4c(F)cc(F)cc4F)n([C@H]4CCOC4)c3n2)CC1		CHEMBL1950289	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944189	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	O=C1NC(=O)/C(=C/c2ccc3nccc(-c4ccncc4)c3c2)S1		CHEMBL3544966	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944190	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	CC[C@H](Nc1ncnc2[nH]cnc12)c1nc2cccc(F)c2c(=O)n1-c1ccccc1		CHEMBL2216870	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
Inactive	17944191	CHEMBL3991906	Kinobeads (epsilon), multiple immobilized ATP-competitive broad spectrum kinase inhibitors, used to assess residual binding of ~300 proteins simultaneously from cell lysate in the presence of a compound. Quantitative readout performed by mass spectrometry.	B	Clc1ccc(Nc2nnc(Cc3ccncc3)c3ccccc23)cc1		CHEMBL101253	>	Kd	nM	30000.0	CHEMBL4246	Homo sapiens	Kd apparent	nM	30000.0
	17996274	CHEMBL4001423	Inhibition of human wild type partial length TEC (L341 to D620 residues) expressed in bacterial expression system at 10 uM by KinomeScan method relative to control	B	Cc1nc2nc(Sc3ccccc3)cnc2cc1NC(=O)Nc1ccccc1		CHEMBL4083528	=	Inhibition	%	9.0	CHEMBL4246	Homo sapiens	INH	%	9.0
	18020379	CHEMBL4005757	Inhibition of full length human His-tagged TEC assessed as inactivation rate by KT178 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Kinact	/s	0.00156	CHEMBL4246	Homo sapiens	Kinact	/s	0.00156
	18020386	CHEMBL4005764	Inhibition of full length human His-tagged TEC by KT178 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Ki	nM	679.0	CHEMBL4246	Homo sapiens	Ki	uM	0.679
	18020393	CHEMBL4005771	Ratio of Kinact to Ki for full length human His-tagged TEC	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	Ratio	10'3/M/s	2.3	CHEMBL4246	Homo sapiens	Ratio	10'3/M/s	2.3
	18020400	CHEMBL4005778	Inhibition of full length human His-tagged TEC in presence of 1 mM ATP by KT178 probe based TR-FRET assay	B	C=CC(=O)N1C[C@H](Nc2ncnc3[nH]ccc23)CC[C@@H]1C		CHEMBL4085457	=	IC50	nM	592.0	CHEMBL4246	Homo sapiens	IC50	nM	592.0
	18053048	CHEMBL4011895	Inhibition of TEC (unknown origin) at 0.1 uM pretreated for 30 mins followed by substrate addition measured after 5 hrs in presence of 1 mM ATP relative to control	B	COC(=O)C1=C(Nc2ccccc2Cl)O/C(=C\c2c[nH]c3ncccc23)C1=O		CHEMBL4089159	=	Inhibition	%	3.0	CHEMBL4246	Homo sapiens	INH	%	3.0
	18084571	CHEMBL4018332	Inhibition of human TEC at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1	Outside typical range	CHEMBL4089245	=	Inhibition	%	-27.0	CHEMBL4246	Homo sapiens	INH	%	-27.0
	18084578	CHEMBL4018339	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4089245	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	18084610	CHEMBL4018332	Inhibition of human TEC at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	=	Inhibition	%	-5.0	CHEMBL4246	Homo sapiens	INH	%	-5.0
	18084617	CHEMBL4018339	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)Nc1cccc(C)c1Nc1ncc2cc(-c3c(Cl)c(OC)cc(OC)c3Cl)ccc2n1		CHEMBL4068896	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	18084670	CHEMBL4018332	Inhibition of human TEC at 10 uM using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method relative to control	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4077859	=	Inhibition	%	-1.0	CHEMBL4246	Homo sapiens	INH	%	-1.0
	18084677	CHEMBL4018339	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	C=CC(=O)N[C@H]1COC[C@H]1Nc1ncc(OCc2c(F)c(OC)cc(OC)c2F)cn1		CHEMBL4077859	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	uM	10.0
	18084686	CHEMBL4018339	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate measured after 120 mins in presence of [gamma33P]ATP by P81 ion exchange chromatographic method	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4	Outside typical range	CHEMBL388978	=	IC50	nM	128000.0	CHEMBL4246	Homo sapiens	IC50	uM	128.0
	18092353	CHEMBL4020208	Inhibition of human TEC using poly[Glu:Tyr] as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition by filter binding method	A	C=CC(=O)Nc1cccc(-c2n[nH]c(NCc3c(F)cccc3Cl)n2)c1		CHEMBL4101977	=	IC50	nM	306.45	CHEMBL4246	Homo sapiens	IC50	nM	306.45
	18092354	CHEMBL4020208	Inhibition of human TEC using poly[Glu:Tyr] as substrate preincubated for 20 mins followed by [gamma-33P]-ATP addition by filter binding method	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	1.86	CHEMBL4246	Homo sapiens	IC50	nM	1.86
	18092358	CHEMBL4020211	Inhibition of TEC (unknown origin) after 2 hrs by LanthaScreen assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	7.0	CHEMBL4246	Homo sapiens	IC50	nM	7.0
	18109355	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Inhibition	%	100.0	CHEMBL4246	Homo sapiens	INH	%	100.0
	18109356	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	Inhibition	%	92.0	CHEMBL4246	Homo sapiens	INH	%	92.0
	18109357	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4071161	=	Inhibition	%	86.0	CHEMBL4246	Homo sapiens	INH	%	86.0
	18109358	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	=	Inhibition	%	71.0	CHEMBL4246	Homo sapiens	INH	%	71.0
	18109359	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C[C@H]1CN(C2COC2)CCN1c1ccc(Nc2cc(-c3ccnc(N4CCn5c(cc6c5CC(C)(C)C6)C4=O)c3CO)cn(C)c2=O)nc1		CHEMBL4065122	=	Inhibition	%	23.0	CHEMBL4246	Homo sapiens	INH	%	23.0
	18109360	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833	=	Inhibition	%	80.0	CHEMBL4246	Homo sapiens	INH	%	80.0
	18109361	CHEMBL4023736	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus at 1 uM by Z'-LYTE assay	A	Cc1c(-c2c(F)cc(C(N)=O)c3[nH]c4c(c23)CC[C@@H](C(C)(C)O)C4)cccc1-n1c(=O)c2cccc(F)c2n(C)c1=O		CHEMBL3952795	=	Inhibition	%	98.0	CHEMBL4246	Homo sapiens	INH	%	98.0
	18109375	CHEMBL4023746	Inhibition of recombinant human cytoplasmic full length His-tagged TEC expressed in baculovirus by Z'-LYTE assay	A	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833	=	IC50	nM	37.9	CHEMBL4246	Homo sapiens	IC50	nM	37.9
	18114877	CHEMBL4025407	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2cc(-c3cccc(NC(=O)c4ccc(C(C)(C)C)cc4)c3C)cn(C)c2=O)ccc1C(=O)N1CCOCC1		CHEMBL4077123	=	Activity	%	95.0	CHEMBL4246	Homo sapiens	Activity	%	95.0
	18203931	CHEMBL4044218	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in Escherichia coli BL21 assessed as residual activity at 1000 nM after 30 mins by Kinomescan method relative to control	B	COc1cc(OC)c(Cl)c(N2Cc3cnc(Nc4ccc(F)cc4)nc3N(C3CCN(C(=O)/C=C/CN(C)C)CC3)C2=O)c1Cl		CHEMBL4092508	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	18243298	CHEMBL4052520	Inhibition of TEC (unknown origin) assessed as residual activity at 1 uM in presence of [33-gamma]-ATP after 60 mins by scintillation counting method relative to control	B	C=CC(=O)Nc1cccc(-c2c[nH]c3nccc(-c4[nH]c(CCCO)nc4-c4ccc(F)cc4)c23)c1		CHEMBL4071827	=	Activity	%	33.0	CHEMBL4246	Homo sapiens	Activity	%	33.0
	18248633	CHEMBL4053916	Inhibition of TEC (unknown origin) at 1 uM relative to control	B	C=CC(=O)Nc1cc(Nc2nccc(-c3cn4c5c(cccc35)CCC4)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4104658	=	Inhibition	%	52.0	CHEMBL4246	Homo sapiens	INH	%	52.0
	18253713	CHEMBL4055141	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	CC1(C)[C@H](Nc2c(C(N)=O)cnn3cc(-c4ccccc4)cc23)CC[C@]1(C)N		CHEMBL4096145	=	Activity	%	99.0	CHEMBL4246	Homo sapiens	Activity	%	99.0
	18253714	CHEMBL4055141	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 50 nM by Kinomescan method relative to control	B	COc1ccc(-c2cc3c(N[C@@H]4CC[C@](C)(N)C4(C)C)c(C(N)=O)cnn3c2)cn1		CHEMBL4080797	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	18265942	CHEMBL4057392	Inhibition of TEC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	7.0	CHEMBL4246	Homo sapiens	INH	%	7.0
	18266158	CHEMBL4057608	Inhibition of TEC (unknown origin) at 0.49 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(NC(=O)C3CC3)noc2c1		CHEMBL4088455	=	Inhibition	%	3.7	CHEMBL4246	Homo sapiens	INH	%	3.7
	18268119	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	CC(C)C(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4069387	=	IC50	nM	378.0	CHEMBL4246	Homo sapiens	IC50	nM	378.0
	18268120	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	CC(C)C(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4075954	=	IC50	nM	428.0	CHEMBL4246	Homo sapiens	IC50	nM	428.0
	18268121	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	COCC(=O)N1CCC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4076024	=	IC50	nM	63.0	CHEMBL4246	Homo sapiens	IC50	nM	63.0
	18268122	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	COCC(=O)N1CCO[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)C1		CHEMBL4062498	=	IC50	nM	232.0	CHEMBL4246	Homo sapiens	IC50	nM	232.0
	18268123	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	Nc1nccn2c([C@@H]3CCCN(C4CCOCC4)C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4077588	=	IC50	nM	170.0	CHEMBL4246	Homo sapiens	IC50	nM	170.0
	18268124	CHEMBL4057974	Inhibition of TEC (unknown origin)	B	Nc1nccn2c([C@H]3CN(C4CCOCC4)CCO3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c12		CHEMBL4060757	=	IC50	nM	191.0	CHEMBL4246	Homo sapiens	IC50	nM	191.0
	18268990	CHEMBL4058121	Inhibition of recombinant human N-terminal His6-tagged TEC (174 to end residues) expressed in baculovirus Sf21 insect cells preincubated for 5 mins followed by Ulight-TK peptide substrate addition after 30 to 60 mins in presence of ATP by fluorescence assay	B	C=CS(=O)(=O)N1CCC[C@@H]1Cn1cc(-c2ccc3c(c2)OCO3)c2c(N)ncnc21		CHEMBL4095253	=	IC50	nM	114.8	CHEMBL4246	Homo sapiens	IC50	nM	114.8
	18282183	CHEMBL4120138	Inhibition of recombinant full length His-tagged human TEC cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	CC(C)n1nc(-c2cnc(N)c(OC(F)(F)F)c2)cc1[C@@H]1[C@H]2CN(C3COC3)C[C@H]21		CHEMBL3719135	=	Inhibition	%	-1.5	CHEMBL4246	Homo sapiens	INH	%	-1.5
	18282502	CHEMBL4120138	Inhibition of recombinant full length His-tagged human TEC cytoplasmic domain expressed in baculovirus expression system at 1 uM by FRET assay relative to control	B	Nc1ncc(-c2cc([C@@H]3[C@H]4CN(C5COC5)C[C@H]43)n(CC3CC3)n2)cc1C(F)(F)F		CHEMBL3715238	=	Inhibition	%	4.8	CHEMBL4246	Homo sapiens	INH	%	4.8
	18282765	CHEMBL4120350	Inhibition of TEC (unknown origin) at 0.45 uM relative to control	B	Cc1n[nH]c(C)c1-c1ccc2c(NC(=O)c3ccc(N4CCN(C)CC4)cc3)n[nH]c2c1		CHEMBL4095072	=	Inhibition	%	7.0	CHEMBL4246	Homo sapiens	INH	%	7.0
	18282992	CHEMBL4120577	Inhibition of TEC (unknown origin) at 0.19 uM relative to control	B	Cc1[nH]nc(C2CC2)c1-c1ccc2c(-c3ccc(N4CCN(C)CC4)nc3)n[nH]c2c1		CHEMBL4125807	=	Inhibition	%	2.0	CHEMBL4246	Homo sapiens	INH	%	2.0
	18283216	CHEMBL4120801	Inhibition of TEC (unknown origin) at 0.164 uM relative to control	B	COC(=O)Nc1cc(-c2c(C3CC3)n[nH]c2C)cc2[nH]ncc12		CHEMBL4129737	=	Inhibition	%	-4.3	CHEMBL4246	Homo sapiens	INH	%	-4.3
	18415106	CHEMBL4152875	Inhibition of TEC (unknown origin)	B	CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1		CHEMBL2057918	=	IC50	nM	64.0	CHEMBL4246	Homo sapiens	IC50	nM	64.0
	18415107	CHEMBL4152875	Inhibition of TEC (unknown origin)	B	Cc1cc2[nH]ncc2cc1-c1cccc2c(N)c(C(N)=O)nnc12		CHEMBL4172284	=	IC50	nM	57.0	CHEMBL4246	Homo sapiens	IC50	nM	57.0
	18415108	CHEMBL4152875	Inhibition of TEC (unknown origin)	B	Cc1c(NC(=O)c2ccc(C(C)(C)C)cc2)cccc1-c1nc(Nc2ccc(C(=O)N3CCOCC3)cc2)c2nc[nH]c2n1		CHEMBL3263640	=	IC50	nM	14.0	CHEMBL4246	Homo sapiens	IC50	nM	14.0
	18415109	CHEMBL4152875	Inhibition of TEC (unknown origin)	B	CC#CC(=O)N1CCC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4175428	=	IC50	nM	5.3	CHEMBL4246	Homo sapiens	IC50	nM	5.3
	18415110	CHEMBL4152875	Inhibition of TEC (unknown origin)	B	C=CC(=O)Nc1cccc(Nc2nc(Nc3ccc(OCCOC)cc3)ncc2F)c1		CHEMBL3301625	=	IC50	nM	6.2	CHEMBL4246	Homo sapiens	IC50	nM	6.2
	18415140	CHEMBL4152870	Inhibition of TEC (unknown origin) by FRET assay	B	C=CC(=O)N1CCC[C@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL3647964	=	IC50	nM	78.0	CHEMBL4246	Homo sapiens	IC50	nM	78.0
	18440473	CHEMBL4157297	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding at 1 uM by Kinomescan method relative to control	B	Cc1cccc(S(=O)(=O)Nc2cc(-c3sc(NC(=O)[C@@H](N)C(C)C)nc3C)cnc2Cl)c1		CHEMBL4174988	=	Activity	%	89.0	CHEMBL4246	Homo sapiens	Activity	%	89.0
	18450305	CHEMBL4178321	Inhibition of recombinant full length N-terminal GST-tagged TEC (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	CCN1CCN(Cc2ccc(-c3cc4c(-c5cccc(N6CCOc7cc(C8CC8)cc(F)c7C6=O)c5CO)ccnc4[nH]3)nc2)CC1		CHEMBL3967108	=	Activity	%	-35.0	CHEMBL4246	Homo sapiens	Activity	%	-35.0
	18450355	CHEMBL4178321	Inhibition of recombinant full length N-terminal GST-tagged TEC (unknown origin) expressed in baculovirus infected Sf9 cells assessed as change in enzyme activity at 1 uM in presence of 2 uM ATP relative to control	B	O=C1c2c(F)cc(C3CC3)cc2OCCN1c1cccc(-c2ccnc3[nH]c(C4=CCN(C5COC5)CC4)cc23)c1CO		CHEMBL3966346	=	Activity	%	-31.0	CHEMBL4246	Homo sapiens	Activity	%	-31.0
	18450768	CHEMBL4178425	Inhibition of His-tagged full-length recombinant human TEC cytoplasmic domain expressed in Baculovirus expression system at 1 uM by FRET-based Z'-LYTE assay	B	C=CC(=O)N[C@@H]1CN(c2nc(Nc3cn(C)nc3OC)c3ncn(C)c3n2)C[C@H]1F		CHEMBL3989970	>	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	18470973	CHEMBL4182618	Inhibition of N-terminal GST-fused human TEC catalytic domain (359 to 631 amino acids) at 0.3 uM	B	Nc1cc(-c2cccc(-n3ccc4cc(C5CC5)cc(F)c4c3=O)c2CO)nc(Nc2cnn(C3CC3)c2)n1		CHEMBL4213985	=	Inhibition	%	92.0	CHEMBL4246	Homo sapiens	INH	%	92.0
	18484429	CHEMBL4186076	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL3969370	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	18484913	CHEMBL4186076	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in Escherichia coli BL21 at 1 uM by Kinomescan method relative to control	B	CCC(=O)Nc1ccc(C(=O)Nc2ccc(Nc3ncc4c(n3)N(C)c3ccc(C)cc3C(=O)N4C)cc2)cc1		CHEMBL4206831	=	Activity	%	93.0	CHEMBL4246	Homo sapiens	Activity	%	93.0
	18502761	CHEMBL4189693	Inhibition of recombinant human TEC using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	0.5	CHEMBL4246	Homo sapiens	IC50	nM	0.5
	18502848	CHEMBL4189693	Inhibition of recombinant human TEC using Poly(Glu, Tyr) 4:1 as substrate after 1 hr by ELISA	A	C=CC(=O)N[C@@H]1Cn2c(c(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1=C		CHEMBL4211949	=	IC50	nM	1.4	CHEMBL4246	Homo sapiens	IC50	nM	1.4
	18507583	CHEMBL4191208	Inhibition of recombinant activated human Tec (174 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate after 40 mins in presence of [gamma-33P]ATP by scintillation counting method	B	CS(=O)(=O)c1ccc(-n2nc(-c3cnc4[nH]ccc4c3)c3c(N)ncnc32)cc1		CHEMBL4207014	=	Inhibition	%	55.0	CHEMBL4246	Homo sapiens	INH	%	55.0
	18551474	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2		CHEMBL4203077	=	IC50	nM	1.65	CHEMBL4246	Homo sapiens	IC50	nM	1.65
	18551475	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3cncs3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2		CHEMBL4202618	=	IC50	nM	4.5	CHEMBL4246	Homo sapiens	IC50	nM	4.5
	18551476	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2		CHEMBL4206487	=	IC50	nM	1.78	CHEMBL4246	Homo sapiens	IC50	nM	1.78
	18551477	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3ccccc31)C2		CHEMBL4211372	=	IC50	nM	0.62	CHEMBL4246	Homo sapiens	IC50	nM	0.62
	18551478	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C#N)cc3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2		CHEMBL4210857	=	IC50	nM	4.32	CHEMBL4246	Homo sapiens	IC50	nM	4.32
	18551479	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccns3)nc3cc(CN[C@@H](C)C(C)(C)C)ccc31)C2		CHEMBL4215807	=	IC50	nM	3.16	CHEMBL4246	Homo sapiens	IC50	nM	3.16
	18551480	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CN4CCOCC4)ccc31)C2		CHEMBL4218914	=	IC50	nM	2.27	CHEMBL4246	Homo sapiens	IC50	nM	2.27
	18551481	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(C)(F)F)s3)nc3ccccc31)C2		CHEMBL4204572	=	IC50	nM	0.98	CHEMBL4246	Homo sapiens	IC50	nM	0.98
	18551482	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(C(F)F)s3)nc3cc(CNCC(C)(C)CO)ccc31)C2		CHEMBL4202941	=	IC50	nM	3.13	CHEMBL4246	Homo sapiens	IC50	nM	3.13
	18551483	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CN[C@H]4CC[C@H](O)CC4)ccc31)C2		CHEMBL4216529	=	IC50	nM	2.0	CHEMBL4246	Homo sapiens	IC50	nM	2.0
	18551484	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(CNCC(C)(C)CO)ccc31)C2		CHEMBL4215147	=	IC50	nM	1.96	CHEMBL4246	Homo sapiens	IC50	nM	1.96
	18551485	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(NC)ccc31)C2		CHEMBL4216187	=	IC50	nM	0.67	CHEMBL4246	Homo sapiens	IC50	nM	0.67
	18551486	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cnco4)s3)nc3cc(F)ccc31)C2		CHEMBL4208358	=	IC50	nM	0.74	CHEMBL4246	Homo sapiens	IC50	nM	0.74
	18551487	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4cc[nH]c(=O)c4)s3)nc3ccccc31)C2		CHEMBL4206765	=	IC50	nM	0.09	CHEMBL4246	Homo sapiens	IC50	nM	0.09
	18551488	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(N)c4)s3)nc3ccccc31)C2		CHEMBL4207292	=	IC50	nM	0.2	CHEMBL4246	Homo sapiens	IC50	nM	0.2
	18551489	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(NC)c4)s3)nc3ccccc31)C2		CHEMBL4219011	=	IC50	nM	0.16	CHEMBL4246	Homo sapiens	IC50	nM	0.16
	18551490	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(N)n4)s3)nc3ccccc31)C2		CHEMBL4217959	=	IC50	nM	0.1	CHEMBL4246	Homo sapiens	IC50	nM	0.1
	18551491	CHEMBL4199506	Inhibition of TEC (unknown origin) using fluorescently labeled peptide as substrate after 3 hrs by microfluidic mobility shift assay	B	C=CC(=O)N1CC[C@]2(C1)C[C@H](n1c(NC(=O)c3ccc(-c4ccnc(C)n4)s3)nc3ccccc31)C2		CHEMBL4214683	=	IC50	nM	0.11	CHEMBL4246	Homo sapiens	IC50	nM	0.11
	18562747	CHEMBL4201927	Inhibition of N-terminal GST-fused human TEC catalytic domain (359 to 631 amino acids) expressed in baculovirus expression system at 0.3 uM using Srctide substrate by mobility shift assay	B	Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cn1		CHEMBL4209441	=	Inhibition	%	99.5	CHEMBL4246	Homo sapiens	INH	%	99.5
	18562748	CHEMBL4201927	Inhibition of N-terminal GST-fused human TEC catalytic domain (359 to 631 amino acids) expressed in baculovirus expression system at 0.3 uM using Srctide substrate by mobility shift assay	B	Cn1cc(Nc2nc(N)nc(-c3cccc(-n4ccc5cc(C6CC6)cc(F)c5c4=O)c3CO)n2)cc1C#N		CHEMBL4204675	=	Inhibition	%	99.2	CHEMBL4246	Homo sapiens	INH	%	99.2
	18653333	CHEMBL4230239	Inhibition of TEC (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc(NC(=O)c3cccc(C(F)(F)F)c3)c2)c2c(N)ncnc21		CHEMBL3736320	=	Inhibition	%	40.0	CHEMBL4246	Homo sapiens	INH	%	40.0
	18653334	CHEMBL4230239	Inhibition of TEC (unknown origin) at 1 uM by mobility shift microfluidics platform based assay relative to control	B	CC(C)n1nc(C#Cc2cccc3cc(-c4cccc(C(F)(F)F)c4)ncc23)c2c(N)ncnc21		CHEMBL4247506	=	Inhibition	%	2.0	CHEMBL4246	Homo sapiens	INH	%	2.0
	18655259	CHEMBL4230976	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	Cc1ccc(NC(=O)c2ccc(CN(CCN(C)C)C(=O)c3cccnc3)cc2)cc1Nc1nccc(-c2cccnc2)n1		CHEMBL4247298	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	18675726	CHEMBL4235703	Inhibition of TEC (unknown origin)	B	C=CS(=O)(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C		CHEMBL4248386	=	IC50	nM	0.9	CHEMBL4246	Homo sapiens	IC50	nM	0.9
	18675727	CHEMBL4235703	Inhibition of TEC (unknown origin)	B	C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c(C)c(C)c23)c1C		CHEMBL4237557	=	IC50	nM	6.4	CHEMBL4246	Homo sapiens	IC50	nM	6.4
	18675728	CHEMBL4235703	Inhibition of TEC (unknown origin)	B	C=CC(=O)Nc1cccc(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)c1C		CHEMBL4241958	=	IC50	nM	2.3	CHEMBL4246	Homo sapiens	IC50	nM	2.3
	18675729	CHEMBL4235703	Inhibition of TEC (unknown origin)	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4c(c23)CCC(C(C)(C)O)C4)cccc1-n1cnc2ccccc2c1=O		CHEMBL4237800	=	IC50	nM	56.0	CHEMBL4246	Homo sapiens	IC50	nM	56.0
	18694033	CHEMBL4253486	Inhibition of recombinant human full length His-tagged TEC expressed in baculovirus expression system at 0.1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	11.0	CHEMBL4246	Homo sapiens	INH	%	11.0
	18694115	CHEMBL4253568	Inhibition of recombinant human full length His-tagged TEC expressed in baculovirus expression system at 1 uM by TR-FRET assay relative to control	B	CC1=Nc2c(F)cc(-c3nc(Nc4ccc(C5CCN(C)CC5)cn4)ncc3F)cc2C12CCCC2		CHEMBL4277900	=	Inhibition	%	2.0	CHEMBL4246	Homo sapiens	INH	%	2.0
	18751252	CHEMBL4263961	Inhibition of TEC (unknown origin) at 1 uM relative to control	B	NC1(c2ccc(-c3cnc4c(-c5ccc(S(N)(=O)=O)c6ccccc56)cnn4c3)cc2)CCC1		CHEMBL4278763	=	Inhibition	%	6.0	CHEMBL4246	Homo sapiens	INH	%	6.0
	18752228	CHEMBL4264565	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as remaining unbound target protein level at 1000 nM by Kinomescan method relative to control	B	COCCN[C@H]1CC[C@H](Nc2cc(-c3csc(NCC4(C#N)CCOCC4)n3)c(Cl)cn2)CC1		CHEMBL4281048	=	Activity	%	92.0	CHEMBL4246	Homo sapiens	Activity	%	92.0
	18757994	CHEMBL4265592	Inhibition of TEC (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4281393	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	nM	10000.0
	18757995	CHEMBL4265592	Inhibition of TEC (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1C[C@@H](NS(=O)(=O)c2cccc(F)c2)c2ccc(-c3ncnc4[nH]ccc34)cc21		CHEMBL4277610	>	IC50	nM	10000.0	CHEMBL4246	Homo sapiens	IC50	nM	10000.0
	18757996	CHEMBL4265592	Inhibition of TEC (unknown origin) in presence of 1 mM ATP concentration	B	N#CN[C@H]1CCc2ccc(-c3ncnc4[nH]cc(-c5cccc(CO)c5)c34)cc21		CHEMBL4292341	=	IC50	nM	8960.0	CHEMBL4246	Homo sapiens	IC50	nM	8960.0
	18858228	CHEMBL4308074	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	CC(C)N1C(=O)C(NCCCN(C)C)=C(c2cn(C)c3ccccc23)C1=O.Cl		CHEMBL4533018	=	Activity	%	99.0	CHEMBL4246	Homo sapiens	Activity	%	99.0
	18886152	CHEMBL4313399	Inhibition of human TEC at 10 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	COc1ccc(-c2nn(-c3cccc(NC(=O)c4cccc(C(F)(F)F)c4)c3)cc2-c2ccncc2)cc1Cl		CHEMBL4553144	=	Inhibition	%	-3.79	CHEMBL4246	Homo sapiens	INH	%	-3.79
	18919435	CHEMBL4322793	Binding affinity to recombinant human N-terminal GST-tagged TEC (359 to 631 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](NCCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4465866	=	Kd	nM	1063.0	CHEMBL4246	Homo sapiens	Kd	nM	1063.0
	18919623	CHEMBL4322793	Binding affinity to recombinant human N-terminal GST-tagged TEC (359 to 631 residues) expressed in baculovirus expression system using Srctide as substrate incubated for 1 hr by TR-FRET assay	B	CO[C@@H]1[C@H](N(C)CCOCCOCCOCCNC(=O)CCC2=[N+]3C(=Cc4c(C)cc(C)n4[B-]3(F)F)C=C2)C[C@H]2O[C@]1(C)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL4576489	=	Kd	nM	1463.0	CHEMBL4246	Homo sapiens	Kd	nM	1463.0
	18938349	CHEMBL4327901	Inhibition of human TEC assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	ClC/C=C/C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4438024	=	Activity	%	101.86	CHEMBL4246	Homo sapiens	Activity	%	101.86
	18938350	CHEMBL4327901	Inhibition of human TEC assessed as residual activity at 1 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	C(=C/c1ccccc1)\C[N+]12CN3CN(CN(C3)C1)C2.[Cl-]		CHEMBL4446405	=	Activity	%	100.33	CHEMBL4246	Homo sapiens	Activity	%	100.33
	18938746	CHEMBL4328265	Inhibition of human TEC assessed as residual activity at 100 uM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay relative to control	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	<	Activity	%	65.0	CHEMBL4246	Homo sapiens	Activity	%	65.0
	18939132	CHEMBL4328629	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	43.1	CHEMBL4246	Homo sapiens	IC50	10'-8M	4.31
	18959000	CHEMBL4333656	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	CC(C)Nc1sc(C(=O)c2ccc(Cl)s2)c(N)c1C#N		CHEMBL4563315	=	Activity	%	94.0	CHEMBL4246	Homo sapiens	Activity	%	94.0
	18965850	CHEMBL4335773	Inhibition of recombinant human N-terminal GST-fused TEC catalytic domain (359 to 631 residues) expressed in baculovirus expression system using biotin-labelled STK/TK as substrate measured after 1 hr by HTRF assay	A	COc1cc2cn[nH]c2cc1-c1ccc(F)c2c(N)c(C(N)=O)cnc12		CHEMBL4475004	=	IC50	nM	227.0	CHEMBL4246	Homo sapiens	IC50	nM	227.0
	19018943	CHEMBL4347052	Inhibition of TEC (unknown origin)	B	Nc1ncnc2c1c(-c1ccc(Oc3ccccc3)cc1)cn2C[C@H]1CCCN1C[C@@H]1CO1		CHEMBL4525187	=	IC50	nM	44.0	CHEMBL4246	Homo sapiens	IC50	nM	44.0
Active	19041303	CHEMBL4352564	Inhibition of human TEC at 10 uM using poly[Glu:Tyr] (4:1) as substrate in presence of [gamma-33P]-ATP	B	CC(C)(C)C(=O)N1N=CC[C@H]1c1ccccc1		CHEMBL4521353		Inhibition	%		CHEMBL4246	Homo sapiens	INH		
	19059853	CHEMBL4358154	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1ccccc1Nc1nc(Nc2ccc(N3CCN(C)CC3)cc2)ncc1C(=O)Nc1c(C)cccc1Cl		CHEMBL4515441	=	Activity	%	95.0	CHEMBL4246	Homo sapiens	Activity	%	95.0
	19061178	CHEMBL4358513	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	A	C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C		CHEMBL4483575	=	Activity	%	24.0	CHEMBL4246	Homo sapiens	Activity	%	24.0
	19061192	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	C=CC(=O)N(C)CCOc1c(N)ncnc1-c1cc(F)cc(NC(=O)c2ccc(C3CC3)cc2F)c1C		CHEMBL4483575	=	Kd	nM	110.0	CHEMBL4246	Homo sapiens	Kd	nM	110.0
	19061193	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	Kd	nM	1.7	CHEMBL4246	Homo sapiens	Kd	nM	1.7
	19061194	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	=	Kd	nM	14.0	CHEMBL4246	Homo sapiens	Kd	nM	14.0
	19061195	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	CC#CC(=O)N1CC[C@@H](n2c(=O)n(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL4071161	=	Kd	nM	6.2	CHEMBL4246	Homo sapiens	Kd	nM	6.2
	19061196	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833	=	Kd	nM	4.5	CHEMBL4246	Homo sapiens	Kd	nM	4.5
	19061197	CHEMBL4358516	Binding affinity to DNA-tagged recombinant TEC (unknown origin) measured after 1 hr by biotinylated-ligand affinity bead-based qPCR analysis	A	CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1		CHEMBL4297674	=	Kd	nM	0.99	CHEMBL4246	Homo sapiens	Kd	nM	0.99
	19090417	CHEMBL4365991	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccnc1)c1cc(C(=O)c2c(F)cccc2Br)c[nH]1		CHEMBL4436895	=	Activity	%	95.0	CHEMBL4246	Homo sapiens	Activity	%	95.0
	19092140	CHEMBL4366614	Inhibition of human TEC at 100 nM using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	COc1ccc(N2C(=O)COc3ccc(-c4cnc(OC)c(NS(=O)(=O)c5ccc(F)cc5)c4)cc32)cc1		CHEMBL4528675	=	Inhibition	%	-4.06	CHEMBL4246	Homo sapiens	INH	%	-4.06
	19114725	CHEMBL4371458	Binding affinity to TEC in SILAC-labeled human MDA-MB-231 cells lysate by mass spectrometry based kinAffinity assay	B	COc1cc2c(Oc3ccc(NS(=O)(=O)c4c(F)cccc4F)cc3F)ccnc2cc1OCCCN1CCN(C)CC1		CHEMBL4462318	>	Kd	nM	3674.0	CHEMBL4246	Homo sapiens	Kd(free)	uM	3.674
Active	19133070	CHEMBL4375210	Inhibition of N-terminal His6-tagged human TEC (174 to end aminoacids) expressed in baculovirus infected Sf21 cells at 1 uM	A	C=CC(=O)N1CCC(CNc2ncnc(N)c2-c2ccc(Oc3ccccc3)cc2)CC1		CHEMBL4072833		Inhibition	%		CHEMBL4246	Homo sapiens	INH		
Active	19133071	CHEMBL4375210	Inhibition of N-terminal His6-tagged human TEC (174 to end aminoacids) expressed in baculovirus infected Sf21 cells at 1 uM	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3ccccc32)C1		CHEMBL4466205		Inhibition	%		CHEMBL4246	Homo sapiens	INH		
	19155410	CHEMBL4381036	Binding affinity to Tec SH3 domain (unknown origin)	B	Nc1ccc2cc(COc3ccc(Cl)cc3)ccc2n1		CHEMBL4580788	=	Kd	nM	9000.0	CHEMBL4246	Homo sapiens	Kd	uM	9.0
	19159681	CHEMBL4382785	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 1 uM by Kinomescan method relative to control	B	C=CC(=O)Nc1cc(Nc2ncc(Cl)c(Nc3ccccc3S(=O)(=O)C(C)C)n2)c(OC)cc1N(C)CCN(C)C		CHEMBL4473365	=	Activity	%	1.0	CHEMBL4246	Homo sapiens	Activity	%	1.0
	19181156	CHEMBL4387367	Inhibition of tracer 178 binding to recombinant full length human His-tagged TEC expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay	B	CCN1CCN(Cc2ccc(Nc3ncc(F)c(-c4cc(F)c5nc(C)n(C(C)C)c5c4)n3)nc2)CC1		CHEMBL3301610	=	Inhibition	%	0.8	CHEMBL4246	Homo sapiens	INH	%	0.8
	19181381	CHEMBL4387367	Inhibition of tracer 178 binding to recombinant full length human His-tagged TEC expressed in baculovirus expression system at 0.1 uM measured after 60 mins by Lanthascreen assay	B	CCN1CC2(C1)CN(c1ccc(Nc3ncc(F)c(-c4cnn5c4[C@H](C)CCCC5)n3)nc1)C2		CHEMBL4545456	=	Inhibition	%	5.0	CHEMBL4246	Homo sapiens	INH	%	5.0
	19187552	CHEMBL4388559	Inhibition of probe binding to TEC (unknown origin) using rabbit reticulate lysate system at 250 nM after 1 hr by luminescence assay relative to control	B	CCOc1cc2ncc(C#N)c(Nc3ccc(OCc4cccc(F)c4)c(Cl)c3)c2cc1NC(=O)CC1CCSS1		CHEMBL4457447	=	Inhibition	%	20.0	CHEMBL4246	Homo sapiens	INH	%	20.0
	19191280	CHEMBL4389548	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system by Kinomescan method	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Kd	nM	420.0	CHEMBL4246	Homo sapiens	Kd	uM	0.42
	19191281	CHEMBL4389548	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system by Kinomescan method	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	>	Kd	nM	1000.0	CHEMBL4246	Homo sapiens	Kd	uM	1.0
	19191326	CHEMBL4389504	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@H]2CCCN(c3ncnc4[nH]ccc34)C2)c1)Nc1ccccc1N1CCCC1		CHEMBL4555459	=	Inhibition	%	73.0	CHEMBL4246	Homo sapiens	INH	%	73.0
	19192167	CHEMBL4389981	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	O=C(Nc1cccc([C@@H]2CN(c3ncnc4[nH]ccc34)CCN2CCO)c1)Nc1c(F)cccc1N1CCCC1		CHEMBL4564973	=	Inhibition	%	45.0	CHEMBL4246	Homo sapiens	INH	%	45.0
	19200423	CHEMBL4391607	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 10 uM by Kinomescan method relative to control	B	O=C(Nc1cc(-c2cn(CCNc3c4c(nc5ccccc35)CCCC4)nn2)ccn1)Nc1cccc2c1C1CCCCN1C2=O		CHEMBL4559936	=	Activity	%	93.0	CHEMBL4246	Homo sapiens	Activity	%	93.0
	19266639	CHEMBL4405589	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system at 1 uM by Kinomescan method relative to control	B	CC[C@H](Nc1nc(N)nc(C)c1C#N)c1nc2cccc(NCc3ccc(C(=O)NO)cc3)c2c(=O)n1-c1ccccc1		CHEMBL4455923	<	Inhibition	%	50.0	CHEMBL4246	Homo sapiens	INH	%	50.0
	19276149	CHEMBL4408152	Inhibition of activated recombinant human TEC (174 to end residues) at 1 uM using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma-33P]-ATP by scintillation counting method relative to control	B	Cc1ccc(NC(=O)C2(C(=O)Nc3ccc(Nc4ncc(F)c(-c5cc(F)c6nc(C)n(C(C)C)c6c5)n4)cc3)CC2)cc1		CHEMBL4445335	=	Inhibition	%	1.0	CHEMBL4246	Homo sapiens	INH	%	1.0
	19306054	CHEMBL4414915	Inhibition of TEC (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	2.0	CHEMBL4246	Homo sapiens	IC50	nM	2.0
	19306055	CHEMBL4414915	Inhibition of TEC (unknown origin) preincubated for 1 hr followed by Biotin-AVLESEEELYSSARQ-NH2 substrate addition in presence of ATP and measured after 1 hr by TR-FRET assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	0.57	CHEMBL4246	Homo sapiens	IC50	nM	0.57
	19306104	CHEMBL4414939	Inhibition of TEC phosphorylation in HEK293 cells peincubated for 3 hrs followed by pervanadate stimulation and measured after 20 mins by MSD assay	A	C=CC(=O)N1CCC([C@@H]2CCNc3c(C(N)=O)c(-c4ccc(Oc5ccccc5)cc4)nn32)CC1		CHEMBL3936761	=	IC50	nM	204.7	CHEMBL4246	Homo sapiens	IC50	nM	204.7
	19306105	CHEMBL4414939	Inhibition of TEC phosphorylation in HEK293 cells peincubated for 3 hrs followed by pervanadate stimulation and measured after 20 mins by MSD assay	A	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	46.7	CHEMBL4246	Homo sapiens	IC50	nM	46.7
	19310336	CHEMBL4416121	Binding affinity to wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual binding level at 10000 nM by Kinomescan method relative to control	B	CN(C)C/C=C/C(=O)Nc1cccc(-c2c(-c3ccccc3)oc3ncnc(N[C@H](CO)c4ccccc4)c23)c1		CHEMBL4521381	=	Activity	%	5.6	CHEMBL4246	Homo sapiens	Activity	%	5.6
	19432579	CHEMBL4429376	Inhibition of partial length human TEC expressed in bacterial system	B	Cc1c(-c2ccc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1cnc2ccccc2c1=O		CHEMBL3918580	=	IC50	nM	13.0	CHEMBL4246	Homo sapiens	IC50	uM	0.013
	20654610	CHEMBL4616778	Inhibition of TEC (unknown origin)	B	CC#CC(=O)N[C@H]1CCCN(c2c(F)cc(C(N)=O)c3[nH]c(C)c(C)c23)C1		CHEMBL4297674	=	IC50	nM	0.9	CHEMBL4246	Homo sapiens	IC50	nM	0.9
	22392177	CHEMBL4667272	Inhibition of tracer 178 binding to recombinant human His-tagged full length TEC expressed in baculovirus expression system at 10 uM incubated for 60 mins by Lanthascreen assay relative to control	B	CN1C(=O)[C@@H](NC(=O)c2n[nH]c3ncc(C(F)(F)C(F)(F)F)cc23)COc2ccccc21		CHEMBL4785812	=	Inhibition	%	-4.5	CHEMBL4246	Homo sapiens	INH	%	-4.5
	22418499	CHEMBL4672808	Inhibition of TEC (unknown origin)	B	Cc1c(-c2c(Cl)cc(C(N)=O)c3[nH]c4cc(C(C)(C)O)ccc4c23)cccc1-n1c(=O)cc2c(Cl)cccn2c1=O		CHEMBL3928976	=	IC50	nM	3.0	CHEMBL4246	Homo sapiens	IC50	nM	3.0
	22423197	CHEMBL4674174	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OC1CCCCC1		CHEMBL4785602	=	Activity	%	97.37	CHEMBL4246	Homo sapiens	Activity	%	97.37
	22423198	CHEMBL4674174	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate assessed as residual activity at 1 uM by [gamma-33P]-ATP assay relative to control	B	Nc1ncc(-c2cnc(C3CCNCC3)s2)cc1OCc1ccncc1		CHEMBL4749141	=	Activity	%	103.77	CHEMBL4246	Homo sapiens	Activity	%	103.77
	22823757	CHEMBL4717050	Inhibition of human TEC	B	C[C@H]1CC[C@@H](c2nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3F)c3c(N)nccn23)CN1C(=O)C1CC1		CHEMBL4103954	=	IC50	nM	63.0	CHEMBL4246	Homo sapiens	IC50	nM	63.0
	22823758	CHEMBL4717050	Inhibition of human TEC	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4F)c4c(N)nccn34)C2)COC1		CHEMBL4799627	=	IC50	nM	69.0	CHEMBL4246	Homo sapiens	IC50	nM	69.0
	22823759	CHEMBL4717050	Inhibition of human TEC	B	CC1(C(=O)N2CCC[C@@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)C2)COC1		CHEMBL4094125	=	IC50	nM	167.0	CHEMBL4246	Homo sapiens	IC50	nM	167.0
	22843543	CHEMBL4720529	Inhibition of human TEC using poly[Glu:Tyr] (4:1) as substrate by [gamma-33P]-ATP assay	B	CN[C@@H]1C[C@H]2O[C@@](C)([C@@H]1OC)n1c3ccccc3c3c4c(c5c6ccccc6n2c5c31)C(=O)NC4		CHEMBL388978	=	IC50	nM	24.6	CHEMBL4246	Homo sapiens	IC50	10^-8M	2.46
	22843887	CHEMBL4720873	Inhibition of human TEC assessed as residual activity using poly[Glu:Tyr] (4:1) as substrate at 1 uM by [gamma-33P]-ATP assay relative to control	B	O=C(Nc1cc2c(Nc3ccc(F)c(Cl)c3)ncnc2cc1OCCCN1CCOCC1)c1cc([N+](=O)[O-])ccc1F		CHEMBL4750196	=	Activity	%	97.4	CHEMBL4246	Homo sapiens	Activity	%	97.4
	22844881	CHEMBL4721556	Inhibition of wild-type human partial length TEC (L341 to D620 residues) expressed in bacterial expression system assessed as residual activity at 1 uM by Kinomescan method relative to control	B	CCOc1nc(Nc2ccc(C(=O)N3CCOCC3)cc2OC)nc2[nH]ccc12		CHEMBL4794578	=	Activity	%	99.33	CHEMBL4246	Homo sapiens	Activity	%	99.33
	22877422	CHEMBL4726193	Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assay	B	C=CC(=O)Nc1ccc2nccc(Oc3ccc(C(=O)Nc4cc(CC)ccn4)cc3)c2c1		CHEMBL4752700	=	IC50	nM	38.0	CHEMBL4246	Homo sapiens	IC50	nM	38.0
	22877423	CHEMBL4726193	Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assay	B	CC#CC(=O)Nc1cc2c(Oc3ccc(C(=O)Nc4ccccn4)cc3)ccnc2cc1OCCN1CCOCC1		CHEMBL4782725	=	IC50	nM	219.0	CHEMBL4246	Homo sapiens	IC50	nM	219.0
	22877424	CHEMBL4726193	Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assay	B	COc1cc2nccc(Oc3ccc(C(=O)Nc4ccccn4)cc3)c2cc1NC(=O)C#CCCN1CCOCC1		CHEMBL4755977	=	IC50	nM	184.0	CHEMBL4246	Homo sapiens	IC50	nM	184.0
	22877425	CHEMBL4726193	Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assay	B	C=CC(=O)N1CCC[C@@H](n2nc(-c3ccc(Oc4ccccc4)cc3)c3c(N)ncnc32)C1		CHEMBL1873475	=	IC50	nM	1.8	CHEMBL4246	Homo sapiens	IC50	nM	1.8
	22877426	CHEMBL4726193	Inhibition of His-tagged recombinant human TEC expressed in baculovirus expression system preincubated for 1 hr by Z'lyte assay	B	CC#CC(=O)N1CCC[C@H]1c1nc(-c2ccc(C(=O)Nc3ccccn3)cc2)c2c(N)nccn12		CHEMBL3707348	=	IC50	nM	29.0	CHEMBL4246	Homo sapiens	IC50	nM	29.0
	22882878	CHEMBL4727430	Inhibition of TEC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4COC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4749037	=	IC50	nM	92.0	CHEMBL4246	Homo sapiens	IC50	nM	92.0
	22882879	CHEMBL4727430	Inhibition of TEC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3)c12		CHEMBL4106978	=	IC50	nM	63.0	CHEMBL4246	Homo sapiens	IC50	nM	63.0
	22882880	CHEMBL4727430	Inhibition of TEC (unknown origin)	B	CC1(C)OC(=O)N2C[C@H](c3nc(-c4ccc(C(=O)Nc5cc(C(F)(F)F)ccn5)cc4)c4c(N)nccn34)CC[C@H]21		CHEMBL4108687	=	IC50	nM	27.0	CHEMBL4246	Homo sapiens	IC50	nM	27.0
	22882881	CHEMBL4727430	Inhibition of TEC (unknown origin)	B	COc1cc(C(=O)Nc2cc(C(F)(F)F)ccn2)ccc1-c1nc([C@@H]2CC[C@H]3CCC(=O)N3C2)n2ccnc(N)c12		CHEMBL4114929	=	IC50	nM	67.0	CHEMBL4246	Homo sapiens	IC50	nM	67.0
	22882882	CHEMBL4727430	Inhibition of TEC (unknown origin)	B	Nc1nccn2c([C@@H]3CC[C@H]4CCC(=O)N4C3)nc(-c3ccc(C(=O)Nc4cc(C(F)(F)F)ccn4)cc3OC3CC3)c12		CHEMBL4107779	=	IC50	nM	277.0	CHEMBL4246	Homo sapiens	IC50	nM	277.0
	23122838	CHEMBL4805189	Inhibition of human TEC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN1CCN(C(=O)c2ccc3cc(CCNc4ccnc5ccc(C#N)cc45)ccc3c2)CC1		CHEMBL4878072	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	23123533	CHEMBL4805777	Inhibition of human TEC assessed as percent of control at 1000 nM by KINOMEscan assay relative to control	B	COc1cc2nc(NC3CC3)nc(NC3CCN(C(C)C)CC3)c2cc1OC.O=C(O)C(F)(F)F		CHEMBL4870304	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	23123985	CHEMBL4806229	Inhibition of DNA-tagged human TEC assessed as percent of control at 50000 nM by qPCR analysis relative to control	B	CN1C(=O)/C(=C2/C(=O)Nc3ccccc32)c2ccccc21		CHEMBL607535	=	Activity	%	100.0	CHEMBL4246	Homo sapiens	Activity	%	100.0
	23125156	CHEMBL4806794	Inhibition of human TEC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	91.0	CHEMBL4246	Homo sapiens	Activity	%	91.0
	23125157	CHEMBL4806794	Inhibition of human TEC assessed as percent of control at 2000 nM by KINOMEscan assay relative to control	B	CN(C)C(=O)c1ccc(N2CCCN(c3ccnc4sc(C(N)=O)c(N)c34)CC2)cc1		CHEMBL2348350	=	Activity	%	81.0	CHEMBL4246	Homo sapiens	Activity	%	81.0
	23128635	CHEMBL4808020	Inhibition of TEC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)csc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL4867844	<	Activity	%	25.0	CHEMBL4246	Homo sapiens	Activity	%	25.0
	23128636	CHEMBL4808020	Inhibition of TEC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(Cl)ccnc3C)s2)cc(NN2CCN(CCO)CC2)n1		CHEMBL4855726	<	Activity	%	25.0	CHEMBL4246	Homo sapiens	Activity	%	25.0
	23128637	CHEMBL4808020	Inhibition of TEC (unknown origin) assessed as residual activity measured at 1 uM	B	Cc1nc(Nc2ncc(C(=O)Nc3c(C)cccc3Cl)s2)cc(N2CCN(CCO)CC2)n1		CHEMBL1421	<	Activity	%	25.0	CHEMBL4246	Homo sapiens	Activity	%	25.0
	23192954	CHEMBL4818915	Inhibition of recombinant human TEC (174 to end residues) using EFPIYDFLPAKKK as substrate incubated for 40 mins in presence of [gamma33P]ATP by scintillation counting method	B	C=CC(=O)N1CC[C@@H](NC(=O)c2sc3nccc4c3c2NC(=O)N4c2ccc(Oc3ccccc3)cc2C)C1		CHEMBL4851021	=	IC50	nM	409.0	CHEMBL4246	Homo sapiens	IC50	uM	0.409
	23209863	CHEMBL4822472	Inhibition of human TEC at 1 uM	B	Cc1nn(C(C)C)c(C)c1-c1nc2c(-c3ccc4c(c3)CCCC[C@H]4NC(=O)c3nc(C(C)(C)C)no3)ccnc2[nH]1		CHEMBL4877846	>	Inhibition	%	80.0	CHEMBL4246	Homo sapiens	INH	%	80.0
	23209898	CHEMBL4822495	Inhibition of human TEC	B	CN1CCN(c2ccc(Nc3cc(-c4cccc(-n5ccc6cc(C7CC7)cc(F)c6c5=O)c4CO)cn(C)c3=O)nc2)CC1		CHEMBL2057918	=	IC50	nM	5.69	CHEMBL4246	Homo sapiens	IC50	nM	5.69
	23291288	CHEMBL4839545	Inhibition of human recombinant Tec (174 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	-5.0	CHEMBL4246	Homo sapiens	INH	%	-5.0
	23291289	CHEMBL4839545	Inhibition of human recombinant Tec (174 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N	Outside typical range	CHEMBL4850154	=	Inhibition	%	-11.0	CHEMBL4246	Homo sapiens	INH	%	-11.0
	23291290	CHEMBL4839545	Inhibition of human recombinant Tec (174 to end) at 5 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	1.0	CHEMBL4246	Homo sapiens	INH	%	1.0
	23291360	CHEMBL4839569	Inhibition of human recombinant Tec (174 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	-10.0	CHEMBL4246	Homo sapiens	INH	%	-10.0
	23291361	CHEMBL4839569	Inhibition of human recombinant Tec (174 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N	Outside typical range	CHEMBL4850154	=	Inhibition	%	-20.0	CHEMBL4246	Homo sapiens	INH	%	-20.0
	23291362	CHEMBL4839569	Inhibition of human recombinant Tec (174 to end) at 50 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	10.0	CHEMBL4246	Homo sapiens	INH	%	10.0
	23291432	CHEMBL4839593	Inhibition of human recombinant Tec (174 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(Cl)cc2Cl)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4467948	=	Inhibition	%	-7.0	CHEMBL4246	Homo sapiens	INH	%	-7.0
	23291433	CHEMBL4839593	Inhibition of human recombinant Tec (174 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2ccc(OC(F)(F)F)cc2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N	Outside typical range	CHEMBL4850154	=	Inhibition	%	-15.0	CHEMBL4246	Homo sapiens	INH	%	-15.0
	23291434	CHEMBL4839593	Inhibition of human recombinant Tec (174 to end) at 500 nM by radiometric scintillation counting analysis relative to control	B	Cc1ccc(C(=O)Nc2cc(C(F)(F)F)cc(C(F)(F)F)c2)cc1C#Cc1cc(-c2cnn(C)c2)cnc1N		CHEMBL4862806	=	Inhibition	%	-3.0	CHEMBL4246	Homo sapiens	INH	%	-3.0
	23299133	CHEMBL4841677	Inhibition of TEC (unknown origin) at 1 uM relative to control	B	C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N		CHEMBL4864983	>	Inhibition	%	80.0	CHEMBL4246	Homo sapiens	INH	%	80.0
	23299135	CHEMBL4841679	Inhibition of TEC (unknown origin)	B	C=CC(=O)N1CCCC[C@H]1c1nc(-c2ccc(C(=O)Nc3cc(C(F)(F)F)ccn3)cc2)c(C(N)=O)n1N		CHEMBL4864983	=	IC50	nM	15.7	CHEMBL4246	Homo sapiens	IC50	nM	15.7
Not Active	23317674	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCC(=N\O)/C(C)=C/c1ccc(F)cc1		CHEMBL3697701		% Control	%	89.0	CHEMBL4246	Homo sapiens	% Control	%	89.0
Not Active	23318142	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCC(=N\O)/C(C)=C/c1ccc(F)c(C)c1		CHEMBL3701197		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23318808	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cn1cncc1[C@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4586794		% Control	%	93.0	CHEMBL4246	Homo sapiens	% Control	%	93.0
Not Active	23319292	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cn1cncc1[C@@](O)(COc1ccc(C#N)cc1-c1ccc(OC(F)(F)F)cc1)c1ccc(C#N)cc1		CHEMBL4526341		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23319928	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCCCN(CCCC)C(=O)CN1C[C@H](c2cc(OC)c3c(c2)OCO3)[C@@H](C(=O)O)[C@@H]1CC(C)(C)CCC		CHEMBL111612		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23320404	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCCCN(CCCC)C(=O)CN1C[C@@H](c2cc(OC)c3c(c2)OCO3)[C@H](C(=O)O)[C@H]1CC(C)(C)CCC		CHEMBL4513786		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23321082	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	c1ccc(N2CCN(Cc3nc4ccccc4[nH]3)CC2)nc1		CHEMBL440687		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23321550	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CSc1cccnc1N1CCN(Cc2nc3ccccc3[nH]2)CC1		CHEMBL4630641		% Control	%	90.0	CHEMBL4246	Homo sapiens	% Control	%	90.0
Not Active	23322180	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCCOc1ccc([C@H]2[C@H](C(=O)O)[C@@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL332794		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23322648	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCCOc1ccc([C@@H]2[C@@H](C(=O)O)[C@H](c3ccc4c(c3)OCO4)CN2CC(=O)Nc2c(CC)cccc2CC)cc1		CHEMBL4533479		% Control	%	96.0	CHEMBL4246	Homo sapiens	% Control	%	96.0
Not Active	23323337	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1ccc2c(c1)O[C@@H](c1ccc(OC)c(OC)c1)C[C@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4093612		% Control	%	89.0	CHEMBL4246	Homo sapiens	% Control	%	89.0
Not Active	23323805	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1ccc2c(c1)O[C@H](c1ccc(OC)c(OC)c1)C[C@@H]2NC(=O)C1(c2ccc3c(c2)OC(F)(F)O3)CC1		CHEMBL4066040		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23324659	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC1=C(C#N)[C@@H](c2ccc3[nH]nc(C)c3c2)C(C#N)=C(c2ccc(Cl)cc2)N1		CHEMBL4522773		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23325294	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@H]1CC[C@@H](Cn2nnc3ccccc3c2=O)[C@@H]1C(=O)O		CHEMBL4585243		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23325762	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(c1ccc(OCCC2CCOCC2)cc1)[C@@H]1CC[C@H](Cn2nnc3ccccc3c2=O)[C@H]1C(=O)O		CHEMBL4539943		% Control	%	95.0	CHEMBL4246	Homo sapiens	% Control	%	95.0
Not Active	23326409	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	NS(=O)(=O)c1cc(NC(=O)Cc2ccccc2)ccc1Oc1cccc(Cl)c1		CHEMBL4521594		% Control	%	96.0	CHEMBL4246	Homo sapiens	% Control	%	96.0
Not Active	23326877	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	NS(=O)(=O)c1cc(NC(=O)C2(c3ccccc3Cl)CC2)ccc1Oc1cccc(Cl)c1		CHEMBL4516843		% Control	%	81.0	CHEMBL4246	Homo sapiens	% Control	%	81.0
Not Active	23327577	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4537788		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23328045	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(NCc1ncc(C(F)(F)F)cc1Cl)c1ccc2c(c1)C1(CCS(=O)(=O)CC1)[C@@H](C1CC1)N2S(=O)(=O)c1ccc(F)cc1		CHEMBL4564312		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23328632	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C#N)cc1		CHEMBL4448899		% Control	%	85.0	CHEMBL4246	Homo sapiens	% Control	%	85.0
Not Active	23329100	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1c(NC(=O)c2cc(C(N)=O)nc3cc(F)ccc23)c(C(F)(F)F)nn1Cc1ccc(C(C)(C)C)cc1		CHEMBL4552180		% Control	%	94.0	CHEMBL4246	Homo sapiens	% Control	%	94.0
Not Active	23329549	CHEMBL4881256	Tec(h) activated Eurofins Kinase panel	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% residual kinase activity	%	112.0	CHEMBL4246	Homo sapiens	% residual kinase activity	%	112.0
Not Active	23330046	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN1CCN(c2cnc3c(C4CCN(C(=O)c5ccc(OC(F)(F)F)cc5N)CC4)ncnc3c2)CC1		CHEMBL4445670		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23330514	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1nc(C2CCN(C(=O)c3ccc(OC(F)(F)F)cc3N)CC2)c2ncc(N3CCN(C)CC3)cc2n1		CHEMBL4455582		% Control	%	96.0	CHEMBL4246	Homo sapiens	% Control	%	96.0
Not Active	23331270	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(N1CCS(=O)(=O)CC1)N1C[C@H](c2ccc(OC(F)(F)F)cc2)C[C@H](c2nc(C3CC3)no2)C1		CHEMBL4630644		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23331738	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1noc([C@H]2C[C@@H](c3ccc(C(F)(F)F)cc3)CN(C(=O)N3CCS(=O)(=O)C3)C2)n1		CHEMBL4630643		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23332325	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1cc(C)c(-n2ccn3nc(-c4cccnc4)cc23)cc1NC(=O)c1cc(C#N)cc(S(F)(F)(F)(F)F)c1		CHEMBL3907057		% Control	%	88.4	CHEMBL4246	Homo sapiens	% Control	%	88.4
Not Active	23332791	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1cc(NC(=O)c2cccc(S(F)(F)(F)(F)F)c2)cc(-n2ccn3nc(-c4cccnc4)cc23)c1		CHEMBL4526351		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23333509	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(=O)C1=C(C)N(c2cccc(C(F)(F)F)c2)C(=O)N[C@@H]1c1ccc(C#N)nc1		CHEMBL3617968		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23334148	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CNCc1ccccc1-c1csc([C@@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4535474		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23334616	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CNCc1ccccc1-c1csc([C@H](C)Nc2nc(C)nc3cc(OC)c(OC)cc23)c1		CHEMBL4520788		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23335595	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1c[nH]c2nccc(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)c12		CHEMBL1971943		% Control	%	86.0	CHEMBL4246	Homo sapiens	% Control	%	86.0
Not Active	23336063	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cn1cc(Cl)c2c(Oc3c(F)cc(Nc4cc(Cl)nc(N)n4)cc3F)ccnc21		CHEMBL4546802		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23336690	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(NC[C@H]1[C@@H]2CN(C(=O)OCc3cc(C(F)(F)F)cc(C(F)(F)F)c3)C[C@H]12)c1ccc2[nH]nnc2c1		CHEMBL4165749		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23337158	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1nccc(COC(=O)N2C[C@H]3[C@H](CNC(=O)c4ccc5[nH]nnc5c4)[C@H]3C2)n1		CHEMBL4552354		% Control	%	94.0	CHEMBL4246	Homo sapiens	% Control	%	94.0
Not Active	23337796	CHEMBL4882167	TEC Invitrogen selectivity data (BI)	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Ctrl	%	103.0	CHEMBL4246	Homo sapiens	% Ctrl	%	103.0
Not Active	23338239	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN(C)C(=O)Cn1cc(-c2nc([C@@](C)(c3ccc(-c4cnc(N)nc4)cc3)C3CC3)no2)cn1		CHEMBL3417525		% Control	%	93.0	CHEMBL4246	Homo sapiens	% Control	%	93.0
Not Active	23338707	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN(C)C(=O)Cn1cc(-c2nc(C3(c4ccc(-c5cnc(N)nc5)cc4)CC3)no2)cn1		CHEMBL4560241		% Control	%	93.0	CHEMBL4246	Homo sapiens	% Control	%	93.0
Not Active	23339319	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCS(=O)(=O)c1cc2cc(C[C@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL3358954		% Control	%	90.0	CHEMBL4246	Homo sapiens	% Control	%	90.0
Not Active	23339787	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCS(=O)(=O)c1cc2cc(C[C@@](O)(CC(C)(C)c3ccc(F)cc3C(N)=O)C(F)(F)F)[nH]c2cn1		CHEMBL4531220		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23340424	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CS(=O)(=O)c1cc(C2(NC(=O)c3cncc4c3cnn4-c3ccc(F)cc3)CC2)ccn1		CHEMBL4456123		% Control	%	99.0	CHEMBL4246	Homo sapiens	% Control	%	99.0
Not Active	23340892	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CS(=O)(=O)NCC[C@H](NC(=O)c1cncc2c1cnn2-c1ccc(F)cc1)c1ccnc(S(C)(=O)=O)c1		CHEMBL4539555		% Control	%	96.0	CHEMBL4246	Homo sapiens	% Control	%	96.0
Not Active	23341549	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(=O)N1CCC(c2ccc(C(=O)NC(=N)N)cc2C(F)(F)F)CC1		CHEMBL2170610		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23342017	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(=O)N1CCC(c2ccc(C(=O)NC3=NCCN3)cc2C(F)(F)F)CC1		CHEMBL4540759		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23342633	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCC(=O)N[C@H]1CC[C@@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834184		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23343101	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCC(=O)N[C@@H]1CC[C@H](C(=O)N(C)c2ccc(-c3nc4ccccc4o3)cc2)C1		CHEMBL1834199		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23343731	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCOC(=O)c1cc2cc(-c3cc(C(=O)NCc4ccc(C(=O)O)cc4)nn3C)ccc2[nH]1		CHEMBL1939876		% Control	%	99.0	CHEMBL4246	Homo sapiens	% Control	%	99.0
Not Active	23344199	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cn1nc(C(=O)NCc2ccc(C(=O)O)cc2)cc1-c1ccc2[nH]ccc2c1		CHEMBL1939880		% Control	%	89.0	CHEMBL4246	Homo sapiens	% Control	%	89.0
Not Active	23344837	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCOCCn1cc(C(=O)Nc2ccc(-n3nc(-c4cccnc4)cc3C(F)(F)F)cn2)ccc1=O		CHEMBL4516982		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23345410	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1ccc2c(O[C@@H]3C[C@H]4C(=O)N[C@]5(C(=O)O)CC5/C=C\CCCCC[C@H](NC(=O)OC5CCCC5)C(=O)N4C3)cc(-c3csc(NC(=O)C(C)C)n3)nc2c1C		CHEMBL4588900		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23345878	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(N[C@H]1CCCCC/C=C\C2C[C@@]2(C(=O)O)NC(=O)[C@@H]2C[C@@H](Oc3ccncc3)CN2C1=O)OC1CCCC1		CHEMBL4516471		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23346454	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1cc(Nc2nccc(C)n2)cc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)c1		CHEMBL3685796		% Control	%	75.2	CHEMBL4246	Homo sapiens	% Control	%	75.2
Not Active	23346923	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1ccc(-c2cnc([C@@]3(O)CC[C@H](C(=O)O)C(C)(C)C3)s2)cc1Nc1cccc(C(F)(F)F)n1		CHEMBL4530401		% Control	%	91.2	CHEMBL4246	Homo sapiens	% Control	%	91.2
Not Active	23347523	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccc1		CHEMBL4538174		% Control	%	93.6	CHEMBL4246	Homo sapiens	% Control	%	93.6
Not Active	23348015	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H](NC(=O)Nc1cc2[nH]ncc2c(CO)n1)c1ccccn1		CHEMBL4557026		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23348594	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(=O)Nc1c(C(C)=O)c(=O)n(C)c2nc(-c3ccc(Cl)cc3Cl)c(-c3ccc(Cl)cc3)cc12		CHEMBL204232		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23349062	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(=O)c1c(NS(C)(=O)=O)c2cc(-c3ccc(Cl)cc3)c(-c3ccc(Cl)cc3Cl)nc2n(C)c1=O		CHEMBL4578164		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23349649	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=S(=O)(NC1CCC(c2cc(F)ccc2F)(S(=O)(=O)c2ccc(Cl)cc2)CC1)C(F)(F)F		CHEMBL1091513		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23350267	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1cc(-c2cn(C3CCc4c(F)cccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1cnc(C)c1		CHEMBL3609637		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23350735	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1cc(-c2cn(C3CCc4ccccc4N(CC(F)(F)F)C3=O)nn2)ccc1-n1ccc(C)n1		CHEMBL4534005		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23351340	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN([C@@H]1CCc2c(CC(=O)O)c3ccccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL561132		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23351808	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN([C@@H]1CCc2c(CC(=O)O)c3cc(S(C)(=O)=O)ccc3n2C1)S(=O)(=O)c1ccc(F)cc1		CHEMBL1643772		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23352247	CHEMBL4882936	TEC Kinase screen	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		Inhibition	%	-2.099	CHEMBL4246	Homo sapiens	% Inhibition	%	-2.0988
Not Active	23352832	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H]1CN(c2cc(-c3n[nH]c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4098877		% Control	%	74.0	CHEMBL4246	Homo sapiens	% Control	%	74.0
Not Active	23353300	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H]1CN(c2cc(-c3nn(C)c4ccc(OC5(C)CC5)cc34)ncn2)C[C@@H](C)O1		CHEMBL4560589		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23354182	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(O)c1cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc2c1		CHEMBL1800685		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23354650	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1c(C(=O)O)cc(-c2ccc(C3CCNCC3)cc2)c2ccc(-c3ccc(C(F)(F)F)cc3)cc12		CHEMBL4566600		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23355382	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COCCOc1nc(-c2ccc(Cl)nc2)nc2c1CN(C(=O)c1ncn3ccccc13)CC2		CHEMBL2204538		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23355850	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(C)CC(=O)N1CCc2nc(-c3ccc(Br)cc3)nc(N(C)Cc3ccccc3)c2C1		CHEMBL4518342		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23356486	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC(C)(O)c1cncc(-c2nc3ccc(F)cc3n2C2CC2)c1		CHEMBL3582478		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23356954	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	FC(F)(F)c1ccc2c(c1)nc(-c1cccnc1)n2C1CC1		CHEMBL3582461		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23357563	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H](c1ccc(F)cc1)N(Cc1cccc(C(=O)O)c1)C(=O)c1cnc2ccccc2c1		CHEMBL3577885		% Control	%	80.0	CHEMBL4246	Homo sapiens	% Control	%	80.0
Not Active	23358210	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(Nc1cccnn1)N1CCC(=Cc2cccc(Oc3ccc(C(F)(F)F)cn3)c2)CC1		CHEMBL1651534		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23358678	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(Nc1cccnn1)N1CC(C/C=C/c2cncc(Oc3ccc(C(F)(F)F)cn3)n2)C1		CHEMBL4780458		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23359264	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1cccc(CNC(=O)c2nc3scc(COCc4ccc(C(=O)O)cc4)c3c(=O)[nH]2)c1		CHEMBL3337894		% Control	%	86.0	CHEMBL4246	Homo sapiens	% Control	%	86.0
Not Active	23359862	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3799292		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23360330	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@@H](c1cccc(C#N)c1)n1cc(Cl)cc(C(N)=O)c1=N		CHEMBL3797887		% Control	%	88.0	CHEMBL4246	Homo sapiens	% Control	%	88.0
Not Active	23360915	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cn1nc(C(F)(F)F)cc1-c1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4455357		% Control	%	79.0	CHEMBL4246	Homo sapiens	% Control	%	79.0
Not Active	23361383	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Nc1cnc(N2CCc3cc(S(=O)(=O)Nc4c(F)cc(Cl)cc4F)cc(N4CCCC4=O)c32)nc1		CHEMBL4585920		% Control	%	99.0	CHEMBL4246	Homo sapiens	% Control	%	99.0
Not Active	23361956	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1nc(N2CC[C@@H](O)C2)ncc1-c1cc(C(F)(F)F)cc2[nH]ncc12		CHEMBL3799512		% Control	%	84.0	CHEMBL4246	Homo sapiens	% Control	%	84.0
Not Active	23362492	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1cc(-n2nc(Cc3cc(F)cc(C(F)(F)F)c3)nc2C)ccc1C(N)=O		CHEMBL4082756		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23362960	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1nc(Cc2cccc(C(F)(F)F)c2)sc1-c1ccc(C(N)=O)nc1		CHEMBL4100408		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23364602	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CO[C@H]1CC[C@H](CNc2ccc(S(=O)(=O)NC(=O)c3ccc(N4CCN(CC5=C(c6ccc(Cl)cc6)CC(C)(C)CC5)CC4)cc3Oc3cnc4[nH]ccc4c3)cc2[N+](=O)[O-])CC1		CHEMBL4228713		% Control	%	74.0	CHEMBL4246	Homo sapiens	% Control	%	74.0
Not Active	23365070	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(NS(=O)(=O)c1ccc(NCC2CCOCC2)c([N+](=O)[O-])c1)c1ccc(N2CCN(Cc3ccc(C(F)(F)F)cc3-c3ccc(Cl)cc3)CC2)cc1Oc1cnc2[nH]ccc2c1		CHEMBL4551344		% Control	%	71.0	CHEMBL4246	Homo sapiens	% Control	%	71.0
Not Active	23365809	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN(C)CC#Cc1ccc(OCCCc2sc(N3CCc4cccc(C(=O)Nc5nc6ccccc6s5)c4C3)nc2C(=O)O)c(F)c1		CHEMBL3342332		% Control	%	97.0	CHEMBL4246	Homo sapiens	% Control	%	97.0
Not Active	23366352	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Cc1c(Oc2c(F)cccc2F)c(OC(C)C)nn1-c1ncc(C2CC2)cc1F		CHEMBL3589752		% Control	%	89.0	CHEMBL4246	Homo sapiens	% Control	%	89.0
Not Active	23366942	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	Nc1c(C(=O)NCc2ccc(C(=O)NCCCC3CCCCC3)cc2)cnn1-c1ccccc1		CHEMBL4436748		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23367410	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(NCCCC1CCCCC1)c1ccc(CNC(=O)c2cnn(-c3ccccc3)c2C(F)(F)F)cc1		CHEMBL4531775		% Control	%	94.0	CHEMBL4246	Homo sapiens	% Control	%	94.0
Not Active	23367762	CHEMBL4884115	TEC ProQinase selectivity panel	B	O=C1c2ccc(Nc3ccc(F)cc3F)cc2CCc2ccc(OC[C@H](O)CO)cc21		CHEMBL2152944		% Residual activity with Skepinone-L	%	115.0	CHEMBL4246	Homo sapiens	% Residual activity with Skepinone-L	%	115.0
Not Active	23368288	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(Nc1cnc(Oc2ccc(F)cc2)nc1)N1CCc2ncccc2[C@@H]1c1ccc(F)cc1		CHEMBL4458424		% Control	%	89.0	CHEMBL4246	Homo sapiens	% Control	%	89.0
Not Active	23368756	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C(Nc1ccc(Oc2ccc(F)cc2)cc1)N1CCc2ncccc2[C@H]1c1ccc(F)cc1		CHEMBL4592872		% Control	%	86.0	CHEMBL4246	Homo sapiens	% Control	%	86.0
Not Active	23369355	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H](c1ccnc(Nc2nc3ccc(-c4cc(N(C)C)ncn4)cc3[nH]2)c1)N1CCN(C(=O)CC(F)(F)F)CC1		CHEMBL4537673		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23369823	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN(C)c1ncnc(-c2ccc3nc(Nc4cc(CN5CCN(C(=O)CC(F)(F)F)CC5)ccn4)[nH]c3c2)c1Cl		CHEMBL4538591		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23370259	CHEMBL4884498	Tec(h) activated Eurofins kinase panel	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% residual kinase activity	%	100.0	CHEMBL4246	Homo sapiens	% residual kinase activity	%	100.0
Not Active	23370791	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CCc1ccccc1C(=O)Nc1n[nH]c2c(C)c(F)c(C3C(C#N)=C(C)N(C)C(C)=C3C#N)cc12		CHEMBL4580220		% Control	%	91.0	CHEMBL4246	Homo sapiens	% Control	%	91.0
Not Active	23371259	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CC1=C(C#N)C(c2ccc3c(c2)c(NC(=O)c2ccccc2C)nn3C)C(C#N)=C(C)N1		CHEMBL4630642		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23372068	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNC(=O)c3cnc4ccccn34)cc2)C1		CHEMBL4591082		% Control	%	94.0	CHEMBL4246	Homo sapiens	% Control	%	94.0
Not Active	23372536	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CS(=O)(=O)N1CCCC(NC(=O)[C@H](CCC2CCCCC2)NC(=O)c2ccc(CNc3ncnc4c3nnn4-c3ccccc3)cc2)C1		CHEMBL4568183		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
	23372912	CHEMBL4884877	TEC(TEC1CGD1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(Cc4ccccc4)nc3C2=O)COc2ccccc21		CHEMBL4088216		IC50	nM	1000.0	CHEMBL4246	Homo sapiens	pIC50		6.0
	23373321	CHEMBL4885168	TEC(TEC1CGD1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3c(nn(Cc4ccccc4)c3Br)C2=O)COc2ccccc21		CHEMBL4549667		IC50	nM	1000.0	CHEMBL4246	Homo sapiens	pIC50		6.0
	23373675	CHEMBL4885452	TEC(TEC1CGD1) Takeda global kinase panel	B	CN1C(=O)[C@@H](N2CCc3cn(CC4CCS(=O)(=O)CC4)nc3C2=O)COc2ccccc21		CHEMBL4097778		IC50	nM	1000.0	CHEMBL4246	Homo sapiens	pIC50		6.0
Not Active	23375114	CHEMBL4886101	TEC Kinase panel	B	CC(C)(O)[C@H](F)CN1Cc2cc(NC(=O)c3cnn4cccnc34)c(N3CCOCC3)cc2C1=O		CHEMBL4475494		Inhibition	%	0.5	CHEMBL4246	Homo sapiens	% Inhibition	%	0.5
Not Active	23375393	CHEMBL4886375	tec protein tyrosine kinase (activated) Millipore kinase panel	B	COCCc1ccc(-c2c(C)nc3c(N4CCOCC4)ccnn23)cn1		CHEMBL2180408		Inhibition	%	7.0	CHEMBL4246	Homo sapiens	% inhibition	%	7.0
Not Active	23375963	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C1CCc2cc(Nc3cc(OC4CCOCC4)c([N+](=O)[O-])cc3Cl)ccc2N1		CHEMBL4075278		% Control	%	82.0	CHEMBL4246	Homo sapiens	% Control	%	82.0
Not Active	23376431	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	N#Cc1ccc(Nc2ccc3[nH]c(=O)[nH]c3c2)c(Cl)c1		CHEMBL4063249		% Control	%	96.0	CHEMBL4246	Homo sapiens	% Control	%	96.0
Not Active	23377008	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=c1nc(-c2ccccn2)sc2ccccc12		CHEMBL4516611		% Control	%	82.0	CHEMBL4246	Homo sapiens	% Control	%	82.0
Not Active	23377476	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	O=C1NC(c2ccccn2)Sc2ccccc21		CHEMBL4561806		% Control	%	75.0	CHEMBL4246	Homo sapiens	% Control	%	75.0
Not Active	23378336	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CNC(=O)Nc1ccc2c(c1)CC[C@@]21OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4282264		% Control	%	90.0	CHEMBL4246	Homo sapiens	% Control	%	90.0
Not Active	23378804	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CNC(=O)Nc1ccc2c(c1)[C@@]1(CC2)OC(=O)N(CC(=O)N(Cc2ccc(F)cc2)[C@@H](C)C(F)(F)F)C1=O		CHEMBL4536197		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23379971	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)O)c(=O)n3ccccc23)CC1		CHEMBL1800285		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23380439	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	N#CC1(c2ccccn2)CCN(Cc2cc(C(=O)N3CCCC3)c(=O)n3ccccc23)CC1		CHEMBL2204283		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23381133	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	COc1ccc2cc(OCC3(C(=O)O)CN(C(=O)c4ccc(F)cc4)C3)ccc2c1		CHEMBL3286797		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23381781	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@H](NC(=O)c1cnc2n1[C@](C)(Cc1ccc(C#N)cc1)C(=O)N2c1cc(Cl)c(F)c(Cl)c1)C(=O)NC1(c2ccccn2)CC1		CHEMBL4530740		% Control	%	75.0	CHEMBL4246	Homo sapiens	% Control	%	75.0
Not Active	23382249	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	C[C@@]1(Cc2ccc(C#N)cc2)C(=O)N(c2cc(Cl)cc(Cl)c2)c2ncc(C(=O)NC3(c4nc(C5CCC5)no4)CC3)n21		CHEMBL4577237		% Control	%	92.0	CHEMBL4246	Homo sapiens	% Control	%	92.0
Not Active	23382873	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CNC(=O)c1ccc(Nc2ncc(C(F)(F)F)c(NCc3nccnc3N(C)S(C)(=O)=O)n2)cc1		CHEMBL3137331		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23383341	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CN(c1ccnc(CNc2nc(Nc3ccc4c(c3)CC(=O)N4)ncc2C(F)(F)F)n1)S(C)(=O)=O		CHEMBL4518706		% Control	%	100.0	CHEMBL4246	Homo sapiens	% Control	%	100.0
Not Active	23384013	CHEMBL4887612	TEC Invitrogen Lab (UK) kinase screen (BI)	B	CCC(F)(F)c1cc(N2CCC(S(C)(=O)=O)CC2)nc2sc(C(N)=O)c(N)c12		CHEMBL4522930		% Ctrl	%	96.0	CHEMBL4246	Homo sapiens	% Ctrl	%	96.0
Not Active	23384487	CHEMBL4888082	Tec(h) activated Millipore kinase panel	B	CC[C@@H](Nc1c(C#N)c(-c2ccc(-c3cccc(C)c3F)cc2)nc2cnccc12)C(=O)O		CHEMBL4802045		Inhibition	%	4.62	CHEMBL4246	Homo sapiens	% inhibition	%	4.62
Not Active	23385256	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CO[C@@H](C)c1c(Nc2ccc([C@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4568735		% Control	%	84.0	CHEMBL4246	Homo sapiens	% Control	%	84.0
Not Active	23385723	CHEMBL4879980	KinomeScan assay: inhibition of TEC	B	CO[C@@H](C)c1c(Nc2ccc([C@@H](N(C)C(=O)C3CCS(=O)(=O)CC3)C(F)(F)F)cc2)cnc2cc(Cl)nn12		CHEMBL4584981		% Control	%	82.0	CHEMBL4246	Homo sapiens	% Control	%	82.0
